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ABSTRACT 
Hepatitis 8 virus (HBV) causes acute liver inflammation that apparently 
resolves completely or advances to chronic hepatitis, cirrhosis and hepatocellular 
carcinoma. These differential outcomes of HBV infection are orchestrated to a 
large extent by the virus-specific T cell responses, which characteristically appear 
late after exposure to hepadnavirus. In this context, the objective of this study 
was to delineate the kinetics and understand inter-relationships between virus-
specific and non-specific T cell proliferative, humoral as well as innate cytokine 
responses, along with serological and molecular markers of hepadnaviral 
infection induced after exposure and re-exposure to liver pathogenic or 
nonpathogenic doses of woodchuck hepatitis vi rus (WHV). Our results revealed 
that infection of woodchucks with either a liver pathogenic (>1 03 virions) or 
nonpathogenic (<1 03 virions) dose of WHV induced strong , but delayed, virus-
specific T cell responses with comparable kinetics. Interestingly, immediately 
after exposure to virus , the non-specific proliferative capacity of lymphocytes in 
response to mitogenic stimulation was heightened and then subsided preceding 
the appearance of WHV-specific T cell response. This augmented non-specific 
proliferative reactivity was accompanied by the increased expression of 
interferon-alpha (IFN-a) , interleukin-12 (IL-12) and IL-2 in circulating lymphoid 
cells; while its decline was associated with activation-induced cell death of 
lymphocytes. Importantly, the postponement of virus-specific T cell response 
coincided with the absence of TN F-a expression , while its rise was marked by 
synchronously elevated expression of TN F-a, IFN-a, IFN-y, IL-2, IL-12, and IL-10 
in lymphoid cells. Nonetheless, the virus-specific T cell responses induced during 
low-dose (occult) infection, in contrast to infection caused by liver pathogenic 
dose, did not provide protection against viral hepatitis. 
We conclude that hepadnavirus infections induce delayed virus-specific T 
cell proliferative responses irrespective of the dose of invading virus and 
symptomatic or asymptomatic outcome of the infection. This postponement of 
anti-viral T cell responses is preceded by the aberrant activation of lymphocyte 
and innate cytokine responses. Such an impaired activation of immune 
responses following hepadnavirus infection represents a possible mechanism 
that allows evasion of initial clearance and subsequent elimination of virus, 
permits its dissemination, and contributes to the establishment of persistence. 
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CHAPTER 1: INTRODUCTION 
1.1 HISTORICAL BACKGROUND OF VIRAL HEPATITIS 
In the 1940s, a British liver disease specialist, Dr. F.O. MacCallum, coined 
the term "hepatitis B" for the form of a liver disease which was transmitted 
through exposure to contaminated blood. The infectious agent which caused this 
form of hepatitis, later named as hepatitis B virus (HBV), was accidently 
discovered by Dr. Baruch Blumberg's laboratory in 1967 while studying the 
inherited genetics of disease susceptibility (Blumberg, 2002). He and his 
colleagues found a protein antigen in the serum of an Australian aborigine which 
reacted with the antibodies from a hemophiliac patient convalescent from 
hepatitis who had received multiple blood transfusions. This protein, which was 
named as an Australia (Au) antigen, is now recognized as a HBV envelope 
protein that carries reactivity of the virus surface antigen (HBsAg). Further in 
1969, Dr. Blumberg along with Dr. I riving Millman isolated HBsAg particles from 
the serum of HBV-infected patients and used it for successful immunization of 
high-risk patients. This finding laid the foundation of the modern day anti-HBV 
vaccine. For his work on HBV, Dr. Blumberg received a Nobel Prize in 1976. 
In 1970, using blood from HBV-infected patients, Dr. David Dane 
distinguished 42-nm viral particles (known as "Dane particles") containing the 
HBV genome, as opposed to 22-nm non-infectious, subviral particles discovered 
by Blumberg. These Dane particles were further identified to be HBV virions. 
These findings prompted the constitution of new laws in 1972 in the United 
States and other countries regarding the screening of donor blood for the 
presence of HBsAg. In 1982-1984, Dr. Hilleman and colleagues produced the 
first subunit vaccine using HBsAg isolated from serum of HBV-infected 
individuals . Later, between 1983 and 1986, Dr. Router and colleagues 
developed the first recombinant subunit vaccine in yeast, which was capable of 
inducing protective immunity against HBV infection. These hallmark studies and 
numerous others in the following years dissected the molecular structure of HBV 
and identified this virus as an etiological agent of acute and chronic viral hepatitis 
type B, and further associated this viral infection with the development of primary 
liver cancer, hepatocellular carcinoma (HCC) . 
1.2 EPIDEMIOLOGY OF HBV INFECTION 
HBV infection causes acute and chronic hepatitis, persistent 
asymptomatic (occult) infection, cirrhosis and HCC. It is the tenth leading cause 
of deaths worldwide. As reported by the World Health Organization (WHO) in 
2004, 2 billion people in the world are infected with HBV, out of which more than 
370 million people are serum HBsAg-positive chronic carriers of the virus 
(Lavanchy, 2004). It is estimated that each year more than 4 million clinical 
cases of acute HBV infection are reported , while approximately 1 million people 
die from liver failure due to chronic hepatitis, cirrhosis or liver cancer. 
The highest prevalence of HBV infection is in the developing countries of 
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Asia and Africa, where the incidence of serum HBsAg-positive infection is as high 
as 1 0-15% of the entire population. Based on the percentile of people that are 
serum HBsAg-positive, the worldwide HBV prevalence is classified into three 
categories: high (8% and above), intermediate (2 - 8%), and low (less than 2%). 
Only 12% of people worldwide live in the areas where HBV endemicity is low, 
while 45% and 43% of people live in intermediate and high endemic areas, 
respectively (WHO report, 2004). In Western countries, the infection is relatively 
infrequent and is acquired mostly during adulthood, while in parts of Asia and 
Africa, it is usually acquired perinatally (Lavanchy, 2004). 
HBV is classified into 8 genotypes (A-H) depending on intergroup genome 
sequence divergence of 8% or more. Each genotype has a distinct geographical 
distribution. Genotype A, F, G and H are more prevalent in Europe and North 
America, while genotype B, C and A, Dare the major genotypes seen in China 
and Southeast Asia, respectively. Genotype E is mostly observed in West Africa. 
In Canada, pertaining to the heterogeneity of the population, the rate of 
HBV prevalence has been estimated between 0.5 to 1.0 %. The highest rate (6-
7%) of HBsAg positivity is observed in immigrants and lnnuits, intermediate (0.3-
0.6%) between First nations, adolescents, STD clinic visitors and residents of 
long-term care facilities, and the lowest amongst the general population (Zang el 
a!, 2001). 
A safe and effective vaccine against HBV has been available since 1982, 
and its global implementation in mass immunization has helped in decreasing the 
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rate of hepatitis 8 prevalence in some countries. The efficacy of anti-HBV 
vaccination has been demonstrated in a population-based study performed in 
Taiwan (Hsu eta/., 1999), when mass immunization reduced the serum HBsAg 
occurrence from 10% to 1 %. Unfortunately, despite the availability of a vaccine 
for more than two decades, the global reservoir of HBV-infected people is 
growing, most likely due to the limited access to this relatively expensive vaccine 
and socioeconomic conditions. 
The transmission of HBV occurs through contaminated blood and blood 
products (percutaneous), from infected mothers to babies (perinatal) , via 
unprotected sexual contacts, and using unsterilized medical devices and 
needles. Since HBV is transmitted through contaminated blood products, the 
testing of blood donors for the presence of HBsAg, antibodies to HBV core 
antigen (anti-HBc) , and most recently , HBV DNA has become mandatory in 
many countries. 
Most adults (80-90%) resolve acute hepatitis B (AH) , while the remaining 
10-15% develop chronic hepatitis B (CH). Diagnosis ofCH is based on the 
presence of HBsAg in serum for more than 6 months. Patients with CH are 100-
200 times more likely to develop HCC than their healthy counterparts (Beasley el 
a/. , 1981). In contrast, children who acquire HBV infection perinatally or during 
early childhood develop CH at a very high rate (80-90%). Nonetheless, it has 
become evident in recent years that the individuals who acquire HBV infection 
become carriers of the virus for their life-time irrespective of the outcome of 
serologically evident infection and hepatitis . The individuals who recover from 
AH harbor low levels of virus for decades in the liver as well as in the lymphatic 
system (Michalak eta/. , 1994, Rehermann eta/., 1996, Yuki el a/. , 2003, 
Raimando eta/., 2006, Michalak, 2007). 
1.3 HBV AND OTHER MEMBERS OF HEPADNAVIRUS FAMILY 
H8V belongs to a family of hepatotropic viruses called Hepadnaviridae. 
The name "hepadnaviridae" is derived from the latin word 'hepa' meaning liver 
and pertains to the liver tropism of this group of DNA viruses. The hepadnavirus 
family contains two genera, namely Orthohepadnaviridae and 
Avihepadnaviridae. HBV is a prototype of mammalian hepadnaviruses, which 
also include other viruses, such as woodchuck hepatitis virus (WHV) (Summers 
eta/. , 1978), ground squirrel hepatitis virus (GSHV) (Marion el a/., 1980) and 
arctic squirrel hepatitis virus (ASHV) (Testut el a/. , 1996). On the other hand, 
duck hepatitis 8 virus (DH8V) (Mason el a/., 1980), heron hepatitis 8 virus 
(HH8V) (Sprengel el a/. , 1988) and Ross' and snow goose hepatitis 8 virus 
(RGH8V and SGH8V, respectively) belong to genus Avihepadnaviridae (Chang 
eta/., 1999). 
The members of Orthohepadnaviridae genus, H8V and WHV, both have a 
very narrow host range. Thus, HBV infects humans, chimpanzees, African green 
monkeys and , rhesus and woolly monkeys, while WHV infects woodchucks 
(Marmota monax) and ground squirrels. 
1.4 GENERAL ORGANIZATION OF HEPADNAVIRUSES 
HBV and WHV are small, partially double-stranded DNA viruses with an 
approximate genome size of 3.2 kilobases (Kb) and 3.3 Kb, respectively. Both 
these viruses are enveloped and possess the smallest genomes of all the 
double-stranded DNA viruses. Their virion sizes are 42 nm and 45 nm 
respectively. The outer envelope lipoproteins of HBV and WHV, carry surface 
antigen reactivity (HBsAg and WHsAg, respectively) and share significant 
antigenic cross-reactivity with each other. These envelope proteins form the 
empty spherical subviral particles and filaments (20-25 nm in diameter) which 
along with infectious virions, circulate freely. Serum HBsAg and WHsAg 
represent the hallmark markers of hepadnaviral infection and are detectable 
during the acute and/or chronic phase of hepatitis B. The envelope proteins 
surround the icossahedral nucleocapsid which is composed of proteins carrying 
core (HBcAg and WHcAg) and e (HBeAg and WHeAg) antigen reactivilies. 
These nucelocapsid particles contain the viral genome and genome-associated 
polymerase essential for hepadnaviral replication. 
1.4.1 Genome organization 
Genomes of hepadnaviruses are formed by partially double stranded, 
relaxed circular DNA molecules. These DNA molecules contain two 
complementary (plus and minus) slrands which are unequal in length. The 
minus-strand is complete and has a nick at a fixed position, while the 
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complementary plus strand is incomplete with variable length that is usually more 
than 50% of the complete positive-strand. Both strands have short cohesive 
overlapping regions at the 5'-end which maintain the circular structure of 
hepadnavirus genome. The minus-strand contains 4 major, overlapping open 
reading frames (ORFs), which encode four viral proteins and are highly 
homologous with each others counterparts from HBV and WHV. The HBV 
mRNA transcripts are either genome-size transcripts (3.5 Kb) or subgenomic 
transcripts (2.4, 2.1 and 0.7 Kb). The genomic transcripts serve as a template 
for the reverse transcription of the HBV minus-strand DNA. In contrast, only two 
species of polyadenylated mRNAs of 3. 7 and 2.1 Kb have been identified for 
WHV. These genomic transcripts also transcribe the mRNAs for the translation 
of pre-core (preC). core (C) and polymerase (P) proteins, while subgenomic 
transcripts transcribe the mRNA templates encoding envelope and the X proteins 
(Couillin el a/., 1999). 
The polymerase ORF, which encodes for DNA polymerase polyprotein, is 
the longest and overlaps all other ORFs. The nucleocapsid ORF contains two in 
frame start codons and encodes for longer precore and shorter core protein. 
Similarly, envelope ORF consists of three in frame ATG start codons which 
initiate the translation of large (preS1), middle (preS2) and small (S) envelope 
proteins. The X protein is encoded by X ORF and is the smallest of all the ORFs 
(Figure 1.1). 
The appropriate expression of these viral ORFs is regulated by four 
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Figure 1.1 Schematic representations of HBV and WHV genomic structures. 
For both HBV and WHV, double stranded DNA is shown with black bold-line 
circles, while repective viral proteins are depicted as black arrows. The viral 
transcripts are indicated with colored lines at the outer circle. The promoters, 
enhancers and direct repeats (DR1 and DR2) are shown as colored-filled 
eclipses, open color eclipses and purple rectangles, respectively. The nucleotide 
positions in both genomes are relative to a unique EcoRI site arbitrarily set as 1 
(Adapted from Wang and Michalak, Doctoral thesis submitted to Memorial 
University of Newfoundland. 2007). 
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promoter elements. The nucleocapsid or core promoter is located within the 
nucleocapsid ORF, directs the transcription of the 3.5 kb HBV transcript, and is 
transcriptionally active in HBV-infected tissues. It also aids the tissue-specific 
HBV gene expression (Vee eta/. , 1989). The transcription of the envelope gene 
is regulated by two different promoters, i.e. relatively silent preS and very active 
S promoter (see Figure 1.1 ). The preS promoter drives the transcription of the 
2.4-kb envelope transcript, which subsequently is translated into large envelope 
protein called preS1 protein. This promoter is located just upstream from the first 
start codon for this protein. Transcriptionally active S promoter drives the 
expression of the 2.4-kb transcript, which is eventually translated into preS2 and 
S envelope proteins. This promoter is located just before the ATG codon that 
initiates expression of the middle envelope protein. Finally, X promoter strictly 
controls the expression of X protein and hence is transcriptionally silent. Apart 
from four promoter sequences, HBV gene expression is also regulated by two 
enhancer elements (E1 and E2) which aid in enhanced promoter activity. The 
E1 enhancer is located between preS1 and S ORFs, while the E2 enhancer is 
located within the X gene sequence. The WHV genome consists of the four 
homologous promoter sequences as in the HBV genome, but contains only E2 
enhancer element. 
1.4.2 Viral Proteins 
In total, the hepadnaviral genome encodes for four major viral proteins. 
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Envelope proteins of HBV and WHV are type II transmembrane proteins and are 
encoded by three in-frame translation initiation codons present at the beginning 
of preS1 , preS2 and S regions within a single ORF (see Figure 1.1). These 
envelope proteins differ in N-terminal amino acid sequences, but share the same 
C-terminal sequences. The preS1 protein is the largest of these three envelope 
proteins and is known to interact with nucleocapsid protein and facilitates the 
enveloping of virion particles. Further, preS1 protein is also hypothesized to 
contain the binding site responsible for binding of the virus to the unidentified 
cellular receptor (Bruss eta/., 1996a). The S protein is the smallest, but the most 
abundant of all the three hepadnaviral envelope proteins, and is the major 
component of both Dane particles and freely circulating subviral particles. The 
preS2 protein is least abundant in serum but is expressed at higher density in 
virions derived from woodchuck livers (Michalak and Lin, 1994). All the 
hepadnaviral envelope proteins exist in glycosylated or non-glycosylated forms 
(Feitelson eta/. , 1983) and can be visualized by Western blot analysis as 
polypeptides of different molecular weights pertaining to the state of glcosylation 
as: 42 and 39 kDa for preS1 , 36 and 33 kDa for preS2, and 26, 23 and 19 kDa 
for S protein. The studies have shown that the infectivity of HBV requires the 
myristylation of the large envelope protein and is independent of the 
glycosylation of any of the three proteins (Bruss eta/., 1996b). 
Similar to the envelope proteins, two hepadnaviral nucleocapsid 
polypeptides are also encoded by two in-frame initiation codons located within C 
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ORF. The translation beginning at the first start codon produces precore 
polypeptide, which subsequently gets transported in endoplasmic reticulum (ER), 
undergoes partial proteolysis and appropriate glycosylation and then is secreted 
as e protein. The second start codon initiates the translation of core protein 
which has an arginine rich carboxyl domain . The N-terminus of the core protein 
mediates the self assembly of these proteins into core particles in the cytoplasm, 
while the arginine-rich carboxyl domain can bind to negatively charged 
hepadnaviral DNA essential for packaging of virions. The WHe (24 kDa) protein 
differs from WHc (22 kDa) in that it is truncated of the N-terminal signal peptide 
as well as the arginine-rich carboxyl terminal residues. Clinically, presence of 
HBeAg in the circulation is associated with actively progressing HBV infection, 
while the appearance of antibodies to HBeAg (anti-HBe) is considered as a good 
prognostic marker. 
The X protein , encoded by X ORF, is 154-aa and 141 -aa long for HBV 
(HBx) and WHV (WHx) , respectively. Even though the exact role of X protein in 
hepadnaviral replication and pathogenesis is unknown, it has been shown that 
the intact WHV X gene is essential for the initiation of WHV infection (Zoulim et 
at., 1994). The X protein is shown to activate proliferation, to induce apoptosis of 
infected cells, and is possibly involved in mediating the development of HCC. 
Hepadnaviral DNA P is the largest of all the four proteins and is composed 
of 845-aa for HBV and 879-aa for WHV. It is encoded by P ORF, which overlaps 
with the other three ORFs and displays DNA-dependent DNA polymerase, 
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reverse transcriptase, and RNase H enzyme activities. The N-terminal domain of 
the P protein provides a primer for the initiation of reverse transcription of HBV 
DNA negative strand . 
1.5 REPLICATION OF HEPADNAVIRUSES 
After the entry into a susceptible target cell, viral polymerase repairs the 
incomplete DNA plus strand of the hepadnavirus genome, which is then joined 
with the minus strand to generate the covalently closed circular DNA (cccDNA). 
The cccDNA is then transported to the nucleus of the infected cells within the 
core particles. Inside the nucleus, cccDNA serves as the template for the 
transcription of the viral pregenomic and messenger RNAs using host RNA 
polymerase II enzyme. These transcripts are polyadenylated and then 
transported back to the cytoplasm where they are eventually translated into 
different viral proteins. Newly formed pregenomic RNA is transported into the 
cytoplasm, where it becomes associated with viral P protein complex and is 
encapsidated by core particles. The reverse transcriptase reactivity of 
polymerase synthesizes a new minus strand DNA using protein primer from the 
N-terminal domain of the polymerase protein, after which , RNAse H degrades 
the pregenomic RNA. This minus strand DNA serves as a template for the 
synthesis of a plus strand and, thus, completes the formation of viral genome 
inside the core particles. Some of these newly formed core particles are 
transported back into the nucleus, where they replenish the hepadnaviral 
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genome pool, whi le the remaining particles are transported into the ER where 
they associate with envelope protein and are secreted into the extracellular 
spaces through non-cytopathic secretory mechanisms (Seeger and Mason, 
2000). These secreted mature virions were first described by Dr. Dane and are 
known as "Dane particles". 
1.6 ANIMAL MODELS OF HBV INFECTION 
The experimental studies on HBV infection are hampered by the fact that 
HBV is strictly host specific and , at the same time, only with great difficulty, can 
be propagated in culture because of its inability to infect cells efficiently in vitro. 
Further, in most of the clinical situations, it is difficult to determine the precise 
time of the infection and to obtain samples during the pre-acute phase, i.e., prior 
to the appearance of clinical symptoms. These constraints have forced a search 
for natural models of hepadnaviral infection in lower species and the 
development of surrogate systems in transgenic animals. The animal models 
which most prominently contributed to our better understanding of HBV 
replication and pathobiology include HBV-infected chimpanzees, woodchucks 
and ducks infected with WHV and DHBV, respectively, as well as the transgenic 
mouse HBV models. In particular, WHV infection in eastern Northern American 
woodchucks (Mannota monax) is recognized as the most relevant natural 
mammalian model of human HBV infection. 
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1.6.1 Woodchuck model of HBV infection 
In 1978. W HV was discovered in the colony of woodchucks at Penrose 
Research Laboratory at Zoological Gardens in Philadelphia, where high rates of 
CH and HCC accompanied by the presence of Dane-like particles were found. 
Following this observation, an experimental animal model of HBV infection was 
established at Cornell University using woodchucks infected with WHV (Tenant 
and Gerin, 2001 ; Tenant eta/. , 2004). The nucleotide sequences of WHV and 
HBV share considerable homology with each other and they are ultrastructurally 
indistinguishable. Infection of woodchucks with WHV induces similar profiles of 
tissue tropism, immunological events, hepatic pathogenesis, disease outcome 
patterns as well as virus-induced hepatocarcinogenesis as those observed 
during HBV infection in humans. 
Unlike chimpanzees, woodchucks are relatively easily accessible and less 
expensive to maintain. The biggest inconvenience in utilizing this model is the 
unavailability of research reagents, however, recent efforts focused on 
production of woodchuck-specific immune cell markers, functionally active 
recombinant proteins and different bioassays have provided new tools for 
investigations in this model. 
Similar to HBV, the natural transmission of WHV occurs through either 
parenteral, i.e., exposure to infected blood or bodily fluids, or perinatal, i.e. , from 
infected mother to the offspring. After exposure to WHV, most of the adult 
woodchucks (approximately 85-90%) display characteristic AH and then 
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successfully resolve hepatitis, while the remaining 10% develop chronic infection. 
The rate of development of CH in neonates infected at birth is higher and ranges 
between 60-90% (Cote el a/., 2000). These outcome statistics are very simi lar to 
those observed in humans infected with HBV. 
Infection of woodchucks with a liver-pathogenic dose ofWHV (i .e. >1000 
virions) (Michalak el a/., 2004) induces characteristic WHsAg-positive, 
symptomatic infection. The incubation period of W HV measured by the 
appearance of W HV DNA in serum and peripheral blood lymphoid cells (PBMC) 
is as short as 10-20 days. It is followed by appearance of WHsAg in circu lation 
between 4-10 weeks post-infection (w.p.i.). Usually, the anti-WHc appears 
between 6-10 w.p.i., while neutralizing anti-WHs appear after the disappearance 
of WHsAg from the serum. Th is correlates with the decreasing severity of 
hepatic inflammation and recovery. The resolution of W HV-induced AH is 
followed by long-term persistence of low level virus replication in the liver and 
lymphatic system and anti-WHc antibodies. 
Woodchucks carrying CH display higher virus loads (up to 10" vi rus 
genome equivalent (vge]/ml) and presence of WHsAg in serum for at least 6 
months. Additiona lly, they are serum WHeAg positive and fail to seroconvert to 
anti-WHe. It is believed that the presence of higher quantities of W HsAg and 
WHeAg in the circulation may tolerize vi rus-specific T and 8 lymphocytes, 
leading to unsuccessful or weaker anti-viral immune responses. Contrary to 
HBV-infected humans, male woodchucks do not display higher rates of CH and 
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subsequent HCC development. 
1.6.2 Other natural models of HBV infections 
Chimpanzees infected with HBV display compatible profiles of liver 
pathology and anti-viral immunological responses, and so far have provided 
valuable information regarding HBV immunopathology (reviewed in Bertoletti and 
Gehring, 2006; Chisari, 2000). However, since chimpanzees are rarely available, 
hard to breed and very expensive to maintain under laboratory conditions, the 
implementation of this very valuable animal model poses major problems. 
Some of the important findings regarding viral entry and hepadnavirus 
replication have come from the studies performed in DHBV-infected ducks. 
Primary duck hepatocytes can be easily isolated from the duck embryos, 
cultured, and infected with DHBV. Thus they provide a relatively easy in vitro 
system. However, DHBV genome lacks the homologous counterpart of HBV X 
gene and encodes only two envelope proteins. Further, OHBV does not induce 
liver pathology, cirrhosis or HCC. Additionally, the avian immune system is 
different than that of humans and, hence, this model is a less attractive option to 
study the immunopathological aspects of HBV infection (reviewed in Funk et af., 
2007). 
1.6.3 HBV transgenic mouse model 
HBV does not infect mouse. However, using embryo microinjection 
---- ----- -------------------------------------
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technology, complete or partial copies of HBV genome have been expressed in 
mice. Different HBV transgenic mouse models generated this way have several 
advantages . The mouse immune system is very well characterized and most of 
the reagents and assays are commercially available to carry out experiments. 
Further, unlike any other animal model of HBV infection , the genetic 
homogeneity of the mice can be easily controlled by using inbred animals 
(Chisari and Ferrari , 1995). 
The transgenic mice expressing the HBV envelope (S) gene under 
liver-specific promoters or the endogenous virus promoters (Babinet eta/., 1985; 
Burket a/. , 1988; Chisari eta/. , 1985; Chisari, 1995) were shown to produce 
envelope protein in the liver as well as in extrahepatic tissues , such as kidney 
and testes (Deloia eta/., 1989). When the albumin promoter was used to drive 
the expression of large envelope protein (preS1) , the intracellular accumulation 
of HBsAg was observed within hepatocytes, which causes expansion of the ER 
and , subsequently liver injury. This HBsAg leads to the ground glass appearance 
of hepatocytes, as observed in patients with CH (Chisari el a/., 1987). Thus, the 
transgenic mouse model has demonstrated that viral envelope proteins can be 
toxic to the hepatocytes under certain conditions (Chisari , 1996). When HBcAg 
and HBeAg were expressed in transgenic mice, these antigens were expressed 
in the nucleus or found in the circulation, respectively (Milich el a/., 1994; 
Reifenberg el a/., 1997; Takashima el a/., 1992). Similarly, after expressing 
nonstructural X protein in transgenic mice, some groups confirmed the 
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involvement of this transactivator in the development of HCC (Koike el at., 1994 ). 
while others showed contradictory results (Lee el a/., 1990). 
The complete genome of HBV has also been expressed in transgenic 
mice under an endogenous viral promoter (Araki el a/., 1989; Burkel at. , 1988; 
Chao el a/., 1991 ; Farza el at. , 1988; Guidotti el at. , 1995) These mice 
assembled HBV virions in hepatic as well as extrahepatic tissues, e.g . kidneys, 
and released them into circulation. Furthermore , circulating HBV virions from 
transgenic mice were able to produce infection in chimpanzees (Heise eta/. , 
1999). However, HBV replicative cccDNA was not detected in these mice. 
The immunological studies carried out in the HBV transgenic mouse 
models have strengthened the concepts of the immunological basis of liver 
pathology induced by HBV infection. The understanding of the importance of 
HBV-specific CD8+ CTLs or CD4+ T cell responses was further advanced in this 
model. Nonetheless, the HBV transgenic model has also emphasized that CTLs 
may not be able to target the cells which reside outside of the liver and express 
the HBV gene products, most probably due to the microvascular barrier that 
exists in these tissues (Chisari , 1996, Guidotti and Chisari, 2001 ). This finding 
has an implication in understanding the mechanism of HBV persistence in the 
face of an otherwise successful and vigorous immune response. It has been 
hypothesized that the extrahepatic HBV replication sites not only act as a 
reservoir of the virus but also generate enough antigenic stimulus for the 
maintenance of the HBV-specific memory responses, as those observed in 
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patients long after recovery (Rehermann eta/., 1996). However, the results from 
the transgenic mouse model should be interpreted with caution since HBV does 
not infect mouse cells, including liver and lymphoid tissues. 
1.7 THE COURSE OF HEPADNAVIRUS-INDUCED LIVER DISEASE 
HBV infection can be broadly classified in two subcategories: serologically 
evident, symptomatic infection and serologically silent, asymptomatic or occult 
infection. 
1. 7.1 Serologically evident symptomat ic HBV infection 
Infection with HBV displays an array of symptoms and variable outcomes. 
After exposure to the virus, HBV infection can progress through any of the 
following phases: incubation period or asymptomatic subclinical phase, acute 
hepatitis (AH), fulminant hepatitis, apparent resolution of infection or serum 
HBsAg-positive chronic hepatitis (C H). 
The incubation period of HBV varies from 4-24 weeks post-infection and is 
accompanied by detectable levels of HBV DNA in the circulation. During this 
phase of HBV infection , patients show mild symptoms such as fatigue, nausea, 
anorexia and slight fever, while in some cases mild jaundice is also apparent. 
Sometimes, this incubation period could also be asymptomatic. Exposure to 
HBV induces asymptomatic infection in an estimated 70% of immunocompetent 
adults (Chisari and Ferrari , 1995), while the remaining 30% display typical 
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symptomatic, clinically evident hepatitis. Approximately, 1% of adults also 
develop a very severe form of the disease known as fulminant hepatitis, which is 
characterized by massive, rapid destruction of hepatocytes resulting in loss of 
liver function and subsequent encephalopathy leading to coma. 
After infection , anti-HBc antibodies of lgM type appear between 4-10 
weeks post-infection. These antibodies can be used as a diagnostic marker of a 
recent exposure to HBV. The peak in serum HBV DNA level is usually 
accompanied by HBsAg in circulation and is usually followed by elevated levels 
of liver enzymes, such as alanine transaminase (AL T) and aspartate 
aminotransferase (AST), indicating hepatic injury. Patients who recover from AH 
and clear HBsAg from serum, develop anti -HBs antibodies that are protective 
and neutralizing in nature. Now, it has been widely accepted that, apparent 
clinical recovery from symptomatic viral hepatitis is always followed by low level 
HBV carriage in the liver as well as in the lymphatic system for decades 
(Michalak el a/., 1994; Yuki el a/., 2003; Raimondo el a/., 2006 ; Mulrooney and 
Michalak, 2007). 
The remaining patients who develop chronic hepatitis B display the 
presence of HBsAg in the circulation for at least 6 months or more along with 
persistent presence of anti-HBc and elevated levels of liver enzymes. This is 
usually accompanied by high levels of circulating HBV virions. The development 
of CH is determined by the age of the individual at the time of exposure . After 
HBV infection , 80-90% of adults resolve AH , while the remaining 10% progress 
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to CH. However, the percentage chronicity development is up to 90% in 
neonatally infected children, as compared to 30-60% in that of children infected 
before the age of 4 years (Okada eta/., 1976). The CH occurs in two different 
histopathlogical forms: active (aggressive) CH and mild (persistent) CH. In 
addition, HBsAg-positive healthy carrier states without apparent liver injury or 
alterations in the levels of AL T and AST are encountered (Hoofnagle eta/., 
1984). Patients with CH display continuous liver inflamation which frequently 
leads to cirrhosis and HCC. 
Even though the exact mechanisms responsible for initiation of HCC are 
not well understood, the progressive and constant inflammation associated with 
continuous regeneration of injured tissue are believed to be involved in the 
initiation of the oncogenic process. Further, it has been well documented that, 
the HBV genome or fragments of subviral DNA can be integrated into the host 
genome, and possibly deregulate cell growth control pathways. The integration 
of HBV DNA in host genome , especially that of the X gene, which has many 
transactivating functions, has been shown to cause the activation of pro-
oncogenes, such as n-ras and c-myc, or disruption of tumor suppressor genes, 
such as p53, potentially leading to oncogenesis (Diao eta/., 2001 ; Elmore eta/., 
1997). 
1.7.2 Occult HBV infection 
Occult HBV infection is defined by the presence of HBV DNA in serum, 
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lymphatic tissues and/or liver in the absence of serum HBsAg (Mulrooney and 
Michalak, 2007). Most of the adults who resolve symptomatic AH, carry low 
levels of virus for decades after apparent complete recovery from HBV infection 
(Michalak eta/. , 1994; Rehermann eta/., 1996; Yuki et a/., 2003; Raimondo et 
a/., 2006). This low level carriage of HBV is called secondary occult infection 
(SOl) and is typically accompanied by anti-HBc antibodies in serum. Regardless 
of strong HBV-specific T cell response and circulating anti-HBc and anti-HBs 
antibodies, the HBV genome can be detected in the serum, PBMC and liver 
samples from patients years after recovery from AH (Michalak eta/., 1994; 
Rehermann eta/., 1996). 
Detailed characteristics of residual SOl have been recognized in the 
woodchuck model of hepatitis B following apparent complete resolution of 
experimentally induced WHV AH. Serial sera, PBMC and liver samples collected 
after resolution of the acute phase of WHV infection indicated the persistence of 
viral DNA when analyzed by very sensitive PCRI nucleic acid hybridization (NAH) 
assays. Additionally, WHV replicative intermediates, e.g., WHV mRNA and 
cccDNA were consistently detected in hepatic as well as lymphatic tissues, 
indicating low level active replication of WHV. This residual infection is 
associated with the development of HCC in 20% of the recovered woodchucks 
(Korba eta/., 1989, Michalak eta/. , 1999). 
More recently, another form of occult infection has been identified and 
characterized. The infection of woodchucks with low doses of WHV (<1000 
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virions) induces serologically undetectable, but WHV DNA positive infection 
(Michalak el a/. , 2004). This form of low-level persistent hepadnavirus infection 
is called primary occult infection (POl) (Michalak, 2000; Michalak eta/., 2004; 
Mulrooney and Michalak, 2007; Michalak, 2007; Michalak et at. , 2007). The 
same studies also confirmed that WHV invades not only the liver but also the 
lymphatic system, and that the cells of the lymphatic system are a reservoir for 
long-term persisting virus. It has been recently shown that virus found in liver 
and lymphatic system is not enriched with any particular variant of WHV 
(Mulrooney and Michalak, 2008). Further, it was also determined that the 
amount of the virus predetermines whether the infection is silent and confined to 
the lymphatic system or serologically evident and liver pathogenic. However, the 
exact mechanisms and kinetics of immune responses determining the outcome 
of infection and the extent to which these responses provide protection against 
reinfection is not fully understood. 
The presence of POl in humans is still not thoroughly investigated. 
However, detection of HBV DNA in the blood or liver samples obtained from 
patients with no history of HBV exposure or anti-HBc/anti-HBs antibody-positivity, 
suggests the existence of this form of infection. It is estimated that, 7-19% of the 
blood donors from endemic areas show the presence of occult infection. In 
Western countries, this prevalence is estimated to be between 0-9% (Matsumoto 
et at. , 1997; lizuka et at., 1992; Douglas eta/., 1993; Weienberger et al., 2000). 
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1.8 IMMUNOLOGY OF HEPADNAVIRUS INFECTION 
1.8.1 General concepts in immunity to viruses 
The mammalian immune system is comprised of a variety of recognition 
systems capable of recognizing the invading pathogens, and is broadly divided 
into two different arms: the innate and adaptive immune systems. The innate 
immune system provides the first line of defense, but does not have the ability to 
identify a particular pathogen with antigenic specificity. On the other hand , the 
adaptive immune response develops secondary to innate immunity and 
recognizes a pathogen in an antigen-specific manner. Additionally, this adaptive 
immune response also generates the antigen-specific memory responses that 
protect the immune host against re-infection with the same pathogen . 
1.8.1.1 Innate immune response 
The invasion by pathogens activates innate immunity through 
inflammatory responses. The first phase of the immune response occurs 
between 0-4 hours (h) post-infection and is known as immediate innate immune 
response . During this phase, the infectious agent is identified by preformed non-
specific effectors which cause either removal of the pathogen or otherwise lead 
to the development of the second phase of immune response. One of the 
components of the early innate immune response is the complement system. 
Complements are small plasma proteins, most of which are proteases, which 
opsonize the infectious agent and then induce different pro-inflammatory 
responses, facilitating the phagocytosis or lysis of the pathogen itself. This 
system can be directly activated by a pathogen or indirectly by pathogen-
antibody complexes. 
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The second phase of innate immunity is called early induced response, 
which is activated when microbe-associated molecular patterns (MAMPs) are 
recognized by host pattern recognition receptors (PRRs) expressed on the cells 
such as dendritic cells (DCs), natural killer (NK) cells, macrophages, etc .. The 
best example of this type of receptors is toll like receptors (TLRs), which 
recognize characteristic components on pathogenic microorganisms, e.g., 
lipopolysaccharide (LPS), and then trigger the production of different chemokines 
and pro-inflammatory cytokines. The identification of the MAMPs on an invading 
pathogen induces the expression of a range of cytokines, such as tumor necrosis 
factor-alpha (TNF-a), IL-1P. IL-2, IL-6, IL-12,and chemokine IL-8. This 
infiammatory response heightens antigen presentation capability and co-
stimulatory molecule expression on the APCs, that further initiates the adaptive 
immune response in an antigen-specific manner (Akira eta/., 2001 ; Janeway and 
Medzhitov, 2002; Kawai and Akira, 2006). 
The infection of cells, especially with viruses, also stimulates the 
production of interferon proteins. Interferons are divided in two major categories: 
type 1, i.e., interferon-alpha (IFN-a) and IFN-beta (IFN-P) and type 2, i.e., IFN-
gamma (IFN-y). The double stranded RNA, which is a replication intermediate 
for many viruses, is recognized by TLR-3 and is a potent inducer of type 1 
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interferons (Andoniou eta/. , 2005; Kawai and Akira , 2006) . The induction of 
these interferons in cells inhibits viral replication and increases major 
histocompatibility complex (MHC) class I expression. The binding of type 1 
interferons to their cognate receptors induces the synthesis of several host 
proteins, including endoribonuclease, PKR kinase and Mx protein , which 
contribute to the inhibition of viral replication. These type I interferons, along with 
TN F-a , IL-2 and IL-12 activate NK cells as well as APCs, including DCs. 
Activated NK cells bear potent cytotoxic properties and are very efficient in 
restricting virus replication and spread of infection. 
1.8.1 .2 Adaptive immune response 
Professional APCs capture the antigens, process them and then present 
the antigenic peptides in the context of MHC class I or II molecules to circulating 
Tcells. 
1.8.1 .2.1 T cell immunity 
T cells are broadly divided into two types: CDS+ and CD4+ T cells. CD4+ 
T cells, also called T helper (Th) cells, identity antigen in the contex1 of MHC 
class II molecules , while CDS+ T cells, also called cytotoxic T cells (CTL) are 
MHC class I restricted . The CD4+ T helper cells are further divided into type 1 
(Th1) and type 2 (Th2) cells, depending upon the type of cytokines produced . 
The activation ofT cells in an antigenMspecific manner leads to the 
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proliferation and differentiation ofT cells into effector T cells. Effector C04+ T 
cells play a central role in providing help to COB+ lymphocytes T and B 
lymphocytes. Additionally, Th1 C04+ T cells secrete cytokines such as IFN-y, 
TN F-a, IL-2, IL-3 and granulocyte monocyte colony stimulating factor (GM-CSF), 
which drive the proliferation ofT cells and activation of macrophages. On the 
other hand, Th2 C04+ T cells are known to produce cytokines, such as IL-10 and 
IL-4, which have antagonistic effects on Th1 T cell responses. Upon activation, 
COB+ T cells kill infected cells through Fasl and perforin pathways and eliminate 
the replication niche of the pathogen. Further, these COB+ T cells can also 
produce IFN-y and TN F-a, which can inhibit viral replication in a non-cytopathic 
way (Guidotti and Chisari, 2001). Some of the effector T and B lymphocytes 
further develop into a memory phenotype, which are rapidly activated after a 
secondary encounter with the same pathogen. They are responsible for 
providing protection against re-infection/challenge. 
1.8.1.2.2 B cell immunity 
When a naive 8 cell encounters an antigen-specific CD4+ T cell in 
lymphoid tissue, the initiation of humoral immune response occurs. Activated B 
cells undergo proliferation, become plasma cells and then secrete antigen-
specific antibodies. The antibodies directed against external virion proteins can 
block the binding of the virus to its receptor on the cell surface and thus prevent 
entry and subsequent infection. These neutralizing antibodies have proven their 
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importance in providing protection against viral infections caused by HBV, 
influenza virus, measles virus and others. Further, antibodies bound to the 
surface of pathogen can activate Fe receptors on phagocytic cells, such as 
macrophages, DCs and granulocytes which , in turn , ingest and kill the pathogen . 
Antibodies can also activate the complement system which can either induce 
phagocytosis, recruit more inflammatory cells to the site of infection or directly 
destroy the pathogen (Gasque, 2004; Tarlinton eta/. , 2008). 
1.8.1.3 Cytokines 
Cytokines are small protein molecules made by cells which act as 
immunomodulators and chemical mediators and affect the function of the 
immune ce lls. They are important signaling molecules in the development and 
maintenance of innate and adaptive immunity. Both haemopoietic and 
non-haemopoietic cells can produce cytokines that can function in either an 
autocrine , paracrine or even an endocrine manner. They can directly inhibit viral 
replication and spread , activate different immune cells and cause tissue injury. 
Activated macrophages secrete a range of cytokines, such as IL-1 ~ . IL-6, 
IL-12, TN F-a , and a myriad of chemokines including IL-8. IL-8 is a potent 
chemokine that attracts inflammatory granulocytes, such as neutrophils, to the 
site of infection . TN F-a is involved in local containment of the infection as well 
as in differentiation and activation of DCs, however, its systemic release can 
cause septic shock. Neutrophils exposed to chemokines and TN F-a produce a 
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respiratory burst that generates oxygen radicals and nitric oxide, and release 
stored lysosomal granules, contributing to the death of the pathogen as well as 
tissue destruction. IL-12, IFN-a and IFN-y are efficient NK cell activators which 
further aid in the development of adaptive T cell response. 
After infection, naive CDS+ and CD4+ T cells undergo differentiation and 
become activated to produce distinct profiles of cytokines after the recognition of 
cognate antigen presented through MHC complex. Activated CDS+ T cells can 
kill pathogen-infected cells either directly through perforin, granzyme and Fasl 
pathways or indirectly in a non-cytopathic fashion by producing IFN-y, TNF-P and 
TN F-a. On the other hand, CD4+ T cells can produce two distinct profiles of 
cytokines and are accordingly classified as Type 1 (Th1) and type 2 (Th2) cells. 
Thus, Th1 cells mainly produce IFN-y, TN F-a, and IL-2 which have macrophage 
activating properties, while CD4+ T cells of Th2 type are known to express IL-4, 
IL-10 and TGF-P that promote the activation of a humoral immune response. 
1.8.2 Immune responses to hepadnavirus infection 
1.8.2.1 Innate immunity against hepadnavirus infection 
Similar to any other viral infection, exposure to HBV stimulates different 
components of innate immunity, that involves priming of granulocytes, NK cells, 
NKT cells, macrophages, dendritic cells and production of anti-viral cytokines 
such as interferons and TN F-a. 
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1.8.2.1 .1 Granulocytes 
Granulocytes are a group of short lived phagocytic cells which include 
neutrophils. eosinophils and basophils. Although the role of the granulocytes 
during hepadnaviral infection is unclear, the role of neutrophil-mediated 
recruitment of non-specific innate immune cells in the liver during the acute 
phase of HBV infection has been demonstrated in the HBV transgenic mouse 
model (Sitia eta/. , 2002). In these mice, the neutrophils were depleted by 
targeting Ly-6G receptor (Gr-1), that is expressed on bone marrow granulocytes, 
peripheral neutrophils, plasmacytoid DCs and certain subsets of monocytes. 
Such a depletion of neutrophils inhibited the recruitment of the antigen non-
specific inflammatory cells to the liver and resultant severity of liver injury without 
affecting virus-specific CTL responses (Sitia eta/. , 2002). These Gr-1 • cells also 
produce matrix-degrading metallo-proteinases (MMPs), which facilitate the 
leucocyte trafficking through solid organs, such as liver (Sternlicht and Werb, 
2001). These MMPs are rapidly induced in livers of the HBV-transgenic mice 
after injection of HBV-specific CTLs and their expression is associated with intra-
hepatic recruitment of inflammatory cells. However, administration of anti-Gr-1• 
antibody in these transgenic mice inhibits the trafficking of non-specific innate 
cells in the liver, suggesting the role of neutrophils in recruitment of inflammatory 
cells during the acute phase of HBV infection (Sitia eta/. , 2002). 
1.8.2.1.2 NK cells 
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NK cells constitute 2% of peripheral and 30% of intra-hepatic T 
lymphocyte population in the mouse liver, while these percentages are variable in 
humans (Doherty and O'Farrelly, 2000). Patients infected with HBV show an 
increased number of circulating NK cells during the pre-acute phase of the 
infection (Webster el a/. , 2000). This study regarding the dynamics of immune 
response during early phases of infection in humans has shown the highest 
frequency of NK cells in the periphery before the development of AH and 
preceding the HBV-specific adaptive CD4 and CD8 T cell immune response 
(Webster el a/. , 2000). Further, these NK cells show increased cytotoxic 
potential and elevated expression of IL-2 that eventually subsides to normal 
levels during recovery phase (Echevarria el a/., 1991 , Monsalve-De el a/. , 2002). 
It is believed that NK cell-mediated cytotoxicity is the major mechanism that 
keeps HBV replication in check during the pre-acute phase of infection and 
before the development of virus-specific adaptive immunity. In woodchucks 
infected with WHV, the acute phase of infection is characterized by the increased 
ability of PBMC to kill NK cell-susceptible target cells through the perforin 
pathway, indirectly suggesting the heightened activation of NK cells (Hodgson el 
a/., 1999). 
Hepatitis C virus (HCV) encodes protein E2, that binds to CD81 molecules 
on the surface of NK cells and consequently inhibits the NK cell-mediated anti-
HCV immune functions. Whether HBV targets the NK cells in this manner and 
inhibits its cellular function in order to persist is not yet known. Interestingly, 
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Chemin and colleagues have shown that PBMC isolated from patients with CHB 
showed HBsAg and HBcAg expressing CD56+ NK cells (Chemin el at., 1994), 
suggesting that HBV can infect these cells in vivo. 
Mouse liver contains high numbers of NK and NKT cells, which constitutes 
60-70% of the total intra-hepatic lymphoid cells, while the remaining one third is 
constituted by conventional lymphocytes (Doherty and O'Farrelly, 2000). Since 
hepatocytes have low expression of the MHC class I molecules, NK cells might 
be the main effector cell types early after infection and before upregulated MHC 
class I expression as observed during AH (Michalak el at., 2000). The activation 
of NKT and APCs can indirectly activate NK cells which has the potential to 
inhibit hepadnaviral replication. It is believed that intrahepatic NK and NKT cells, 
which become activated after HBV infection, are the major producers of IFN-y 
during AH. The inhibition of NK cell recruitment to the liver by blocking either 
chemokines such as IP-10 and Mig, or by depleting the neutrophils (Sitia el at., 
2002), ameliorates the liver injury (Kakimi el at. , 2001 ), suggesting that these 
cells have the capacity to mediate hepatic injury. 
In chimpanzees infected with HBV, an increased number of intra-hepatic 
NK and NKT cells, along with elevated IFN-y and TN F-a expression, is 
accompanied by decreased HBV replication (Thimme el at., 2003; Weiland el at., 
2004). The findings in this report were supported by the observation in HBV-
transgenic mice, wherein IL-18- or IL-12-mediated activation of NK cells leads to 
the inhibition of HBV transcripts and replicative intermediates in the liver as well 
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as extra-hepatic tissues, i.e., kidney (Cavanaugh eta/., 1997; Kimura eta/. , 
2002a). Interestingly, the superinfection of HBV-transgenc mice with 
Schistosoma mansoni or Plasmodium (malaria) parasites (Pasquetto eta/., 
2000), both of which activate the intrahepatic NK cells, suppresses HBV gene 
replication in the liver as a secondary effect of the intrahepatic immune response. 
The HBsAg-carrier transgenic mice, which have high prevalence of HCC 
development, had a decreased number of intrahepatic NK cells (Chen eta/., 
2005). These NK cells also displayed lowered cytotoxic potential and were 
poorly activated after poly (I:C) stimulation (Chen eta/. , 2005). 
Additionally, NK-cell derived IFN-y non-cytopathically restricts the virus 
spread in hepatocytes early after infection and upregulates the expression of 
MHC class I molecules on their surface, facilitating the enhanced antigen 
recognition by virus-specific CTLs (Guidotti and Chisari, 2006). In transgenic 
mice, IFN-y and TNF-a inhibit the HBV gene expression and replication in 
hepatocytes probably by destabilizing the viral RNA in the nucleus of the infected 
cell and accelerating its degradation, without destroying the cell itself (Guidotti 
and Chisari, 2001 ). This phenomenon of non-destructive viral purging is also 
validated in human hepatocytes (Suri 2001). 
IL-2-stimulated NK cells, also called lymphokine activated killer (LAK) 
cells, have a higher potential to secrete anti-viral cytokines and kill the target 
cells. The increased levels of IL-2, observed during AH, showed a positive 
correlation with the increased cytotoxicity of NK cells and better virus control 
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(Monsalve-De el a/. , 2002). Further, during CH, NK cells had impaired functional 
capabilities, which was partly attributed to the detached IL-2 receptor alpha chain 
in activated cells (Monsalve-De el a/. , 2002). Interestingly, administration of IL-2 
in HBV-transgenic mice inhibits the viral gene expression in a TN F-a dependent 
manner (Guilhot el a/. , 1993; Guidotti el a/., 1994; Uprichard el a/., 2003). Since 
hepatocytes are not known to express receptors for IL-2 (Smith, 1988), the IL-2-
driven inhibitory effect is believed to originate from the immune cells that traffic 
through the liver, express the IL-2R and produce high amount of TN F-a upon 
activation, such as NK cells and macrophages. 
Apart from direct activation by HBV, the NK cells can also be indirectly 
activated by action of other immune cells and cytokines. In the HBV transgenic 
mouse model, administration of a-galactoceramide activates NKT cells to 
produce IFN-y and IFN-aip, that subsequently recruit NK cells into the liver. 
Similarly, anti-CD40 antibody-activated intrahepatic APCs produce IL-12 and 
TN F-a and trigger IFN-y production by NK and T cells, which further mediates 
the inhibition of HBV replication in the livers of transgenic mice (Kimura eta/., 
2002b). 
Because of the difficulty in obtaining liver samples from healthy individuals 
or HBV infected patients, most of the studies related to intrahepatic NK cells are 
carried out in animal models. Similarly, insight into the involvement of NK cells in 
the pathogenesis of hepadnavirus infection comes from studies performed in 
HBV transgenic mice or chimpanzees. Since there is an inherent difference 
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between the composition of intrahepatic lymhphocytes between mouse and 
humans (Doherty and O'Farrelly, 2000), the data derived from the mouse model 
has its own limitations. Nonetheless, it provides valuable basic information on the 
involvement of NK cells in the disease progression and virus control during 
hepatotropic virus infection. 
1.8.2.1.3 NKT cells 
NKT cells are non-classical T cells that share partial characteristics of 
conventional T and NK cells and express a~ T cell receptors (TCRs) which are 
restricted by MHC-Iike CD1d molecules that present glycolipid molecules. NKT 
cells are derived from a separate hemopoetic lineage than conventional T cells. 
Both human and mouse NKT cells are autoreactive with CD1d expressing cells 
and identify marine sponge-derived glycolipid a-galactoceramide, a microbial 
a-glycuronylceramides and autoantigen isoglobotrihexosylceramide in the 
context of CD1 d (Bendelac eta/., 2007; Swann eta/., 2007; Behar and Porcelli, 
2007). In mice, NKT cells make up approximately 0.5% in peripheral blood and 
lymph nodes, 2.5% in spleen, and almost 30% of total lymphocytes in liver 
(Doherty and O'Farelly, 2000, Bendelac eta/. , 2007). In humans the frequencies 
of NKT cell occurrence in different lymphoid organs vary between individuals, but 
overall, they seem to be 10 times less frequent than in mice, in all the locations. 
CD1 d is constitut ively expressed on DCs, macrophages, B cells, Kuffer cells and 
endothelial cells. Interestingly, hepatocytes constitutively express CD1d on their 
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surface in mice and not in humans (De alia el a/., 2004). However, during an 
inflammatory process, such as viral hepatitis , human hepatocytes also 
constitutively express CD1d (De lalla el a/. , 2004) . This constitutive expression 
on hepatocy1es and other intrahepatic cells makes them effective, CD1d-bearing 
antigen presenting cells capable of presenting antigenic glycolipids to NKT cells 
in the liver. NKT cells are activated when CD1d bearing cells present the proper 
glycolipid antigen. In consequense, they express CD40L and produce massive 
amounts of IL-4 , followed by a burst of IFN-y. Then , NKT cells undergo 
apoptosis within 3-4 days. 
Pertaining to their high prevalence in hepatic tissue, NKT cells have been 
implicated in the immunopathogenesis of HBV infection. Using the HBV 
transgenic mouse model, it has been shown that the intravenous injection of a-
galactoceramide activates intrahepatic NKT cells to produce IL-4 and IFN-y 
simultaneously (Kakimi el a/., 2000). These activated NKT cells rapidly 
disappear from the liver, most probably ~ue to activation-induced cell death 
(AICD) , but activate and recruit NK cel ls which produce IFN-y and IFN-a/P, 
causing inhibition of the HBV replication. A similar study also showed that the 
a-galactoceramide-induced NKT-mediated inhibition of HBV replication was 
diminished in IFN-y and IFN-a/p KO mice, but was unaffected after depletion of 
CD4+ and CDS+ T cells. This suggested that NKT-mediated inhibition of HBV 
replication was interferon-dependent, butT cell independent (Kakimi el a/., 
2000). 
38 
Human hepatoma cell line , Hep3b, derived from HBV-induced HCC, 
induces tumors in athymic nude mice. Recent studies in this model have shown 
that adoptive transfer of NKT cells , activated in the presence of either tumor· 
specifi c or HBV-specific antigen (HBsAg) , can inhibit the development of tumors 
in these mice (Shibolet eta/., 2003 , Margalit eta/., 2005) . 
When HBV transgenic mice, expressing HBsAg in their liver were 
backcrossed with immune deficient Rag-/- mice and were adoptively transferred 
with naive splenocytes, they developed AH within 2-3 days post-transfer (Baron 
2002). The analysis of the intrahepatic cell population in these animals showed 
that the livers from the HBV-Env x Rag-1-/- mice were infiltrated with a large 
number of NKT cells expressing IL-4 and IFN-y, suggesting their activation 
(Baronet a/., 2002). Further, depletion of NK 1.1+ cells from the naive 
splenocytes ameliorated the early acute hepatitis, while exclusive transfer of 
sorted NK 1.1 +cells augmented liver pathology. Additionally, hepatitis was 
induced in the animals which expressed transgenic HBV envelope gene only, 
while mice that did not carry the transgene remained unaffected after the transfer 
of naive splenocytes, suggesting the role of NKT cells in mediating hepatitis. 
The studies so far have acknowledged the involvement of NKT cells in the 
inhibition of virus replication during HBV infection. However, the nature of 
molecules on hepatocytes that are recognized by these cells during this HBV 
infection are unknown. Since NKT cells are known to identify hydrophobic 
ligands, it is hypothesized that the possible ligands for NKT cells include the 
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myristylated part or hydrophobic peptides of HBV envelope protein expressed by 
HBV-infected hepatocytes (Baron el a/. , 2002). It is also believed that infection 
with HBV might trigger the aberrant processing of endogenous host lipids and 
glycolipids and induce their presentation as hydrophobic ligands (Bendelac el a/., 
1997; Chiu el a/. , 1999). 
1.8.2.1.4 Antigen presenting cells 
Even though the involvement of APCs in mediating innate immune 
response has been demonstrated in HBV-transgenic mice, it has not been 
entirely recognized during natural HBV infection. In the HBV transgenic mouse 
model, a single i.v. injection of anti-CD40 antibody recruits activated APCs in the 
liver and causes noncytopathic inhibition of HBV replication. However, the 
depletion of APCs by liposome-encapsulated dichloromethylene diphosphonate 
(L-MDP) that causes apoptosis of macrophages and DCs, but not ofT cells, 
abolishes the antiviral effects associated with anti-CD40 activation. This 
suggests the possible role of activated APCs in inhibiting HBV replication in aT 
cell-independent way. 
Different viruses are also known to target APCs as a strategy to evade the 
host immune response. Measles virus infects DCs, affects their maturation, 
induces TRAIL expression leading to apoptosis in interacting T cells and 
subsequently causes the generalized immune suppression in infected patients 
(Vidalain el a/., 2000). On the same note, different studies have shown that 
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HBV also can infect DCs. The presence of HBV DNA and RNA has been 
documented in DCs from patients with CH. These HBV-infected DCs are known 
to have impaired immunological functions, such as antigen presentation, cytokine 
secretion and initiation ofT cell response (Arima et at., 2003; Beckebaum et at., 
2003). These findings in human studies are also supported in the woodchuck 
model wherein the WHV DNA and cccDNA was demonstrated in monocyte 
derived DCs (Michalak and Mulrooney, personal communication). 
1.8.2.2 Adaptive immunity against hepadnaviruses 
Although innate immune responses contain the initial viral replication and 
spread, cellular immunity governed by virus-specific T and B lymphocytes 
maintain long-term anti-viral immunity as well as rapid secondary memory 
immune response upon re-exposure to the same virus. 
1.8.2.2.1 Cellular Immunity 
Hepadnavirus-specific cellular immunity is mediated by two major subsets 
of conventional CDS+ and CD4+ T cells. Although, the kinetics of these cellular 
responses immediately after HBV infection are not delineated, studies have 
shown that the strength and breadth of these T cell responses during AH, 
determine the outcome of the infection. 
1.8.2.2.1.1 COB+ T cells: 
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Activated HBV-specific CDS+ T cells identify the virally infected cells and 
kill them in a highly precise, MHC class !-restricted manner. The qualitative 
attributes of this virus-specific CDS+ T cell response appear to orchestrate the 
outcome of hepadnaviral infection. HBV-infected patients who develop strong, 
multispecific and polyclonal CDS+ T cell responses during AH, inhibit the 
infection and recover from hepatitis (Chisari, 1997; Rehermann eta/., 1996). In 
contrast, patients with weak, narrow and oligoclonal virus-specific CTL responses 
develop a HBsAg-positive CH (Ferrari el a/., 1990; Bertoletti and Ferarri, 2003; 
Guidotti and Chisari, 2006). 
The analysis of HBV-specific CDS+ T cell responses during AH that 
progresses to resolution shows the successful generation of CTL responses 
against HBV core, envelope and polymerase proteins. (Rehermann el a/., 1995; 
Rehermann eta/. , 1996; Bertoni eta/., 1997). The analysis of HLA-A2-HBV 
tetramer-positive CDS+ T cells obtained during AH indicated the quantitative 
hierarchy for HBV core, polymerase and envelope antigens in CDS+ T cells 
(Maini el a/., 1999). The direct quantitation of HBV-specific CDS+ T cells in the 
circulation further revealed that HBcAg,8_27-specific CDS+ T cells comprised 1.3% 
of total CDS T cells and were accompanied by CDS+ T cells that were specific for 
other epitopes of HBV. This hierarchy and multispecificity of HBV-specific CDS+ 
T cells was detectable even one year after the resolution of acute infection, but 
was almost undetectable in the patients with CH (Maini eta/., 1999). 
During multispecific CDS+ T cell response, the CTL repertoire is directed 
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against different HBV antigens, while the polyclonal T cell response recognizes a 
single HBV antigen in the context of diverse TCRs. Bertoletti eta/., 1994, had 
shown that, patients with CH displayed a monospecific CTL response to HBc18_27 
epitope without mounting stronger reactivity to any other HBV antigenic epitopes . 
The sequence analysis of the HBV from these patients revealed that the virus 
genome was mutated at HBc,..27 epitope, suggesting that the epitope was no 
longer recognized by the prevalent CTL response. It is believed that the 
polyclonality of the CTL response provides a practical advantage since CTLs with 
different TCRs directed with similar specificity could easily identify substituted 
residues within the epitope (Maini and Bertoletti, 2000) . These findings suggest 
that multispecificity and polyclonality of anti-HBV CTL response prevents the 
development of escape mutants and subsequently determines a favorable 
outcome from the infection. 
The activation of a virus-specific T cell response is delayed after primary 
exposure to hepadnavirus and is detectable only after 8-12 w.p.i. (Menne et al. , 
2002a; Bertoletti and Ferrari, 2003; Webster eta/. , 2000). This delayed 
appearance of a virus-specific T cell response is a hallmark cha racteristic of 
hepadnavirus infection since other viral infections, such as SIV, HIV or 
cytomegalovirus activate similar responses after 1-2 w.p.i. (reviewed in Wherry et 
a/. , 2004). Although , the reasons behind this characteristic, delayed arise of a 
virus-specific T cell response are poorly understood, it is believed that the 
impaired innate responses early after hepadnaviral exposure may postpone the 
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appearance of HBV-specific T cells. On the same note, the peak frequency of 
HBV-specific COB+ T cells during AH does not exceed 1% of circulating COB+ T 
cells, which is again lower than that observed during other infections such as 
LCMV, EBV and HIV (Callan eta/. , 199B; Ogg eta/. , 199B). 
The peak frequency of the virus-specific COB+ T cells during AH type B 
infection is accompanied by the highest degree of hepatic injury, as measured by 
the elevation in the serum levels of liver enzymes, such as AST and ALT. The 
best evidence explaining the importance of the COB+ T cells in the control of 
HBV infection comes from the studies in the chimpanzee HBV infection model. 
In this model, the depletion of COB+ T cells using anti-COB antibodies during the 
acute phase of infection resulted in the prolonged persistence of HBV infection 
(Thimme eta/., 2003). On the contrary, some studies have suggested that the 
maximal reduction in hepadnavirus load during AH precedes the peak in the 
virus-specific T cell responses (Guidotti eta/. , 1999; Chang and Lewin , 2007) . 
Even though these studies challenge the concept that CTL-mediated clearance 
of virus-infected cells is a main mechanism of inhibition of replication of HBV, it 
should be remembered that these cells also produce cytokines such as IFN-y 
and TNF-o, which might control the infection via a non-cytopathic mechanism. 
Of note, after infection with HBV, not all individuals develop elevated levels of 
liver enzymes or display clinical symptoms of hepatitis, indicating that IFN-y 
and/or TNF-o mediated non-cytolytic pathway could constitute a major 
mechanism of clearance of HBV (Kakimi eta/., 2003). In transgenic mice, 
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adoptively transferred HBV-specific CDS T cells can inhibit HBV gene expression 
non-cytopathically in the HBV transgene-replicating hepatocytes. Apart from the 
fact that almost 100% of hepatocytes are infected with HBV at the peak of 
infection (Guidotti and Chisari, 2001), only a minor percentage appears to be 
actually killed during resolution of hepatitis. This observation supports the notion 
that the non-cytopathic clearance of virus is a major anti-viral pathway after 
hepadnaviral infection. 
The precise involvement and significance of the particular subset ofT 
cells in the inhibition of HBV infection was delineated in a chimpanzee 
experiment wherein the CDS+ or CD4+ T cells were depleted using specific 
antibodies. In this experiment, chimpanzees were infected with 108 HBV v.g.e. 
and administered exclusively with either anti-COS or anti-CD4 antibodies during 
the acute phase of infection (i.e., 6 w.p.i.) . In anti-COS antibody-treated 
chimpanzee, the peak HBV viremia during the acute phase of infection persisted 
for longer time periods, which was followed by the delayed onset of liver injury. 
Further, reappearance of the CDS T cells was correlated with increased IFN-y 
mRNA and decreased HBV load in the liver, and was also accompanied by mild 
liver injury. Surprisingly, the dynamics of HBV infection in anti-CD4 antibody-
treated chimpanzee was similar to that of control chimpanzee, which received 
isotype control antibody. This suggests that deletion of CD4+ T cells during the 
acute phase of HBV infection does not change the disease dynamics . This 
experiment demonstrated that the CDS+ T cells are the main mediators of 
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inhibition of HBV replication , as well as hepatic injury. Nonetheless, the results 
from this experiment should be interpreted with caution since the administration 
of anti-CD4 (or anti-CDS) antibodies was not performed until6 w.p.i. , which could 
have provided enough time for CD4+ T cells to perform their helper functions 
long before the depletion event. 
1.8.2.2.1.2 CD4+ T cells 
Just like CDS+ T cells, HBV-specific CD4+ T cells are multispecific and 
polyclonal and show reactivity against different HBV antigens when monitored in 
a proliferation assay. During acute HBV infection progressing towards recovery, 
CD4+ T cell responses are strong , reactive against multiple HBV antigenic 
epitopes and are of a Th1 type. Their reactivity is accompanied by a successful 
virus-specific CDS+ T cell response (Ferrari eta/., 1990; Penna eta/., 997). A 
population based study has shown that this multispecificity of CD4+ T cell 
response against multiple HBV antigens is due to heterozygosity of MHC class II 
alleles, and is often associated with a more favorable outcome i.e. , resolution of 
AH (Thursz eta/., 1997). 
The patients with AH that progress to resolution display strong anti -HBc T 
cell responses, while in patients with CH these responses are either weak or 
absent (Ferrari eta/. , 1990). This impairment of CD4+ T cell responsiveness 
during serum HBsAg- as well as WHsAg-positive chronic infection can be 
reversed after treatment with an antiviral agent, lamivudine, suggesting that high 
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viral or antigen load may contribute to this characteristic hyporesponsiveness of 
CD4+ T cells (Livingston el a/. , 1999; Bani eta/., 1998; Menne eta/., 2002c) 
Epitope mapping studies have shown that 95% of patients in the acute 
phase of infection show strong antigenic reactivity against an immunodominant 
epitope located between 50-69 residues of HBcAg, irrespective of their human 
leukocyte antigen (HLA) haplotype (Ferrari eta/., 1991 ). The similar pattern of 
immunodominance has been observed in the woodchuck model of hepatitis 8 , 
where the majority of WHV-infected woodchucks show a response to an 
antigenic epitope located between 97-110 amino acid residues of WHcAg 
(Menne et a/., 1997). Overall CD4+ T cell responses generated after HBV 
infection are directed at the highest frequency to antigenic epitopes of core 
protein than to the epitopes of any other HBV protein (Penna eta/., 1996). It is 
recognized that, HBcAg can initiate the immune response in a T cell dependent, 
as well as, in an independent manner, which may be due to the fact that T cell 
immune responses to this antigen are more vigorous than to any other virus. 
Interestingly, these HBc-specific CD4+ T cells are known to extend help during 
the induction of anti-HBs antibody response (Milich eta/., 1986). The anti-HBs 
antibody response generated with the help of HBcAg-specific CD4+ T cells was 
believed to be responsible for the protection of HBcAg immunized chimpanzees 
against HBV-induced hepatitis (Murray eta/., 1984; Milich et a/., 1995). Similarly, 
woodchucks immunized with peptide containing an immunodominant peptide 
encoded within WHcAg or WHcAg-encoding plasmid were protected against 
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WHV-induced hepatitis (Menne eta/., 1997; Wang eta/. , 2007). 
Similar to HBV-specific COB+ T cell response, reactivity of virus-specific 
CD4+ T cells to different HBV antigens appears at 10-12 w.p.i. in HBV-infected 
individuals (Bertoletti and Ferrari, 2006) and between 6-12 w.p.i. in WHV-infected 
woodchucks (Menne eta/. , 2002). Again, compared to other viral infections, the 
appearance of virus-specific CD4+ T cell reactivity is delayed and is believed to 
be a consequence of the impaired early innate immune response or long 
incubation period of HBV. This CD4+ T cell response persists long after the 
resolution of AH, as measured by the proliferative capacity of lymphocytes after 
stimulation with HBV-specific antigens. Even though HBV-specific CDS+ T cells 
are assumed to be the main effector T cells during HBV infection, virus-specific 
CD4+ T cells provide help in developing this CTL response and thus indirectly 
determines the outcome of AH. Further, it is also shown that the maintenance of 
antigen-specific effector CDS+ T cells require CD4+ T cell help, especially of Th1 
type (Cardin eta/. , 1996; Zajac eta/., 199S). 
It is hypothesized that, during hepadnaviral SOl, low level virus replication 
provides enough antigenic stimulation for the maintenance of the memory and 
effector HBV-specific CD4+ T cells. PBMC isolated from patients with resolved 
AH type B display the distinct subsets of virus-specific CD4+ T cells which carry 
markers of current activation or memory phenotye, indicating the continuous 
regeneration of effector as well as long-term maintenance of memory CD4+ T 
cells. The importance of this residual T cell response in controlling the virus 
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replication during SOl was demonstrated in a recent study carried out in the 
woodchuck model. In this study, woodchucks convalescent from symptomatic 
WHV infection and treated with the immunosuppressant agent, cyclosporin A, re-
developed serum WHsAg-positive WHV infection (Menne eta/., 2007) . These 
results indicate that after recovery from AH , successful anti-viral cellular immunity 
is essential for the long-term control of hepadnaviral replication as well as 
reactivation . 
In the mouse model , it has been shown that, HBeAg and HBcAg can 
selectively elicit either Th2 or Th1 CD4+ T cell responses, respectively (Milich et 
a/., 1994 and 1998) It was shown that, when mice were immunized with HBeAg 
and HBcAg together, the Th2 CD4+ T cell response induced by HBeAg was 
dominant over the Th1 CD4+ T ce ll response induced by HBcAg, resu lting in the 
skewing of the immune response towards the Th2 type. It is hypothesized that 
this type of skewing of helper CD4+ T cell response to Th2 type could be one of 
the immune evasion mechanisms used by hepadnavirus to avoid elimination by 
the virus-specific immune responses and establish persistent infection. 
1.8.2.2.2 Humoral immunity 
Antibody responses directed against different HBV antigens can be 
detected in patients following exposure and is critical in providing protection 
against re~infection and maintaining active anti-viral immunity. Anti-HBV 
antibodies can provide an important barrier against the infection, if they are 
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present prior to virus invasion. The neutralizing antibodies developed after 
natural HBV infection, especially anti-HBs antibodies, are known to restrict cell-
to-cell spread of virus and to protect against infection upon re-exposure to the 
virus. Apart from its protective role, anti-HBV antibodies are believed to mediate 
complement-mediated ADCC or phagocytosis of virally infected cells. 
Unlike virus-specific T cell responses, anti-HBc antibody responses that 
occur during the acute phase of HBV infection that progresses to either 
resolution or chronicity are usually indistinguishable. In both groups of patients, 
the presence of anti-HBc antibodies is readily detectable. Although, anti-HBs or 
anti-HBe antibodies usually become detectable only in patients with resolving 
AH, after disappearance of serum HBsAg and HBeAg, respectively (Milich eta/., 
1995). 
The appearance of anti-HBs antibodies is considered to be a good 
indicator of resolution of acute HBV infection. These antibodies are not 
detectable by commercial assays during the early pre-acute phase or in patients 
with CH type B. It is believed that, during chronic HBV infection, anti-HBs 
antibodies form circulating immune complexes with excess HBsAg. However, 
when specific assays that detect traces of anti-HBs antibodies complexed to 
HBsAg are used, these antibodies can also be detected in patients with CH 
(Maruyama eta/. , 1994). The anti-HBs antibodies are believed to prevent cell-to-
cell spread by blocking the viral receptors essential for cell surface attachment 
(Milich eta/., 1995; Huang eta/., 2006). 
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Other HBV envelope proteins, i.e. preS1 and preS2 also induce antibody 
responses. Anti-preS 1 antibodies are the first antibodies to appear during the 
incubation period of HBV or WHV (around 4 w.p.i.), preceding the appearance of 
anti-core antibodies (Klinker! el a/., 1986; Jin el a/., 1996). In contrast, anti-
preS2 antibodies appear later during the acute phase of infection and can 
circulate simultaneously with anti-preS 1 antibodies (Budkowska el a/. , 1988). 
Interestingly, anti-preS2 antibodies were not detectable during AH that 
culminated inCH, regard less of HBeAg or anti-HBeAg status (Budkowska el a/. , 
1992; Coursaget eta/., 1988). 
Similarly, anti-HBc antibodies of lgM type appear relatively early after HBV 
invasion (10-12 w.p.i), while anti-HBe antibodies are usually detectable later 
during HBV infection (Rehermann and Nascimbeni, 2005). Anti-HBe antibodies 
usually appear after the clearance of HBeAg and are associated with better 
prognosis and benign hepatitis. Anti-HBc antibodies of lgG class persist for life 
after recovery from AH and represent a reliable marker of previous exposure to 
the virus. In WHY-infected woodchucks, anti-WHc antibodies also persist for a 
life-time (Coffin el a/., 2004). The biological function of the anti-HBc and anti-
HBe is poorly understood. Unlike anti-HBs antibodies, anti-WHc antibodies are 
produced at a high titer by the majority of infected patients (Milich el a/., 1995). 
Even though it is believed that anti-HBc or anti-HBe antibodies are not virus 
neutralizing, passive immunization of chimpanzees with anti-HBe antibodies has 
been shown to be protective against HBV infection (Prince el a/., 1983). 
,---------------------------------------
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Antibodies to polymerase or X protein have also been detected in HBV-
infected patients. Reports have shown that antibody to the c-terminus of 
polymerase protein can be detected during the acute phase of infection (Weimer 
eta/., 1989), whi le higher titers of anti-HBx antibodies have been found in 
patients with CH (Stemler eta/., 1990) but not in those with AH or resolved HBV 
infection. 
However, anti-HBV antibodies induced during natural infection can induce 
pathological effects in the liver as well as extrahepatic tissues. The immune 
complexes formed between anti-HBs antibodies and HBsAg can cause 
membranoproliferative glomerulonephritis, necrotizing vasculitis and arthritis in 
patients with chronic hepatitis (reviwed in Milich eta/., 1995 and Michalak, 2004). 
Further, Michalak eta/. have shown that complement dependent cytotoxicity 
directed against hepatocytes expressing HBcAg, HBsAg or asialoglycoprotein 
receptor (ASGPR) can contribute to the injury of HBV-infected hepatocytes, 
particularly in patients with severe CH (Diao eta/., 1998) 
1.8.2.3 Cytokine responses during hepadnavirus infection 
Both in vivo and in vitro evidence suggest that cytokines , especially 
interferons and TNF-a directly inhibit HBV replication. In vitro , the HBV 
replication can be inhibited by recombinant TNF-a by accelerating the 
degradation of HBV mRNA, while virus core promoter has been shown to be 
sensitive to the actions of IFN-y, TN F-a and IFN-a (Ando eta/., 1994; Gilles et 
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a/., 1992; Tsui eta/. , 1995). Further, the observation that intrahepatic induction 
of IFN-y and TN F-a triggers the degradation of preformed HBV RNA in the 
nucleus of the hepatocytes confirms the ability of these cytokines in controlling 
HBV gene expression, as observed in in vitro studies (Tsui et a/., 1995). Recent 
evidence suggests that IFN-y and TN F-a induce the cleavage of La autoantigen, 
which has function in stabilizing HBV mRNA and, thus, exposing the 
endonuclease-sensitive site of the HBV mRNA (Heise eta/., 1999). 
In chimpanzees infected with 5 x 107 HBV virions, virus DNA from serum 
and liver seemingly disappears in the absence of hepatic injury and long before 
the appearance of virus-specific T cell response during AH (Thimme eta/., 
2003). In these chimpanzees, viral replication is almost completely abolished 
soon after appearance of CD3 and IFN-y mRNA in the liver and that this occurs 
several weeks before the peak of liver disease, suggesting the non-cytopathic 
control of HBV replication. Similarly, depletion of IFN-y and TNF-a producing 
CDS+ T cells during AH prolongs the duration of peak viremia in HBV-infected 
chimpanzees (Thimme eta/., 2003), further supporting the role of these 
cytokines in inhibiting viral replication. 
The type of cytokine response, i.e., Th1 or Th2, is also associated with the 
outcome of HBV infection. The CD4+ T cells from patients who recover from AH 
display a Th1 cytokine profile, while the T cell clones generated from the PBMC 
of patients with CH produce predominantly Th2 type cytokines (Penna eta/. , 
1997; Bertoletti eta/., 1997). Further, the patients with CH, who respond to 
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interferon therapy produce more IL-12 and Th1 cytokines than that of interferon 
nonresponders (Penna eta/. , 1997; Bertoletti eta/., 1997). 
The best evidence suggesting the importance of different cytokines in the 
control of HBV replication, as well as in mediating liver injury, came from the 
transgenic mouse models of HBV. In these models, it has been shown that the 
cytokines, such as IFN-y, TNF-a, IFN-a/p, IL-12, IL-18 and IL-2 (reviewed in 
Guidotti and Chisari, 2001 ), independently or in conjunction with each other, 
inhibit the HBV replication. Activated HBV-specific CTLs adoptively transferred 
in a transgenic mouse expressing full length replicative form of HBV produce 
IFN-y and TN F-a and inhibit HBV gene expression in the liver, as well as 
mediate intrahepatic inflammation and subsequent liver damage (Guidotti eta/. , 
1994). When these transgenic mice were pre-administered with anti-IFN-y or 
anti-TN F-a antibodies, the adoptive transfer of HBV-specific CTLs failed to inhibit 
the HBV gene expression. Further, the ability of HBV-specific CTLs to inhibit the 
HBV replication was intact in the HBV transgenic mice which were knocked out 
for perforin molecules, suggesting that the inhibition of replication is not solely 
dependent on direct killing of hepatocytes (Guidotti eta/., 1999). It has been also 
shown that administration of recombinant murine IL-12 in HBV transgenic mice 
induces IFN-y, IFN-a/p and TN F-a responses in the liver, that further inhibits the 
HBV gene expression principally in a IFN-y dependent manner (Cavanaugh et 
a/. , 1997). Interestingly, superinfection of HBV transgenic mice with hepatotropic 
pathogens, such as LCMV, cytomegalovirus, adenovirus or plasmodium parasite 
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induces a strong intrahepatic Th 1 type cytokine response and ultimately inhibits 
HBV gene replication as a secondary effect (Cavanaugh el a/., 1998). These 
findings further stress the importance of the cytokine responses in the inhibition 
of HBV replication. 
Nonetheless, the cytokines induced after HBV infection also mediate 
hepatic inflammation and liver injury. The hepatocytes from the HBV transgenic 
mouse which overexpress HBsAg in the liver have been shown to be more 
susceptible to lysis by IFN-y (Gilles el a/., 1992). In these mice, administration of 
recombinant IFN-y induces liver disease similar to that observed during fulminant 
hepatitis. The fact that this type of liver injury can be markedly reduced by 
pretreating mice with anti-IFN-y antibodies suggests the role of IFN-y in 
mediating liver injury during HBV infection. In the same mice, LPS-induced 
intrahepatic cytokine response and resultant severe liver inflamation is inhibited 
by treating the animals with anti-TN F-a monoclonal antibodies. Further, a liver-
specific expression of IFN-y in a HBV transgenic mouse induces transaminases 
and histologically evident hepatitis similar to that observed during CH (Chen et 
at., 2007). In vitro, HBV-expressing rat cell lines are susceptible to apoptosis to 
varied concentrations of TN F-a, ranging from 200-20,000 U/ml, and this 
susceptibility directly corresponds to the HBV gene expression (Guilhot el at., 
1996). 
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1.9 PURPOSE OF THE STUDY 
Although the importance of virus-specific T cell and anti-viral cytokine 
responses in determining the outcome of hepadnaviral infection and mediating 
associated liver disease is acknowledged, the mechanisms behind the delayed 
appearance of the adaptive cellular responses in hepadnavirus infection and the 
inter-relationship between them and innate responses in the initial (pre-acute) 
phase of infection are poorly understood. Further, the features and kinetics of 
secondary (memory) virus-specific T cell response after the re-exposure of the 
virus-immune individuals or animals to different doses of the same hepadnavirus 
are also not well recognized. Similarly, recent studies from our laboratory, 
characterizing different attributes of low-level carriage of hepadnavirus during 
POl , have prompted questions regarding the properties of adaptive and innate 
immune responses that may accompany this type of virus persistence. The 
accomplishment of these objectives was difficult due to the unavailability of 
sensitive assays as well as appropriate woodchuck-specific reagents. Hence, 
the aims of the present study were focused on the development of the assays to 
monitor T cell proliferative responses and T cell susceptibility to apoptotic death 
and, subsequently, to determine the kinetics and inter-relationship between 
adaptive and innate responses during different phases of hepadnaviral infection 
and after challenge with virus. This project encompasses both in vivo and in vitro 
experimentation in the WHV-woodchuck model of hepatitis B. 
In this context, the aims of the study were as follows: 
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1. Development of in vitro assays and molecular reagents for the assessment of 
cellular and cytokine immune responses in woodchucks infected with WHV. 
1.1 Development of an in vitro T lymphocyte proliferation assay based on 
staining of dividing cells with CFSE (carboxyfluorescein di-acetate succinimidyl 
ester) dye to determine strength and longevity of WHV-specific and mitogen-
induced T cell proliferative response in the course of WHV infection. 
1.2 Cloning, sequencing and expression of the gene encoding for 
woodchuck IL-2 (wll-2) to produce biologically active recombinant wll-2 (rwll-2) 
in prokaryotic and eukaryotic protein expression systems, to aid the studies on T 
cell responses in the woodchuck model. 
2. Determination of the profiles and dissection of the kinetics of WHV-specific 
and generalized (mitogen-induced) T cell proliferative responses, and analysis of 
expression of cytokines and immune cell marker genes in PBMC and liver 
samples sequentially obtained after primary infection and subsequent re-
exposure to WHV. 
2.1 To analyze hepadnavirus-specific T cell proliferative responses 
against different WHV antigens during symptomatic infection induced with a liver-
pathogenic dose of WHV (> 103 virions) by using the traditional adenine 
incorporation assay and comparing the results with those obtained by applying 
more sensitive CFSE-based lymphocyte proliferation assay. 
2.2 To determine the kinetics of the generalized immune competency of 
lymphocytes using their mitogen-induced proliferative capacity as a measure, 
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along with the gene expression of selected cytokines and immune cell surface 
markers in sequential PBMC samples, to elucidate the potential reasons behind 
the delayed appearance of virus-specific T cell response after exposure to 
different doses of WHV. 
2.3 To investigate whether the infection of woodchucks with low, liver 
nonpathogenic dose ( <1 03 virions) of WHV evokes development of virus-specific 
T cell response and gene expression of cytokines and immune cell surface 
markers in PBMC. If so, to determine the profiles ofT cell proliferative 
responses and to delineate their interrelationship with cytokine expression 
patterns, during establishment and progression of POL 
2.4 To assess the profiles of headnavirus-specific T cell proliferative 
responses and their relation to cytokine expression after challenge of 
woodchucks recovered from AH or those with established persistent POl . 
CHAPTER 2: GENERAL MATERIALS AND METHODS 
2.1 ANIMALS AND VIRUS INOCULUM 
2.1.1 Woodchucks 
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The woodchucks (Marmota monax) used in these studies were maintained 
at the Woodchuck Viral Hepatitis Research Facility at the Health Sciences 
Centre, Memorial University of Newfoundland, St. John's, Newfoundland. 
Animals were housed under environmental and biosafety conditions specifically 
established for this species and the infection protocols were approved by the 
Institutional President's Ethics Committee. 
Woodchucks infected with WHV were housed separately from non-
infected, healthy animals. The healthy status of the non-infected animals was 
regularly monitored by evaluating the absence of WHV DNA by nested PCR 
followed by nucleic acid hybridization (PCR-NAH; sensitivity <10 vge/ml) and 
anti-WHc antibodies or WHsAg by ELISA, to eliminate the possibility of previous 
exposure with WHV. 
After infection with WHV, the acute phase of infection was diagnosed 
when serum became positive for WHsAg and antibody to WHV core antigen 
(anti-WHc), but when WHs antigenemia lasted no longer than 6 months. CH 
was considered when WHsAg, accompanied by WHV DNA and anti-WHc, 
persisted for longer than a 6-month period (Hodgson and Michalak, 2001). 
59 
2.1 .2 WHV inocula 
The woodchucks were infected with well characterized WHV inocula 
derived from the sera of chronically infected animals. The inoculum WHV/tm3 
(Genbank number AY334075, Michalak eta/., 2004) and WHV/tm4 were derived 
from sera of woodchucks with serum WHsAg-positive WHV infection and 
contained 2.2 x 1010 vge/ml and 3.8 x 1011 vge/ml, respectively. The comparative 
nucleotide sequence analysis of WHV/tm3 and WHV/tm4 showed the 
heterogeneity at nine nucleotides and has been described in detail elsewhere 
(Mulrooney-Cousins and Michalak, 2008). 
2.1.3 Infection of woodchucks 
All the infection protocols were performed after restraining the 
woodchucks under isofluorane-induced anaesthesia (CDMV Inc. , St. Hyacinthe, 
Quebec) . The animals were infected intravenously with the different doses of 
WHV as described in the Materials and Methods section for each experiment. 
2.2 SAMPLE COLLECTION 
2.2.1 Blood collection 
Woodchucks were bled from the digitalis vein under aseptic conditions 
into tubes with no additives (Becton Dickinson , Rutherford, New Jersey) for 
serum isolation (Section 2.2.2) or into tubes containing sodium ethylenediamine 
tetra-acetic acid (EDTA; Becton Dickinson) for plasma and PBMC isolation . The 
blood samples were processed immediately to avoid any undesired effects on 
the survival of PBMC. 
2.2.2 Serum isolation 
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Blood samples collected in the tubes containing no preservatives were 
positioned in a slanted position and allowed to clot for 2-3 h. The tubes were 
then spun down at 700 x g for 5 min and the layer of the serum from the top was 
carefully removed . These serum samples were aliquoted into smaller volumes 
and stored at -20 ' C. 
2.2.3 Isolation and storage of peripheral blood mononuclear cells (PBMC) 
PBMC were isolated from sodium EDT A-treated blood by density gradient 
centrifugation. In brief, whole blood was diluted with an equal volume of 
phosphate buffered saline, pH 7.4 (PBS) containing 1 mM EDTA (PBS-EDT A) 
and centrifuged through Ficoii -Paque Plus (Amersham Pharmacia Biotech , AB , 
Uppsala, Sweden). The top layer of the plasma was carefully removed without 
disturbing the underlying layer of PBMC and stored at -20 'C. The PBMC were 
collected , washed with PBS-EDT A, and incubated with ammonium chloride cell 
lysing buffer (ACK buffer, see Appendix B) for 15 minutes at room temperature 
to eliminate residual red blood cells (lew and Michalak , 2001 ). The cells were 
washed with 10 ml of PBS-EDT A, assessed for viability by the trypan blue dye 
exclusion method and then counted in a hemocytometer. Usually, more than 
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99% cells were viable in the isolated PBMC. 
In this study, isolated PBMC were usually used to perform the proliferation 
assays (see Section 3.2), while the remaining cells were resuspended in Trizol 
solution (Invitrogen, Auckland, New Zealand) and stored at -20 ' C. These frozen 
PBMC samples were later processed to isolate RNA (see Section 2.6.1 ). 
2.2.4 Liver biopsies 
Woodchucks were sedated by an intramuscular injection of ketamine (23 
mg/kg; Ketaset; CDMV Inc.) and xylazine (10 mg/kg; Lloyd Laboratories, 
Shenandoah, Iowa), and then anaesthetized using 2-4% isofluorane (CDMV 
Inc.). The surgicallaprotomy was performed on the animals to obtain a liver 
biopsy sample, which was further divided aseptically into several fragments. 
Liver biopsy pieces of 1-2 mm3 each were immediately frozen in liquid nitrogen 
for future nucleic acid analyses, while other fragments of about 5-mm3 each were 
fixed in 10% buffered formalin (Fisher Scientific, Nepean, Ontario) for histological 
examination or embedded in HistoPrep (Fisher Scientific) and then frozen in 
isopentane pre-cooled in liquid nitrogen for future immunofluorescent (IFL) 
examination. 
2.2.5 Collection of specimens at autopsy 
The woodchucks were euthanized with an overdose of ketamine-xylazine 
and immediately blood was collected by cardiac puncture. The tissue samples 
from liver, spleen, lymph nodes, bone marrow, kidneys, pancreas, and skeletal 
muscles were removed aseptically and preserved , as explained for liver biopsy 
samples (see Section 2.7). 
2.3 ASSAYS FOR THE SEROLOGICAL AND MOLECULAR MARKERS OF 
WHV INFECTION 
2.3.1 Detection of WHV DNA 
2.3.1.1 Isolation of WHV DNA 
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To isolate WHV DNA, either 100 ~L of serum or 100 mg of liver tissue 
homogenized in 100 ~L of Hank's balanced salt solution (HBSS) were 
resuspended in 200 ~L of DNA lysis buffer (10 mM Tris-HCI, pH 8.0, with 10 mM 
NaCI, 1 mM EDTA, and 0.5% sodium dodecyl sulfate [SDS) containing 200 ~g 
proteinase K [Invitrogen)). The samples were incubated at 42' C overnight in a 
shaking incubator, then extracted two times with equal volumes of 
Tris-HCI-buffered phenol followed by chloroform/isoamyl alcohol (24:1). DNA 
was precipitated from the aqueous phase using one-tenth volume of 3 M sodium 
acetate and 2.5 volumes of absolute ethanol (Sigma Chemical Co.) for 12 hat 
-20 ' C. The precipitated DNA was washed with 70% ethanol, resuspended in 
sterile water and quantified by measuring its absorbance at 260 nm using a DU 
530 spectrophotometer (Beckman Instruments Inc., Fullerton , CA) . 
2.3.1.2 Amplification ofWHV DNA 
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The presence of WHV DNA in the isolated DNA samples was detected 
after amplifying 1-4 ~g of total genomic DNA using WHV gene-specific primers in 
direct PCR followed by nested PCR and Southern blot hybridization. The 
sequences of the oligonucleotide primers used for amplification and their location 
in the WHV genome have been previously reported (Coffin and Michalak, 1999; 
Michalak eta/. , 1999). For direct PCR, three sets of primers amplifying 
fragments of WHc, WHx or WHs genes were used. To enhance sensitivity of 
DNA detection , the first round of direct PCR amplification was followed by 
another round of amplification in nested PCR using three sets of primers internal 
to the above mentioned direct primer pairs (Coffin and Michalak, 1999; Michalak 
eta/. , 1999). 
In general, direct PCR detection of WHV DNA utilized 1 X reaction buffer 
comprising 1.5 mM MgCI2 with 50 mM KCI in 20 mM Tris-HCI buffer (pH 8.4) and 
2.5 U of Taq DNA polymerase, 200 ~M of each dNTP (all from Invitrogen) , 300 
ng of each oligonucleotide primer in a 100 ~L total volume. The PCR reaction 
mixture was added with 1-4 ~g of genomic DNA and overlaid with 100 ~L of 
mineral oil (Sigma Chemical Co.) to prevent evaporation. The amplification of 
WHV DNA was performed in a programmable thermal cycler (Twin Block System; 
Ericomp Inc., San Diego, CA) using the following steps: first step- 94 'C for 5 
min , Second step- 94 ' C for 30 sec, 52 ' C for 30 sec and 72 ' C for 30 sec; for 30 
cycles, third step- 72 ' C for 15 min. For each PCR reaction, a plasmid 
containing WHV DNA and DNA isolated from liver or serum of a WHsAg-positive 
-I 
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chronically infected woodchuck were used as positive controls (Coffin and 
Michalak, 1999; Lew and Michalak, 2001 ). For nested PCR, 10 ~L of the direct 
PCR mixture was re-amplified under the same conditions as the direct reaction. 
As negative controls, a water and a mock sample, containing all reagents used 
during the DNA extraction and PCR were included (Michalak el a/., 1999). 
2.3.1.3 Detection of WHV DNA 
2.3.1.3.1 Agarose gel electrophoresis 
The WHV DNA amplified in a PCR reaction was visualized on the 
standard 1% agarose gel. For this pupose, 1% agarose gel was prepared with 1 
X TAE buffer (40 mM Tris-HCI buffer, pH 8.0, 1 mM EDTA,) containing 0.5 ng/ml 
of EB. Next, 18 ~L of PCR reaction was mixed with 2 ~L of DNA loading dye 
(1 0% Ficoll-400, 0.25% bromophenol blue, 0.25% xylene cyanol FF, 50 mM 
EDTA, 10 mM Tris-HCI buffer) (all from Sigma Chemical Co.) and loaded into the 
wells of a 1% agarose gel (Invitrogen) along with molecular weight standard (1 00 
bp ladder or 1 kb ladder; Invitrogen). The electrophoresis was performed at 100 
V for 50 min, the DNA bands were visualized under a UV light, and the image 
was recorded using an imaging system (ChemiGenius 2, Syngene; Frederick, 
MD). 
2.3.1.3.2 Southern blot hybridization 
The agarose gel containing the PCR products was denatured with 1.5 M 
NaCI with 0.5 M NaOH for 30 min and then neutralized with two changes of 1.5 
M NaCI in 1 M Tris-HCI buffer (pH 8.0) for 30 min each . Further, DNA from the 
gel was transferred on to nylon membrane (Amersham Biosciences, Uppsala, 
Sweden) by downward capillary transfer for 12-16 hand the membrane was 
baked at 80 oc in a vacuum oven for 2 h. 
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The nylon membrane was prehybridized at 65 ' C for 1 h in a sealed glass 
tube using 6 ml of hybrid ization buffer containing 100 ~g/ml sonicated salmon 
sperm DNA (Sigma Chemical Co.), 5 ml 6 X SSG (standard saline citrate) , 0.5 
ml 50 X Dendhardt's solution and 0.5 ml 10% SDS. Further, the membrane 
was hybridized overnight at 65 ' C with radiolabeled WHV-specific DNA or 
oligonucleotide (Coffin and Michalak, 1999; Michalak el a/. , 1999). Next day 
blots were washed twice in 2 X SSG with 0.1% SDS for 10 min at room 
temperature (RT) followed by two washes with 0.2 X SSG and 0.1 % SDS for 10 
min each. The membranes were taken out, blotted against paper towels, 
covered in plastic wrap and exposed to a multipurpose phosphor screen or 
exposed to X-ray film (MRP-1 ; Eastman Kodak Co., Rochester, NY) at -70 ' C in 
autoradiography cassettes. 
The relative quantity of the WHV DNA in the test samples was determined 
after comparing their band intensity with that of serial dilutions of recombinant 
WHV DNA, using either phosphoimager (Cyclone system, Canberra Packard 
Ltd., Montreal, Quebec) or densitometry (Gene Tools software on the 
ChemiGenius-2 imaging system). 
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2.3.2 Detection of WHV surface antigen (WHsAg) 
Detection of WHsAg in the woodchuck serum samples was performed 
using an in-house ELISA. For this purpose, flat bottom 96-well plates 
(Linbro!Titertek; ICN Biomedicals, Aurora, OH) were coated with anti-WHs 
antibodies and incubated overnight at 4 ' C. The plates were washed three times 
with PBS and blocked by adding 300 ~L of 0.25% Tween-20 (Sigma Chemical 
Co., St. Louis, MO) in PBS (blocking buffer) at RT for 1 h. Plates were washed 
with PBS and 50 ~L of either test serum samples or appropriate controls were 
added and incubated for 1 hat RT. Mouse anti-WHs was added (diluted 1:1000 
in blocking buffer) and incubated for 1 h at RT. The unbound antibody was 
washed out and then alkaline phosphatase (AP)-conjugated goat anti-mouse 
antibody (Jackson Laboratories) was added (diluted 1:1000 in blocking buffer) 
and incubated for 1 hat RT. The assay was developed by adding 50 ~L of 
soluble AP substrate (p-nitrophenyl phosphate; Sigma Chemical Co.) for 30 min 
and then terminated by adding 50 ~L of 0.1 M EDTA. The absorbance of the 
developed reaction was measured at 400 nm using a microplate reader (BioRad 
Laboratories, Hercules, CA). The samples with absorbance 2.1 greater than the 
negative control were considered as WHsAg positive. 
2.3.3 Detection of antibodies to WHV surface antigen (anti-WHs) 
As previously described (Michalak el a/., 1990 and 1999), commercially 
available, cross-reactive anti-HBs ELISA (AUSAB EIA, Abbott Laboratories) was 
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used to detect anti-WHs antibodies in the serum samples. Briefly, HBsAg-coated 
polystyrene beads were incubated overnight with 200 ~L of either test 
woodchuck serum along with appropriate positive and negative control sera 
supplied by the manufacturer, as well as with anti-WHs positive and negative 
woodchuck sera. Next day, the beads were washed with water and incubated 
with 200 ~L of a biotin-tagged HBsAg. Rabbit anti-biotin conjugated with 
horseradish peroxidase (HRPO) was added for 2 h at 4 ' C. The beads were 
washed to remove unbound conjugates, transferred to fresh tubes, and 
incubated with 300 ~L of freshly prepared a-phenylenediamine solution 
containing hydrogen peroxide for 30 min at RT. Further, the beads were 
transferred to fresh tubes and the HRPO reaction was stopped by addition of 1 
ml of 1 N H,SO, . Using a Quantum II dual-wavelength analyser (Abbott 
Laboratories), the absorbance was measured at 492 nm The samples with 
absorbance values ;?: 0.05 cutoff value were considered positive (Michalak eta!., 
1990 and 1999). 
Alternatively, an in-house developed woodchuck-specific ELISA was also 
employed to detect anti-WHs antibodies. For this purpose, wells of a 96-well 
ELISA plate were coated with purified WHsAg at a concentration of 200 ng per 
well in 50 ~L of PBS and incubated overnight. Next day, wells were washed and 
then 300 ~L of blocking solution containing 1% milk powder and 0.05% Tween-
20 in PBS, at RT was added. After 1 h, blocking solution was discarded and the 
plate blotted dry. Then, 50 ~L of test serum along with serum collected from 
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healthy animals as a negative control were added to each well , incubated at RT 
for 1 hand then washed with PBS three times. Next, 50 ~L of mouse anti-WHV 
preS2 antibody prepared in blocking solution at a dilution of 1: 1 000 was added to 
each well for 1 h, RT. Further, the wells were washed three times with PBS and 
a 1:1000 diluted AP-conjugated goat anti-mouse lgG (Jackson lmmunoresearch) 
for 1 h, RT was added . Finally, wells were washed three times with PBS and 
developed with 50 ~L of p-Nitrophenyl phosphate (pNPP) reagent (Sigma) for 30 
min at RT. The reaction was stopped with 50 ~L of 0.1 M EDTA and absorbance 
was read at 405 nm. The test samples were considered positive for anti-WHs 
when the absorbance values from respective wells were below the cutoff values 
calculated as: mean of absorbance from negative control wells minus 3 standard 
derivations (SD) . 
2.3.4 Detection of antibodies to WHV core antigen (anti-WHc) 
The detection of anti-WHc antibodies was performed by using a 
competitive ELISA previously developed in this laboratory, where in anti-WHc 
present in the test sample competes with HRPO-Iabeled anti-WHc for binding to 
immobilized WHcAg (Michalak el a/., 1999). For this purpose, a 96-well , 
flat-bottom plate (LinbrofTitertek; ICN Biomedicals) was coated with woodchuck 
anti-WHc antibodies at 1 ~g protein in 50 ~L of PBS per well and incubated at 4 
°C for overnight. Next day, wells were washed three times and blocked with 
blocking buffer (as explained for WHsAg ELISA) for 2 h at RT. Further, 0.5 ~g 
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of WHcAg in 50 ~L volume was added to each well and the plate was incubated 
at RT for 2 h. Next, the plate was washed 4 times with PBS, blotted dry and the 
test serum sample or appropriate controls were added to each well and 
incubated with 25 ~L of anti-WHc labeled with HRPO (diluted 1:2,500 in blocking 
buffer) for 2 h. The wells were washed 3 times with PBS and supplemented with 
50 ~L of 3,3',5,5'-tetramethylbenzidine (TMB) substrate (BioRad Laboratories). 
After 30 min, the reaction was stopped by adding 50 ~L of 1 N sulfuric acid and 
absorbance at 450 nm was measured using a microplate reader (BioRad 
Laboratories). For this assay, serum samples collected from healthy animals 
served as negative controls, while sera from woodchucks chronically infected 
with WHV were used as positive controls. The degree to which the test sample 
inhibited the binding of HRPO-Iabeled anti-WHc was calculated as follows: 
percent inhibition = 100 (test sample optical density (OD) + negative control OD x 
1 00). The assay results were accepted when the positive controls inhibited 95% 
of the HRPO-anti-WHc binding to WHcAg and the negative controls gave no 
inhibition. Samples that produced 50% inhibition were considered positive for 
anti-WHc. 
2.3.5 Measurement of serum sorbitol dehydrogenase (SOH) 
The levels of SDH in serum were measured by using a standard SDH 
enzyme assay (Sigma Chemical Company, St. Louis, MO) with slight 
modifications. Briefly, 100 ~L of fresh woodchuck serum sample was added to 
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700 ~L of SOH buffer A (0.05 M Tris-HCI, pH 8.0, containing 100 ~M 
Oithiothreitol), 100 ~L of 10 mM nicotinamide adenine dinucleotide (NAO; Sigma 
Chemicals) and 100 ~L of 1M sorbitol in a cuvette and mixed properly. The 
cuvette was immediately placed in a spectrophotometer, absorbance at 340nm 
(A340) adjusted to 0.000 and then net A340 recorded at 30 sec intervals for 5 
min. For the same serum sample, a blank assay was performed using a similar 
protocol, except replacing 1M sorbitol solution with 100 ~L of water. The 
absorbance for each test and blank sample was plotted on a graph and 
coefficient of absorbance per min (t.A/min) was determined by determining the 
slope of each graph line. Further, net .A/min was calculated by subtracting the 
slope of the blank sample from that of the test sample. The amount of SOH 
present in the serum sample was calculated using the formula: 
SOH [mili-lnternational Units(miU)/mL] = [(oA/min) x 1 x 60] 
[0.00622 X 0.5] 
wherein: 
1 = reaction volume (ml) 
0.00622 = micromolar absorptivity of NAO at 340 nm 
0.1 = sample volume (ml) 
One International Unit (IU) of an SOH enzyme converts 1 ~mol of 
substrate per minute under the specified conditions of the procedure. In this 
assay, for healthy woodchucks the normal range of SOH in serum ranged from 0 
to 20 IU/ml (Chen et at. , 1992, Michalak, 1998). The levels of SOH were 
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considered elevated when it contained more than 2.1 ± 3 SD above the control 
values detected in the same animal prior to WHV exposure. Typically, during the 
acute phase of symptomatic WHV infection , SDH values in infected woodchucks 
ranged between 30 to 400 miU/mL. 
2.4 PRODUCTION OF RECOMBINANT WHV PROTEINS 
2.4.1 Cloning of cDNAs encoding for WHV proteins in plasmid vectors 
2.4.1.1 Cloning of WHc, WHe and WHx cDNAs in pCR II vector 
Different WHV eDNA sequences encoding for virus proteins were 
amplified by PCR and then cloned in an appropriate vector, as described earlier 
(Wang eta/., 2005). The following WHV proteins were amplified using 
respective gene-specific primer sequences: WHcAg encoded by nucleotides 
from 2021 to 2584 (rWHcAg), truncated WHeAg encoded by nucleotides 2021 to 
2467 (rWHeAg), and X protein encoded by nucleotides 1503-1928 (rWHxAg). 
The nucleotide positions mentioned above refer to WHV/tm3 genome sequence 
as previously described (Genbank AY334075; Michalak ef a/., 2004). The WHV 
gene-specific primers also contained the additional nucleotide sequences 
encoding for Nde I and Xho I restriction enzymes at the 5-' and 3'-ends, 
respectively, to faci litate the further cloning of these inserts in pET 4.1 b 
expression vector. The PCR fragments generated were directly cloned into pCR 
II plasmid vector using TOPO-TA Cloning Kit (Invitrogen , Carlsbad , CA). For this 
purpose, 4 ~L of each PCR product was mixed with 1 ~L NaCI and 1 ~L of TOPO 
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pCR II and incubated at RT for 30 min . Then, 2 ~L of this reaction mixture was 
added to 50 ~L of thawed competent Escherichia coli (E. coil) TOP1 0 cells 
(Invitrogen) and kept on ice for 30 min. For the transformation of recombinant 
DNA into E. coli, these competent cells were heat shocked for 45 sec at 42 ' C, 
immediately placed on ice for 2 min , added with 400 ~L of LB medium and 
incubated at 37 ' C for 1 h in a rotator at 200 rpm. A 100 ~L aliquot of each 
transformation reaction mixture was then spread onto LB agar (Difco 
Laboratories, Detroit, Ml) plates containing 50 ~g/ml of kanamycin and coated 
with 40 ~L of X-Gal (Sigma Chemical Co.). The plates were incubated at 37 ' C 
for 16-24 h and the white bacterial colonies were identified as the positive 
colonies containing recombinant DNA insert. 
2.4.1.2 Plasmid isolation and enzymatic manipulations 
The white recombinant colonies obtained after transformation of E. coli 
were picked up using sterile pipette tips, labeled, transferred to 5 ml of LB broth 
supplemented with 50 ~g/ml kanamycin and further incubated overnight in a 
shaker incubator at 37 ' C. The next day, a 1.5-ml aliquot of this LB broth was 
pelleted at 20,000 x g for 20 sec in Eppendorf tubes and the cells were 
resuspended in 100 ~L of glucose Tris-EDTA (GTE; see Appendix B) for 5 min at 
RT. The bacteria cells were lysed with 100 ~L of freshly prepared 0.2 N 
NaOH/1 % SDS for 5 min at RT. This solution was neutralized by adding 100 ~L 
of pre-chi lled 3 M potassium acetate (pH 5.5) on ice for 5 min which aids in the 
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removal of chromosomal DNA and proteins . The tubes were centrifuged at 
20 ,000 x g for 5 min to pellet cell debris and chromosomal DNA. The 
supernatant was transferred to a fresh Eppendorf tube and plasmid DNA was 
precipitated with 1 ml of 95% ethanol for 10 min at RT. The plasmid pellet was 
centrifuged at 15,000 x g for 5 min, washed with 1 ml of 70% ethanol , air-dried , 
resuspended in 30-50 ~L of TE buffer, and stored at -20 ' C until further use. 
The plasmids isolated this way were subjected to restriction enzyme digestion 
(see Section 2.4.1.3) and gel electrophoresis for the confirmation of the proper 
WHV gene insert. 
In some instances, to obtain higher quantities of plasmid with a greater 
purity, large-scale plasmid DNA preparation were done using Maxi/Midi plasmid 
preparation kits (Qiagen). For this purpose , 1 ml of E. coli culture harboring 
appropriate recombinant plasmid insert, as judged by miniprep analysis 
described above, was added to 100 ml of superbroth medium supplemented 
with 50 ~glml of the appropriate antibiotic (kanamycin or ampicillin) and 
incubated overnight in a shaker incubator at 200 rpm , 37 °C. Next day, bacterial 
cells were centrifuged at 10,000 rpm for 15 min at 4 oc and resuspended in 10 
ml of P1 solution (see Appendix B) supplemented with 100 ~glml RNase A. 
Next, 10 ml of P2 solution (see Appendix B) was added for 5 min at RT to lyse 
the bacteria, which was further neutralized with 10 ml of ice-old P3 solution (see 
Appendix B) on ice for 30 min. This mixture was passed through a filter cartridge 
provided with the kit to remove chromosomal DNA and bacterial proteins. The 
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filtrate was run through a column containing DNA binding resin , washed twice 
wilh QC buffer (see Appendix B) , and plasmid DNA was eluted with 15 ml of QF 
buffer (see Appendix B). The eluted plasmid DNA was precipitated by adding 
10.5 ml of isopropanol (Sigma Chemical Co.) for 5 min at RT, followed by 
centrifugation at 20,000 x g for 30 min. The plasmid preparation was washed 
with 70% ethanol, resuspended in 500 ~L of TE buffer, quantified as previously 
described, and stored at -20 ' C. 
2.4.1.3 Restriction enzyme digestion analysis 
The recombinant plasmids isolated from a mini , midi or maxi preparations 
were analyzed by digesting them with appropriate restriction enzymes to confirm 
the proper WHV DNA insert. The restriction enzyme digestion was performed 
using either a single or double enzyme reaction . For single enzyme digestion, 
0.5- 1 ~g plasmid DNA, 10 U enzyme (usually in 1 ~L ; no more than 10% of 
reaction volume), 2 ~L appropriate buffer and 1 ~L of RNAse solution were 
resuspended in sterile water, to make a final volume of 20 ~L per reaction . 
When performing double enzyme digestion , 20 ~L of final reaction volume 
contained 0.5- 1 ~g plasmid of DNA, 1 ~L of each enzyme, 2 ~L appropriale 
compatible buffer and 1 ~L of RNAse solution in steri le water. The reaction 
mixture was incubated 37 ' C for 18-24 hand the presence of proper insert in the 
plasmid backbone was analyzed by performing agarose gel electrophoresis. 
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2.4.1.4 Purification of WHV gene inserts 
Since all the recombinant WHV proteins contained additional nucleotide 
sequences encoding for Nde I and Xho I restriction enzymes at the 5'- and 3'-
ends respectively (see Section 2.4.1 .1), the respective plasmids were digested 
with these enzymes to obtain the insert containing the WHV gene sequence. 
The digested plasm ids were run on a 1% low melting point agarose (Invitrogen) 
gel , the band containing the PCR product of interest was visualised , excised , 
placed in a 1.5-ml Eppendorf tube and heated at 65 ' C. Next, 1 ml of DNA 
binding resin was added to the tube, incubated at RT for 1 min and then passed 
through a Wizard minicolumn (Promega Corp ., Madison, WI) using vacuum 
suction. The column was washed twice with 80% isopropanol and then 
centrifuged at 12,000 x g for 20 sec to remove residual alcohol. Finally, 30 ~L of 
prewarmed TE buffer was added to a column and incubated for 2 min at RT. 
Next, the column was spun at 12,000 x g for 20 sec, RT to elute the insert DNA. 
The eluted W HV gene insert was subcloned in pET 4.1 b expression vector. 
2.4.1.5 Subcloning to generate recombinant WHV proteins 
The WHV DNA gene inserts encoding for respective proteins and 
containing additional Nde I and Xho I enzyme flanking sequences (see Section 
2.4.1 .1) were first ligated in pET 4.1b vector (Novagen, Darmstadt, Germany). 
For this ligation reaction, 2 ~L of Nde 1/Xho I digested pET 4.1b vector was 
added to 6 ~L of WHV gene insert, 4 ~L ligation buffer, 2 ~L of 10 mM ATP 
(Invitrogen), 1 ~L of T4 DNA ligase and 5 ~L of sterile water to make a final 
volume of 20 JJ L. The reaction mixture was incubated at 14 °C for overnight. 
Next day, 10 ~L of ligation reaction mixture was transformed in E. coli, BL21 , 
DE3 cells as described for TOP10 cells (section 2.4.1.1). When ligated in the 
proper orientation, all the WHV gene inserts also contained an additional pET 
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4.1 b derived six histidine amino acids at the carboxyl end followed by a stop 
codon. The transformed E. coli colonies from the LB agar plates containing 100 
~g/ml of ampicillin or 50 ~g/ml of carbenicillin were picked up and cultured in 
the 5 ml of superbroth (see Appendix B) supplemented a with similar regimen of 
either antibiotic, to generate the stock inoculum to be used in expression 
experiments. 
2.4.2 Expression and purification of recombinant WHV proteins 
2.4.2.1 Induction of recombinant protein expression in E. coli 
The expression cultures were started by adding 1 ml of stock inoculum in 
100 ml of superbroth supplemented with 100 ~g/ml of ampicillin or 50 ~g/ml of 
carbenicillin. The cultures were incubated at 37 ' C in a shaking incubator at 200 
rpm until the growth density (absorbance at 600 nm) reached 2.0. At this stage, 
5 ml of culture was aliquoted and cultured in a separate tube as an uninduced 
control. The rest of the culture was added with isopropyl 
~-0-1-thiogalactopyranoside (IPTG; Invitrogen) at the final concentration of 1 ~M 
to induce the expression of the recombinant proteins in the bacterial cells and 
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incubated for an additional 2 h. Both induced and uninduced cultures were 
terminated by chilling them on ice for 1 0 min and then centrifuging the cells at 
4000 rpm, for 15 min at 4 ' C. The pellets were stored at -70 ' C until further use. 
2.4.2.2 Preparation of inclusion bodies 
The cell pellets were thawed on ice for 10-15 mins, supplemented with 1 
ml of Bug Buster reagent (Novagen) in the presence of 25 U/ml benzonase 
(Novagen). After 30 mins of incubation at RT, the pellet was centrifuged at 
16,000 x g for 20 min at 4 ' C to precipitate the insoluble inclusion body (I B) 
fraction from that of the cytoplasmic protein fraction. The cytoplasmic fraction 
was collected without disturbing the IB precipitate and stored at -20 ' C until 
further analysis. Further, the IB fraction was treated with lysozyme at a final 
concentration of 200 ~g/ml for 5 min at room temperature, followed by three 
washes with 1:1 0 diluted BugBuster reagent and then suspended in denaturing 
buffer B (see Appendix B) containing 8 M urea. Both IB and cytoplasmic 
fractions from both IPTG-induced and uninduced cultures, were then examined 
by sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
(SDS-PAGE)/Western blotting to determine the presence of the recombinant 
proteins. 
2.4.2.3 SDS-PAGE and Western blot analysis 
The samples to be tested by SDS-PAGE analysis were resuspended in a 
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loading buffer (6X) containing 3% SDS, 5% 2-mercaptolhanol, 10% glycerol in 
62.5 mM Tris-HCI buffer, pH 6.8 for 10 min at 95 ' C. A denaturing 12% or 15% 
separating polyacrylamide gel was prepared in 37.5 mM Tris-HCI buffer, pH 8.8, 
with 0.1% (wtlvol) SDS along with a 3% acrylamide upper stacking gel in 12.5 
mM Tris-HCI buffer, pH 6.8, with 0.1% (wtlvol) SDS and were loaded in a 
mini-gel apparatus (Mini-Protean II dual slab cell; Bio-Rad Laboratories, 
Hercules, CA). The samples along with a protein molecular weight marker ladder 
were loaded in the wells of the upper gel and separaled in the stacking gel at a 
constant voltage of 200 V for about 45 min in reservoir buffer (20 mM glycine, 2.5 
mM Tris base). The gel apparatus was dissembled and the polyacrylamide gel 
was either put in a small plastic tray containing 0.5% coomassie blue staining 
solution and incubated for 2-3 h or transferred onto nitrocellulose (NC) 
membrane for Western blotting. The stained gel was further destained with 
destaining solution (10% acetic acid) for 2-3 h to visualize protein bands. The 
molecular weights of the protein bands were determined by comparing them with 
lhat of the molecular weight ladder. 
Alternatively, proleins sepatated by SDS-PAGE were direclly transferred 
onto a NC membrane (Amersham) by semi-dry transfer using a Bio-Trans unit 
(Gelman Inc., Ann Arbor, Ml). The efficiency of protein transfer was determined 
using a pre-stained molecular weight marker (lnvilrogen). After transfer, NC 
blots were incubated with PBS containing 10% normal goat serum and 0.025% 
Tween-20 for 1 h at RT, to block nonspecific binding sites. Next, the NC bioi was 
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incubated with mouse anti-histidine primary antibodies resuspended in blocking 
buffer at 1:1000 dilution for 2 hat RT or overnight at 4 ' C. The NC blot was 
washed twice with blocking buffer and added with goat anti-mouse lgG antibody 
conjugated with AP at 1:5000 dilution for 1 hat RT. Again , the blot was washed 
twice with blocking buffer and developed for 5-1 0 min in a solution containing 
nitro-blue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate, as described in 
the supplier's instructions (Sigma Chemicals). The developing reaction was 
stopped by washing the NC blot in cold water. 
2.4.2.4 Affin ity chromatography purification 
The IB pellet dissolved in 4 ml of buffer B was incubated at RT on a 
rotator for 2 h and then added to 1 ml of 50% nickel-nitriloacetic acid (Ni-NTA) 
slurry (Novagen). This mixture was incubated at RT for 2 h on a rotating shaker 
at 20-30 rpm , to insure the proper binding of the histidine residues on 
recombinant proteins with the Ni-NTA slurry. Next, the IB-Ni-NTA slurry mixture 
was loaded on a syringe column plugged with sterile wool. The mixture was 
allowed to run through the column without applying any force and flow-through 
fractions were collected . The column was washed twice with 4 ml of Buffer C 
(see Appendix B) and wash fractions were collected. Finally, the recombinant 
protein bound to resin was eluted twice with 500 ~L of Buffer E (see Appendix B), 
collected in sterile Eppendorf tubes and stored at -20 ' C until it was analyzed by 
SDS-PAGE and Western blotting or refolded using gradient dialysis. 
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2.4.2.5 Refolding of purified recombinant proteins 
Recombinant WHV proteins purified under denaturing conditions were 
further refolded by dialyzing them against a series of decreasing concentrations 
of Buffer E. Dialysis tube with molecular weight cut off value of 12000 Da was 
cui into pieces of 10-15 em each and immersed in 250 ml of water containing 
100 ~g sodium bicarbonate and 12.5 mg EDTA, boiled for 10-15 min and allowed 
to cool at room temperature. A pinch of sodium azide was added and tubes 
were stored at 4 ' C until further use. Affinity purified recombinant proteins were 
poured into dialysis tubes, sealed properly using thread knots, and then 
immersed in a flask containing 250 ml of 6 M Buffer E. Dialysis on a magnelic 
stirrer was performed at 4 ' C for overnight. After every 18-24 h, the dialysis buffer 
was changed to a lower molarity (4 M, 2 M and 1 M Buffer E. Finally, 1 M Buffer 
E was replaced by sterile PBS and dialysis was performed for additional 2 days 
at 4 ' C. Next, the recombinant proteins in it were collected in sterile Eppendorf 
tubes. Small aliquots of these proteins were used for determination of protein 
content, while the remaining volume was supplemented with phenylmethyl 
sulfonyl fluoride (PMSF, 0.1 ~M final concentration ; Sigma Chemicals), as a 
protease inhibitor, and stored at -20 ' C in small (100 ~L) aliquots. 
2.4.2.6 Quantitation of recombinant proteins 
The quantitation of proteins was done using standard bicinchoninic acid 
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(BCA) assay. For this purpose , one volume of copper sulfate solution was added 
to 50 volumes of bicinchoninic acid solution. As a standard , serial dilutions of 
BSA (1 mg/ml; Sigma Chemicals) in the range of 0 to 100 ~g were prepared in 
separate test tubes in a fina l volume of 100 ~L. Then, 50 ~L of each 
recombinant protein to be quantified was added in a separate test tube and 
supplemented with 50 ~ L of sterile water. Each tube containing standard and 
test sample was mixed with 2 ml of protein determination reagent and 
incubated at 37 ' C for 30 min. Then , the tubes were cooled at RT for 5 min and 
absorbance was measured at 562 nm (A562). The standard curve was obtained 
using A562 values of serial dilutions of BSA which were used to estimate the 
protein content of the test samples. 
2.5 PROCUREMENT OF OTHER WHV ANTIGENS AND MITOGENS 
2.5.1 Purification of WHsAg 
A discontinuous sucrose gradient followed by a cesium chloride (CsCI) 
gradient were used to purify WHsAg from the serum of a woodchuck chronically 
infected with W HV. First, 7 ml of WHsAg-positive woodchuck serum was 
centrifuged at 3,000 rpm , 4 °C for 30 min to remove possible sediments. Next, 6 
ml of discontinuous sucrose gradient was prepared by overlaying 1.5 ml each 
20% (bottom of the gradient), 15%, 10% and 5% (top of the gradient) sucrose in 
0.01M Tris-HCI buffer, pH 7.5 containing 500 mM NaCI and 1 mM EDT A. The 
pre-cleared woodchuck serum (7ml) was carefu lly laid on the top of this gradient 
and centrifuged at 40,000 rpm at 4 ' C for 18 h. The resulting pellet was 
resuspended in 1 ml of 15 mM NaCI by sonication at 9 amps for 45 sec and 
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solid CsCI was added to make up a density of 1.30 glcm' in a 2 ml volume. 
Separately, CsCI gradient solutions were prepared at different densities ranging 
from 1.1 to 1.35 g/cm3, in 0.01 M Tris-HCI buffer, pH 7.5 containing 500 mM NaCI 
and 1 mM EDTA. To mount the density gradient, 2 ml of 1.35 glcm' CsCI 
(bottom of the gradient) was overlaid with 2 ml each of 1.30 g/cm3 CsCI-WHsAg 
pellet suspension and 1.25 g/cm', 1.2 glcm' and 1.1 g/cm' (top of the column) of 
CsCI solutions. The gradient was spun down at 40,000 rpm, 10 ' C for 20 h. 
From the top of the gradient, 500 ~L aliquots were collected and the pellet was 
saved. The presence of WHsAg in different fractions was assessed by ELISA 
with anti-WHsAg antibody and fractions containing peak WHsAg reactivity were 
pooled together. Again, solid CsCI was added to these fractions to make up a 
density of 1.30 g/cm3 and applied on a CsCI density gradient. The second 
gradient was prepared by overlaying 2 ml of 1.35 g/cm3 CsCI solution (as 
explained above; bottom of the column) with 2 ml of CsCI-WHsAg pellet and 9 
ml of 1.15 g/cm' CsCI solution (top of the column) and centrifuged at 40,000 
rpm at 10 ' C for 20 h. Similar to the first CsCI gradient, 500 ~L fractions were 
collected, assayed for WHsAg by ELISA and fractions containing peak WHsAg 
reactivities were pooled. This pool was dialyzed against 0.01 M Tris-HCI buffer, 
pH 7 .4, for 24 h at 4 ' C with at least three changes of buffer. The protein content 
of purified WHsAg was measured using a standard BCA assay and then stored 
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at -20 ' C in small aliquots. 
2.5.2 lmmunodominant WHc97_110 peptide 
Synthetic WHV core peptide (WHc97.,0) , encompassing amino acids 
located in positions 97 to 11 0 of the virus nucleocapsid protein was prepared by 
Synprep Corporation (Dublin , CA) . This peptide is known to contain an 
immunodominant epitope of WHc antigen recognized by the T lymphocytes from 
most of the WHV-infected woodchchucks (Menne eta/., 1 997) and was 
implemented in our experiments to evaluate WHV-specific T cell response along 
with other WHV antigens. 
2.5.3 Mitogens 
Different mitogens were used as non-specific stimulators in proliferation 
assays to monitor generalized proliferative capability of PBMC, as an indicator of 
their overall immune competence. These mitogens included: Concanavalin-A 
(ConA; Pharmacia Fine Chemicals, Uppsala, Sweden) , pokeweed mitogen 
(PWM, Phytolacca americana agglutinin; ICN Biochemicals Inc. , Aurora , Ohio) 
and phytohemagglutinin (PHA; ICN Biochemicals Inc.). The varied 
concentrations of the mitogens used in different experiments have been 
described under respective sections in Materials and Methods sections. 
2.6 Real time reverse transcription-polymerase chain reaction (RT-PCR) 
r---------------------------------------------------------------------
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2.6.1 Isolation of RNA 
Total RNA was isolated from PBMC or liver tissue samples using Trizol 
reagent according to the manufacturer instruction . As described in Section 
2.2 .3, PBMC samples already resusended in Trizol reagent and frozen at -20 oc 
were thawed at RT for 10-15 min. For liver biopsy or autopsy samples , a small 
piece (approx. 1 ~g in weight) was recovered from -80 °C freezers and 
homogenized in 1 ml of Trizol reagent. Either PBMC sample or homogenized 
liver tissue resuspended in 1 ml of Trizol were mixed on a rotator for 30 min , 
added with 200 ~L of chloroform , shaken vigorously for 15 sec and then 
centrifuged at 12,000 x g for 15 min at 4 °C. The upper aqueous layer was 
collected into a fresh tube, added with 500 ~L of isopropanol, incubated at RT for 
10 min, and kept at -20 oc overnight for the precipitation of RNA Next day, the 
tubes were centrifuged at 12,000 x g for 10 min at 4 octo pellet the RNA The 
pellet was washed in 1 ml of RNAse-free 75% ethanol , dried in a vaccum 
chamber for 5-7 min and resuspended in 8 IJL of autoclaved RNase-free water. 
Further, the possible contamination of total RNA with that of genomic DNA was 
eliminated by treating RNA samples with DNAse I (Ambion Inc. Tx). For this 
purpose, to 8 ~L of RNA sample was added 1 ~L of DNAse I and 1 ~L of reaction 
buffer and incubated for 15 min at RT. The reaction was stopped by adding 1 ~L 
of stop solution and incubating the samples at 70 °C for 10 min. The samples 
were then chilled on ice for 2 min, briefly centrifuged and quantitated using a 
spectrophotometer. Finally, 2 ~g of total RNA was immediately used for a 
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reverse transcription reaction or stored at -20 °C. 
2.6.2 Preparation of eDNA 
The total RNA isolated as above was converted in eDNA by using a 
reverse transcription (RT) reaction kit (Invitrogen), as per vendor's instructions. 
After quantitation, the concentration of total RNA was adjusted in such a way that 
2 ~g of total RNA was present in a total of 8 ~L volume. To this RNA sample 
was added 2 ~L of random primers (100 ng/~1), 4 ~L of 5X RT buffer (375 mM 
KCI, 15 mM MgCI2 in 250 mM Tris-HCI buffer, pH 8.3; Invitrogen), 2 ~L of 
dithiothreitol (OTT; 0.1 M; Invitrogen), 2 ~L of deoxynucleotide triphosphate 
(dNTP) mixture (10 mM dATP, dCTP, dGTP and dTTP each, all from Promega), 
10 U of RNase inhibitor (RNasin; 40 U/~L; Promega), and 200 U of reverse 
transcriptase from Moloney murine leukemia virus (Invitrogen) in a total of 20 1-1L 
per reaction. The reaction mixture was incubated at 37 oc for 1 h and then at 95 
' C for 5 min to convert RNA samples into eDNA. The eDNA samples prepared 
this way were stored at -70 °C until PCR amplification was performed. 
2.6.3 Real time RT-PCR 
A LightCycler (LC; Roche Biosciences) thermocycler instrument was used 
in this study to perform real time RT PCR. The 20 ~L eDNA prepared as above 
(see Section 2.6.2) was diluted (1 :4) with 60 ~L of sterile water and 2 ~L of this 
diluted eDNA was used in each real time PCR reaction. The LC PCR buffer was 
86 
prepared by adding 100 ~L of 1 OX PCR buffer (Invitrogen), 80 ~L of MgCI2 
(Invitrogen), 40 ~L of BSA (10 mg/mL) and 8 ~L of 25 mM dNTP mixture in 572 
~L sterile water. Nex1, 2 ~L diluted eDNA or 2 ~ L water, as a negative control, or 
2 ~L of appropriate plasmid with known copy number of the respective gene, as 
a positive control, were loaded into LC capillaries (Roche Biosciences). Each 
capillary was added with 16 ~L of freshly prepared LC PCR buffer, 0.2 ~L of Taq 
DNA polymerase, 0.667 ~L of 10X SYBR I dye (Invitrogen), and 2 ~L of gene-
specific primer mixture containing plus and minus primers at a concentration of 5 
pmol each. The primer sequences for each gene amplified in real time PCR are 
shown in Table 5.1 the capillaries were loaded into the LC carousel, briefly spun 
down and inserted into the chamber of the LC module (Roche Biosciences) to 
perform the reaction as per conditions established previously (Guy et a/. , 2006). 
LightCycler quantification soflware (Roche Diagnostics) was used for 
enumeration of copy numbers of the respective gene amplified . 
2.7 HISTOLOGICAL EXAMINATION OF LIVER TISSUE SAMPLES 
As described previously (Michalak et at. , 1999, Hodgson and 
Michalak, 2001 ; Michalak et at. , 2004), liver tissue samples were embedded in 
paraffin blocks. These liver fragments were cut into 5-~m thin sections and 
stained with hematoxylin and eosin, Mason-trichrome, periodic acid Shiff or 
impregnated with silver. The sections were examined under a microscope to 
assess histological lesions. Morphological alterations encountered in 
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hepatocellular, extrahepatocellular, intralobular and portal compartments of 
hepatic parenchyma were graded on a numerical scale from 0-3, as described in 
previous works (Michalak et at. , 1999, Hodgson and Michalak, 2001 ; Michalak el 
a/., 2004). This numerical score has been referred to herein as the histological 
degree of hepatitis. 
88 
CHAPTER 3: FLOW CYTOMETRIC QUANTITATION OF T CELL 
PROLIFERATION AND DIVISION KINETICS IN WOODCHUCK MODEL OF 
HEPATITIS 8 
This study has been published in Immunological Investigations, 2005; 34(2): pp 215-236 
3.0 SUMMARY 
Woodchucks infected with woodchuck hepatitis virus (WHV) represent the 
closest natural animal model to study the immunopathogenesis of liver injury 
caused by essentially noncytopathic, highly human specific hepatitis 8 virus 
(HBV). The importance of antiviral T cell response in induction of hepatitis and in 
control of HBV replication has been demonstrated . However, the understanding 
of how these responses contribute to the development of different 
immunomorphological forms of liver disease and their outcomes remain elusive. 
In this study, we established and standardized a flow cytometry assay using 
peripheral blood mononuclear cells labeled with carboxyfluorescein diacetate 
succinimidyl ester (CFSE) to assess WHV-specific and mitogen-driven T 
lymphocyte prol iferative responses in woodchucks. The assay is of significantly 
greater sensitivity than the adenine incorporation assay currently used when 
applied to measure either WHV-specific T cell responses in acute (P < 0.001 ) 
and chronic (P < 0.03) viral hepatitis or those induced by mitogens in both 
healthy and WHV-infected animals. It also provides a new type of information, 
not previously available, characterizing the strength of woodchuck T cell 
,----------------------------------------
proliferative reactivity by measuring cell division rates. The study shows that 
woodchuck PBMC labeled with CFSE exhibit light scatter and fluorescence 
profi les compatible to those of human PBMC, allowing quantitation and 
deconvolution of the flow cytometric data by applying the existing analytical 
softwares. The availability of this novel assay should facilitate a more precise 
and comprehensive evaluation of hepadnavirus-specific and generalized T cell 
responses in experimental WHV hepatitis. 
3.1 INTRODUCTION 
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Hepatitis B virus (HBV) is a noncytopathic DNA virus, the prototype of the 
hepadnaviral family. This pathogen infects an estimated 2 billion people, 
including more than 350 million persons with symptomatic chronic infection 
(WHO report, 2000). It contributes towards 0.5 to 1.2 million deaths annually 
(Lavanchy, 2004). The virus causes acute and chronic hepatitis, cirrhosis, and 
hepatocellular carcinoma (Chisari and Ferrari, 1995). It also induces persistent, 
probably lifelong, serologically silent (occult) infection (Michalak eta/., 1994; 
Rehermann eta/. , 1996; Yuki eta/. , 2003) . A large body of evidence indicates 
that the host cellular immune reactions directed against HBV proteins, 
particularly those mediated by T lymphocytes, are crucial to the development of 
liver disease and , at the same time, in restriction of virus replication in hepatic 
tissue (Bertoletti eta/., 1994; Maini eta/. , 2000; Thimme eta/. , 2003). It also 
becomes apparent that the strength and breadth of the initial T helper and 
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cytotoxic T cell responses are important in determining the final outcome of the 
disease, i.e., whether acute infection resolves or progresses to chronic hepatitis 
(reviewed in Chisari , 1997 & Michalak, 2004). Investigations of these events in 
humans are hampered by practical and ethical difficulties in acquisition of 
relevant samples, especially from individuals with acute hepatitis and with well-
defined onset of the infection. Chimpanzees infected with HBV have provided 
valuable insights to some aspects of the T cell response kinetics, but because of 
their restricted usage , the data available are sparse and derived from singular 
animals (Bertoni eta/., 1998; Thimme eta/., 2003; Weiland eta/. 2004). Studies 
in HBV transgenic mice allowed detailed characterization ofT cell immune 
responses towards different viral protein epitopes and contribution of these 
responses to hepatocellular injury in mice (Moriyama eta/. , 1990; Guidotti eta/. , 
1994; Chisari, 1996 ; Nakamoto eta/., 1998, Guidotti eta/., 1999); however, these 
observations require validation in the natural models of hepadnavirus infection. 
The infection of woodchucks (Marmota monax) with woodchuck hepatitis 
virus (WHV) has a disease course and the rates of recovery or progression to 
chronic hepatitis simi lar to those seen in hepatitis B (Michalak, 1998). This 
animal model is accepted as the closest natural system for studies of the HBV 
pathobiology and the pathogenesis of liver injury in hepatitis B (Michalak, 1998; 
Menne and Tennant, 1999). Evaluations completed so far have shown that the 
dynamics of WHV-specific T cell responses in woodchucks are compatible with 
those observed in HBV-infected humans (Menne eta/., 1998; Menne eta/., 
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2002a). However, the measurement of these responses by nucleotide 
incorporation assays currently used is elaborate, of low sensitivity, and involves 
biohazardous reagents. Among others, this is due to the fact that cultured 
woodchuck lymphocytes have very low levels of thymidine kinase activity, making 
implementation of assays based on 3H-thymidine incorporation impractical (Cote 
and Gerin, 1995; Maschke eta/., 2001). Alternatively, 3H-adenine was used to 
overcome this problem (Kreuzfelder eta/., 1996). However, since this nucleotide 
is incorporated into RNA, stimuli which induce cell proliferation and a higher RNA 
transcription cause a greater adenine incorporation leading to high background 
values and decreased assay sensitivity. 
In recent years, different cell dyes (e.g., CFSE, PKH, calcein, H33342) 
have been applied to label lymphocytes and monitor their proliferation kinetics 
(Parish, 1999). Among them, 5-(and-6)-carboxyfluorescein diacetate 
succinimidyl ester (CFDA-SE; commonly named as CFSE) is a membrane 
permeant dye that covalently binds to cytoplasmic proteins forming stable 
fluorescent conjugates, which can be readily tracked by fiow cytometry (Lyons 
and Parish, 1994). During each cell division, intracellular CFSE concentration is 
halved in daughter cell generations, allowing monitoring of the mitotic activity of 
proliferating cells (Nordan eta/., 1999; Bernard eta/. , 2003). Studies have 
shown that the assays measuring lymphocyte proliferation using CFSE gave 
overall more consistent results and a greater sensitivity than those using 
radiolabeled nucleotides (Angulo and Fulcher, 1998; Fulcher and Wong, 1999; 
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Mannering eta/., 2003). Further, the CFSE assay has been successfully applied 
to assess division kinetics of both naturally and in vitro activated cells in a variety 
of animal and cell culture systems (Fujioka eta/., 1994; Hodgkins et at., 1996; 
Fulcher and Wong, 1999; Warren, 1999; Oostendorp eta/., 2000; Sathiyaseelan 
and Baldwin, 2000; Dengler eta/. , 2001 ; Miller eta/. , 2002; Schneider eta/., 
2002; Chen et al., 2003; Li et a/. , 2003; Mueller-Stahl eta/., 2003). 
In this work, we developed and standardized the CFSE-based flow 
cytometric assay to monitor lymphocyte proliferation in the woodchuck model of 
HBV infection. We established conditions to measure both virus-specific and 
non-specific T cell proliferative responses. Furthermore, we compared the 
sensitivity of the CFSE assay with that of the adenine incorporation assay that is 
currently used. The CFSE assay, due to its superior sensitivity, reproducibility 
and the ability to measure kinetics ofT cell division, should provide a valuable 
tool in more precise and comprehensive measurements ofT cell responses in 
the woodchuck model of hepatitis B. 
3.2 MATERIALS AND METHODS 
3.2.1 Animals 
Eight healthy eastern American woodchucks (Marmota monax) and 17 
infected with WHV (11 with acute and 6 with chronic viral hepatitis) served as 
blood donors. WHV-positive animals were infected with 1.1 x 1010 DNase-
protected virus genome equivalents (vge) (Michalak eta/., 1999; Hodgson and 
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Michalak, 2001). Acute infection was diagnosed when serum became positive 
for WHV surface antigen (WHsAg) and antibody to WHV core antigen (anti-
WHc), but when WHs antigenemia lasted no longer than 6 months. Chronic 
WHV infection was considered when WHsAg, accompanied by WHV DNA and 
anti-WHc, persisted for longer than a 6-month period (Hodgson and Michalak, 
2001). Serial liver biopsies obtained from these animals at yearly intervals 
showed histological features of chronic hepatitis, as described previously 
(Michalak, 1998; Michalak eta/., 1999). Healthy animals were negative for 
serological markers of WHV infection and nonreactive for WHV DNA, as 
determined by testing total DNA extracted from randomly selected serum, 
peripheral blood mononuclear cell (PBMC) and liver biopsy samples by nested 
PCR-Southern blot hybridization assay with WHV genome-specific PCR primers 
(sensitivity, 10 vge/ml) (Michalak eta/., 1999; Michalak eta/., 2004). The study 
protocol was approved by the Institutional President's Committee on Animal 
Bioethics and Care. 
3.2.2 PBMC isolation 
PBMC were isolated from sodium ethylenediamine tetra-acetic acid 
(EDT A)-treated blood by density gradient centrifugation. In brief, whole blood 
was diluted with an equal volume of phosphate buffered saline, pH 7.4 (PBS) 
containing 1 mM EDTA (PBS-EDT A) and centrifuged through Ficoii-Paque Plus 
(Amersham Pharmacia Biotech, AB, Uppsala, Sweden) . PBMC were collected , 
washed with PBS-EDT A, and incubated with ammonium chloride cell lysing 
buffer for 15 minutes at room temperature to eliminate residual red blood cells 
(Lew and Michalak, 2001) . PBMC viabi lity was assessed by trypan blue 
exclusion and the cells were counted in a hemocytometer. 
3.2.3 Mitogens and antigens 
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Concanava lin-A (ConA; Pharmacia Fine Chemicals, Uppsala, Sweden), 
pokeweed mitogen (PWM, Phyto/acca americana agglutinin; ICN Biochemicals 
Inc., Aurora , Ohio) and phytohemagglutinin (PHA; ICN Biochemicals Inc.) were 
used as nonspecific stimulants ofT cell proliferation . Synthetic WHV core 
peptide (WHc97•110) , encompassing amino acids located in positions 97 to 110 of 
the virus nucleocapsid protein and containing a WHV core T cell 
immunodominant epitope (Menne et at., 1997), was prepared by Synprep 
Corporation (Dublin , CA). This peptide was implemented to evaluate WHV-
specific T cell response (Menne eta/., 2002b) . Bovine serum albumin (BSA; 
Sigma Chemical Camp., St. Louis, MO) was used as an irrelevant antigen and a 
negative control. Two-fold serial di lutions of mitogens (0.6- 40 ~glml) , WHc97.110 
peptide (1 .2- 20 ~glml) and BSA (1.2 -10 ~glm l) were used to standardize the 
assay conditions and to determine optimum concentrations to measure 
proliferation ofT lymphocytes and kinetics of their division in different animals. 
3.2.4 Cell CFSE labeling and culture 
--------------~-------------------------------------------------------
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PBMC at 1 x 107/ml in PBS were supplemented with 50 ~M CFSE 
(Molecular Probes, Eugene, Oregon) to achieve final concentrations ranging 
between 0.6 ~M and 5 ~M for the preliminary experiments aimed at determining 
the optimal CFSE labeling dose and 1.2 ~M for the final working assay. The cells 
were incubated at 37 ' C for 10 min and then washed twice with 10 ml of 5% fetal 
calf serum (FCS; GIBCO-Invitrogen Corporation , Auckland , New Zeland) in PBS 
(PBS-FCS). The cells were resuspended at 1 x 106 cells/ml in complete AIM-V 
lymphocyte culture medium (GIBCO-Invitrogen Corporation) supplemented with 
10% FCS. CFSE-stained PBMC were cultured in triplicate at 1 x 105 cells/well in 
96-well flat-bottom tissue culture plates (Becton Dickinson Labware, Franklin 
Lakes, NJ) in the presence of different concentrations of test mitogens, WHc97_, 10 
peptide or BSA. As controls , CFSE-Iabeled cells cultured with AIM-V medium 
alone and cells not stained with CFSE but stimulated with test mitogens or 
antigens were included. The plates were incubated at 37 ' C for 5 days, unless 
otherwise indicated . The cells from triplicate wells were pooled , supplemented 
with 5 ml of PBS-EDT A, spun down, resuspended in 1 ml of PBS-EDT A, and 
analyzed in a FACSCalibur flow cytometer (Becton Dickinson). 
3.2.5 Flow cytometry analysis 
Flow cytometry data were acquired for 2 x 104 to 5 x 104 events from each 
test sample by measuring CFSE fluorescence using an argon laser with 488 nm 
excitation wavelength and a 430/25 filter (FL 1 channel) . The woodchuck 
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lymphocyte population was defined by plotting total events using forward (FSC) 
and side (SSC) light scatter properties and normal human PBMC as the 
reference standard (see Figure 3.1). The woodchuck lymphocyte fraction was 
electronically gated to exclude cellular debris and granular cells other than 
lymphocytes. The kinetics of cell division were determined by deconvoluting and 
analyzing the reduced CFSE fluorescence using BD CeiiQuest Pro (Becton 
Dickinson) or Mod Fit LT (Verity Software House, Topsham, ME) softwares. 
Different quadrant and gate markers in BD CeiiQuest Pro software, which define 
cells with a higher (CFSE""'") and a lower (CFSE"m) fluorescence, were used to 
determine cell division index (C.D.I.) by applying the formula: percentage of 
CFSE' ;m cells after mitogen or antigen stimulation divided by percentage of 
CFSE0'm cells without stimulation. Mathematical deconvolution of halved cellular 
CFSE fluorescence, available in the Proliferation Wizard module of Mod Fit L T 
software, was used to determine the proliferation index (P.I.) and the number of 
daughter cell generations. Proliferative response with C .D.I. or P.l. values 
greater than 3 standard deviations (SO) above the mean value from controls (i.e., 
unstimulated PBMC from the same animal or PBMC stimulated with WHc97_, 0 
peptide from uninfected animals) was considered as positive. 
3.2.6 Adenine incorporation lymphocyte proliferation assay 
An adenine incorporation assay was applied in parallel with CFSE staining 
to comparatively determine the sensitivity and versatility of the CFSE assay in 
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detecting T lymphocyte proliferative responses in woodchucks. For this purpose, 
PBMC were cultured with or without test mitogen, WHc97_110 or BSA, under the 
same conditions as in the CFSE assay. After 96-h culture, the cells were 
supplemented with 0.5 ~Ci of 2-' H-adenine (Amersham Pharmacia Biotech) and 
incubated for 12-18 h. Then , cells were harvested on a glass fibre filte r 
membrane (Wallac Oy, Turku , Finland) using an automatic ce ll harvester 
(Harvester 96; Tomtec, Hamden, CT), and counts per minute (cpm) per well were 
determined in a T opcount Scintillator (Packards Bioscience Company, Meriden, 
CT). The average cpm counts from readings of triplicate wells, containing either 
stimulated or control cells , were calculated to define mean cpm values. The 
stimulation index (S.L) was calculated by dividing mean cpm obtained after a 
mitogen or antigenic stimulation by mean cpm detected in the absence of a 
stimulant. An S.L value of >3.1 was considered as positive. 
3.3 RESULTS 
3.3.1 Effects of CFSE on woodchuck PBMC survival 
To determine whether CFSE may affect survival of woodchuck lymphoid 
cells in culture, PBMC from healthy animals (n = 4) were exposed to different 
concentrations of CFSE (0.6 to 5 ~M) and cultured for up to 7 days. Cells not 
exposed to CFSE dye (designated as 0 ~M) and those incubated with CFSE and 
counted immediately after labeling and washing (designated as time 0) were 
used as controls. Cell viability was determined at the end of each incubation 
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period by trypan blue exclusion and expressed as the mean percent viability:!: 
SO. The results showed that the survival of cultured woodchuck PBMC, either 
stained with CFSE or not, progressively declined over culture time, however, it 
was not influenced to any appreciable extent by the concentration of CFSE (data 
not shown). Thus, CFSE-Iabelled PBMC showed viability comparable to that of 
unstained cells or cells exposed to CFSE but not cultured (time 0). Similar 
results were obtained when viability of PBMC was examined by flow cytometry 
using cells labelled with CFSE and propidium iodide (data not shown). PBMC 
from animals infected with WHV showed identical CFSE labeling and survival 
properties as those from healthy woodchucks (data not shown). As there was no 
difference in %viability of cells labelled with different concentrations of CFSE 
and concentration of 1.2 ~M did not interfere with reading of PI fiuorescence, 1.2 
~M CFSE was chosen for staining of woodchuck PBMC in subsequent 
experiments. 
3.3.2 Comparison of CFSE profiles of woodchuck and human PBMC 
Freshly isolated human and woodchuck PBMC stained with 1.2 ~M CFSE 
were cultured with or without ConA for 5 days and analyzed by fiow cytometry. 
As illustrated in Figure 3.1, woodchuck PBMC, either unstimulated or stimulated 
with mitogen, displayed comparable light scatter patterns to those of human 
PBMC. In Figure 3.1, lower right (LR) quadrant in dot-plots and M1 gate in 
histograms represent resting lymphocytes with no change in CFSE fiuorescence 
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(CFSE""'" cells), while lower left (ll ) quadrant and M2 gate represent the 
dividing cells with lowered CFSE fiuorescence (CFSE''• cells). As anticipated, 
control PBMC cultured without ConA showed no loss in CFSE fiuorescence in 
either LL quadrant or gate M2 (1% CFSE''• cells), which indicates that most of 
the cells were not proliferating in the absence of the test mitogen. In contrast, 
ConA-stimulated cells in either LL quadrant or gate M2 showed extensive 
reduction in CFSE fluorescence (95% CFSEdim cells), indicating proliferation of 
lymphocytes and generation of daughter cells. Overall, the results revealed that 
woodchuck and human lymphocytes produced similar CFSE light scatter and 
f luorescence patterns when either cultured with or without a stimulant. It was 
concluded that flow cytometric parameters used for identification of human 
lymphocytes are also applicable for lymphocytes derived from woodchuck PBMC. 
3.3.3 Assessment of analytical suitability of CFSE-Iabelled woodchuck 
lymphocytes 
After establishing light scatter parameters identifying CFSE-Iabelled 
woodchuck lymphocytes, the mitogen-driven proliferation of the cells was 
examined to determine analytical suitability of the flow cytometric data generated 
using different CFSE fluorescence deconvolution approaches. For this purpose, 
healthy PBMC were stained with CFSE and cultured with 5 ~g/ml of ConA, PHA 
or PWM or without mitogen for 5 days. As shown in Figure 3.2, PBMC were first 
plotted according to the FSC-SSC pattern and gated for lymphocyte population 
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Figure 3.1 Comparison of flow cytometric profiles of human and woodchuck 
PBMC labeled with CFSE. PBMC were stained with 1.2 ~M CFSE. cultured for 5 
days without (unstimulated) or in the presence of 5 ~g/ml of ConA, and analyzed 
by flow cytometry. Forward (FSC) and side (SSC) light scatter properties of the 
cells were used to differentiate between lymphocytes and other cells using 
human PBMC as a standard. Lymphocytes were gated to resting (gate R1) and 
blastogenic (gate R2) cells. Dot-plots and histograms included lymphocytes 
either from R1 or R2 or from R1 + R2 gates. LL quadrant in dot-plots and M2 
gated region in histograms define the proportion of proliferating lymphocytes with 
halved fluorescence. Percent values indicate proportion of the total lymphocytes 
present in each quadrant or gate. 
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Figure 3.1 
fSC v•.SSCprofile 
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(R1 gates are equal to R1 + R2 gates in Figure 3.1). Subsequently, the cells in 
the R1 gate were analyzed using either BD CeiiQuest Pro (histograms and dot-
plot profiles) or ModFit L T (ModFit L T profiles). With BD CeiiQuest Pro, the 
analysis showed that the mitogen-stimulated lymphocytes produced a large 
population of CFSE';m cells (>78% in either M2 gates or LL quadrants with C.D.I. 
>149), whereas those unstimulated exhibited the CFSE"''"' phenotype for most of 
the cells (Figure 3.2). However, while ConA, and PWM gave comparably high 
magnitudes of woodchuck lymphocyte proliferation (C.D.I. >186), stimulation with 
PHA led to relatively lower cell expansion (C.D.I. 149). Quantification of the 
lymphocyte division by deconvoluting CFSE fluorescence using Mod Fit L T 
demonstrated that woodchuck lymphocytes that responded to mitogen were 
mainly in daughter generations 4 to 6, although they could be tracked up to 6-8 
generations. Also, while the calculated P.l. values for lymphocytes stimulated 
with ConA and PWM were similar, the value obtained for cells incubated with 
PHA was the lowest. This was consistent with the results from the histogram and 
dot-plot profile analyses. Overall, the different analytical approaches tested 
confirmed the versatility of the flow cytometric data generated using CFSE-
stained woodchuck lymphocytes. 
3.3.4 Determination of optimal culture time of CFSE-Iabelled PBMC 
After establishing that the CFSE-Iabelled woodchuck PBMC were suitable for the 
quantitative assessments of lymphocyte proliferation and division kinetics, the 
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Figure 3.2 Flow cytometric quantification of proliferation and daughter cell 
generations of mitogen-stimulated woodchuck lymphocytes. PBMC labeled with 
1.2 ~M CFSE were cultured for 5 days with 5 ~g/ml of ConA, PHA or PWM or 
medium alone (unstimulated), harvested , washed , and analyzed by flow 
cytometry. Lymphocyte population was gated using light scatter properties (R1 
gate). The CFSE fluorescence data from cells in gate R1 were re-analyzed with 
BD CeiiQuest Pro (histograms and dot-plots) or ModFit L T (Mod Fit L T profiles). 
CFSE"m cells were separated from CFSE'"'"' cells by gates in histograms and 
quadrant lines in dot-plots, and percent of CFSE';m cells and C.D.I. calculated , 
respectively. Deconvolution of CFSE fluorescence with Mod Fit L T separated 
daughter cells into generations. Using unstimulated cells to define parent 
generation, P.l. values were determined. Percent of CFSEdlm cells and C.D.I. or 
P.l. values for unstimulated and stimulated PBMC are shown in respective plots. 
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CFSE assay conditions were standardized. In the first instance, the optimum 
time period for culture of CFSE-Iabelled lymphocytes was determined. For this 
purpose, CFSE-stained PBMC from healthy animals (n = 3) were cultured for 1, 
3, 5, 7 and 10 days with 5 or 10 ~g/ml of ConA or PHA or with 2.5 or 5 ~g/ml of 
PWM, analyzed by flow cytometry, and their C.D.I determined. As shown in 
Figure 3.3, lymphocytes stimulated with two concentrations of three different 
mitogens produced maximum mean proliferative responses on day 5. A similar 
result was obtained when cells were exposed to WHc97_110 peptide (see Figure 
3.5). Although stimulated lymphocytes gave a comparable number of CFSE' 'm 
cells when cultured for 5, 7 or 10 days (data not shown), C.D.I. values were 
noticeably lower for the cells cultured for longer than 5 days due to an increased 
proliferation of unstimulated cells in control wells. Based on these results, 
woodchuck PBMC labelled with CFSE were cultured for 5 days in subsequent 
experiments. 
3.3.5 Determination of optimal mitogen concentrations for assessing 
CFSE-tabelled lymphocyte proliferation 
To determine the range of mitogen concentrations which would be most 
appropriate for assessing the extent of woodchuck lymphocyte proliferation and 
their division kinetics, CFSE-Iabelled PBMC were cultured for 5 days with 
increasing 2-fold serial concentrations of ConA (1.2- 40 ~g/ml), PHA (1 .2 - 40 
~g/ml) or PWM (0.6- 20 ~g/ml). Figure 3.4A illustrates the typical patterns and 
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Figure 3.3 Determination of optimal culture time for CFSE-Iabeled woodchuck 
lymphocytes. PBMC from 3 healthy animals were stained with 1.2 ~M CFSE and 
cultured in the presence of ConA or PHA at 5 (open symbols) or 10 ~g/ml (filled 
symbols) or PWM at 2.5 (open symbols) or 5 ~g/ml (filled symbols). Cells were 
harvested after 1, 3, 5, 7 and 10 days and analyzed by BD Cell Quest Pro to 
determine the percent of CFSEdim cells and C.O.I. The data shown at each time 
point represent the C.D.I. values for 3 PBMC samples each stimulated with two 
concentrations of the mitogens tested. The mean C. D. I. values are marked. 
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Figure 3.4 Determination of optimum concentration ranges of mitogens to 
evaluate proliferative potency of CFSE-Iabelled woodchuck lymphocytes. 
Isolated PBMC were cultured for 5 days with six 2-fold serial dilutions of ConA or 
PHA (1 .2 - 40 ~g/ml) or PWM (0.6- 20 ~g/ml) or without mitogen (control), and 
analyzed by flow cytometry. Deconvolution of CFSE fluorescence and 
determination of P.l. was done using Mod Fit L T software. (a) Profiles of 
lymphocyte daughter cell generations from a single healthy woodchuck donor 
after stimulation with six two-fold serial concentrations of each mitogen tested . 
(b) Cumulative data from four independent experiments in which PBMC from 9 
healthy animals were examined . The results were shown as means.±. SO. 
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the range of responses to different mitogen concentrations using PBMC from a 
single healthy woodchuck donor. Deconvolution of CFSE fluorescence into 
generations showed that various concentrations of the same mitogens produced 
variable numbers of daughter cell generations and , in consequence, P.l. values, 
although the highest and the lowest amounts of the mitogens usually stimulated 
cells to the lowest degree. 
Figure 3.4B shows the cumulative data from 9 healthy animals. As 
depicted, any amount of ConA, PHA or PWM tested was able to stimulate , at 
least to some degree, proliferation of PBMC (represented by high error bars). 
However, overall , the greatest proliferation and the most daughter cell 
generations were seen when PBMC were cultured with ConA at 5 ~g/ml , PHA at 
10 ~g/ml or PWM at 2.5 ~g/m l (Figure 3.4B). Among the mitogens tested , ConA 
gave the greatest P.l. (Figure 3.4A and Figure 3.4B) and C.D.I. (not shown) 
values. Nevertheless, due to fluctuations in mitogen-driven lymphocyte 
proliferative responses in different animals, it was concluded that five 2-fold serial 
dilutions of each mitogen, i.e ., ConA and PHA at 1.2-20 ~g/ml and PWM at 0.6 -
10 ~g/ml, should be routinely tested for truly thorough determination of the 
response in woodchucks. 
3.3.6 Measurement of WHV-specific lymphocyte proliferation 
After standardization of the conditions using non-specific mitogens, CFSE 
assay was applied to test WHV-specific T cell responses using synthetic peptide 
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Figure 3.5 WHV-specif ic T lymphocyte proliferation profiles determined by flow 
cytometry. PBMC isolated from a healthy woodchuck and a WHV-infected 
animal were labeled with 1.2 ~M CFSE and cultured unstimulated or stimulated 
with 10 ~g/m l WHc97_11 0 peptide for 5 days_ Different analytical methods were 
employed to evaluate WHV-specific T lymphocyte proliferation response, as 
described in the legend to Figure 3.2. 
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WHc91. 110 , as a virus-specific antigen . PBMC from either healthy or WHV-
infected woodchucks were stimulated with the peptide (see below) and analyzed 
by flow cytometry. It was found that lymphocytes in response to WHV peptide 
gave the light scatter and CFSE fluorescence profiles comparable to those 
induced by mitogens (Figure 3.5). Although all methods of the cytometric data 
analysis used for evaluation of mitogen-induced T cell responses (see Figure 
3.2) were applicable to monitor rather weak proliferation driven by WHc97_110 
peptide, C.D.I. values were found to define this reactivity with the highest 
precision. Hence, C.D. I. units were used in the subsequent experiments to 
quantify WHV-specific lymphocyte response. 
3.3.7 Eva luation of WHV-specific T cell responses using CFSE assay 
T a determine the optimal culture period and concentrations of WHc97_110 
peptide, PBMC from WHV chronically infected (n = 4) and healthy (n = 4) 
animals were cultured for 3, 5, 7, 10 and 14 days with 2-fold serial dilutions of the 
peptide ranging between 1.2 and 10 ~g/ml. The highest proliferative response 
produced by a given PBMC sample against any concentration of the WHc97. 110 
peptide or mitogen was defined as a peak response. As shown in Figure 3.6A, 
lymphocytes from healthy animals did not proliferate following incubation with 
WHc97_110 peptide for any of the time periods examined . In contrast, lymphocytes 
from WHV-infected animals responded , producing the peak C.D.I. mean value 
after 5 days in culture. Similarly as it was observed with mitogen stimulations, 
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Figure 3.6 Evaluation of WHV-specific T cell responses using CFSE assay. (a) 
PBMC from 4 healthy animals and 4 WHV-infected woodchucks were cultured 
with four 2-fold serial concentrations of WHc97.,, peptide (1.2- 10 ~g/ml) for the 
time periods shown. Their CFSE fluorescence was analyzed by BD CeiiQuest 
Pro software and C.D.I. determined. The data shown represent the peak C.D.I. 
values given by PBMC from each animal with any of four WHc97_110 
concentrations tested. The mean peak C.D.I. values are marked. (b) 
Cumulative data from four independent experiments in which PBMC from 7 
healthy animals, 11 with acute WHV hepatitis and 6 with chronic WHV hepatitis 
which were cultured for 5 days with four 2-fold serial concentrations of WHc97. 110 
peptide (1.2- 10 ~g/ml). Only the peak T cell proliferation response (peak C.D.I.) 
against any concentration of the peptide for each test PBMC sample is shown. 
The mean peak C.D.I. values are marked for each group of animals. The dotted 
line represents the cut off value determined as described in Materials and 
Methods. Mann-Whitney test was used to compare the data between the 
groups. 
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CFSEdim cells were also abundant after 7- and 10-day culture (data not shown) , 
but the peak C. D. I. mean values were lower than those of day 5, since 
unslimulated cells in control wells proliferated to a greater extent. Furthermore, 
there was no evident correlation between the peptide concentration and the 
magnitude of the response. Therefore, four 2-fold serial concenlrations of the 
peptide ranging between 1.2 and 10 ~g/ml were routinely used in subsequent 
tests. 
Figure 3.68 shows cumulative data from examining lymphocytes from 7 
heallhy animals, and from 11 woodchucks with acute and 6 with chronic WHV 
hepatitis using WHc97_, , peptide. The woodchucks in acute phase of hepatitis 
showed the strongest WHV-specific T cell response (peak C.D.I. mean 16.5 ± 
SD 3.3) , as compared to the animals with chronic hepatitis (peak C.D.I. mean 5.7 
± SD 1.2), whi le T lymphocytes from healthy woodchucks did not respond (peak 
C.D.I. mean 1.6 ± SD 0.1). Statistical analysis using nonparametric Mann-
Whitney test confirmed that the lymphocyte proliferation in WHV-infected animals 
was significantly greater than that in healthy woodchucks and thai the animals 
with acute hepatitis demonstrated overall a stronger response to WHc97_110 
peptide than those chronically infected (Figure 3.68) . 
3.3.8 Comparison of CFSE and 3H-adenine incorporation assay 
Assessment ofT cell proliferation was carried out simultaneously using 
CFSE and 3H-adenine incorporation assay to compare the relative sensitivity of 
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Figure 3. 7 Comparison of sensitivity of CFSE and 3H-adenine incorporation 
assays in detecting T cell proliferation responses. PBMC from healthy animals (n 
= 7) and from woodchucks with acute (n = 11) or chronic (n = 6) WHV hepatitis 
were analyzed in parallel using CFSE and 3H-adenine incorporation assays. For 
both assays , cells were cultured for 5 days with 2-fold serial concentrations of 
ConA (1.2- 20 ~g/ml) or WHc97. , 0 peptide (1.2- 10 ~g/ml) and their proliferation 
responses assessed to define peak C.D.I. and S.l. values. The dotted lines 
represent the cut off values for each assay and group tested . The statistical 
analysis of data was performed using Wilcoxon signed rank test. 
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the assays in detecting woodchuck lymphocyte proliferation. In both assays, 
PBMC from healthy and WHV-infected animals were stimulated for 5 days with 
2-fold serial concentrations of ConA (1.2- 20 ~g/ml) or WHc, _,,peptide (1 .2- 10 
~g/ml). The peak C.D.I. and S.l. were determined and compared using Wilcoxon 
signed rank test. As shown in Figure 3.7, stimulation with ConA gave a stronger 
PBMC response in all three groups of animals that was readily detectable by 
both assays, but the magnitude of the response was significantly greater in 
CFSE assay than that determined by 3H-adenine incorporation assay (P < 0.01 ). 
As expected, lymphocytes from healthy animals did not respond to stimulation 
with WHc97_110 peptide in either CFSE or 3H-adenine incorporation assay. Based 
on the cut off value of these assays, i.e., mean C.D.I. plus 3 SO given by PBMC 
from healthy animals or S.l. ":3.1, it was found that the CFSE assay detected 
WHc97_110 peptide-specific T cell response in 10 of 11 animals with acute hepatitis 
and in all 6 with chronic WHV hepatitis, while the 3H-adenine incorporation assay 
failed to detect the response in 7 of 11 and 5 of 6, respectively. In addition, the 
magnitudes of the lymphocyte proliferation measured by the CFSE assay were 
significantly greater for both acutely (P < 0.001) and chronically (P < 0.03) 
infected woodchucks than those determined using the 3H-adenine incorporation. 
Therefore, the data clearly showed the CFSE assay's superiority, considering 
both the sensitivity with which WHV-specific proliferation was detected and the 
magnitude of the response. In addition, the CFSE assay provided a new set of 
valuable data characterizing the division kinetics on the woodchuck T cells, which 
were not available using the 3H-adenine incorporation assay. 
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3.4 DISCUSSION 
In this study, the conditions to quantify woodchuck T lymphocyte 
responses using flow cytometry and cells stained with CFSE dye were 
established. Until now, different nucleotide analogues, such as adenine, uridine 
or bromodeoxyuridine (BrdU), have been employed for this purpose (Kreuzfelder 
eta/. . 1996; Menne eta/. , 1997; Shanmuganathan et a/. , 1997). The present 
report describes a more sensitive, non-radioactive and relatively simple approach 
to measure both antigen-driven and mitogen-induced division of woodchuck 
lymphocytes. 
CFSE is a cell membrane permeant dye which becomes fluorescenl only 
after diffusing into the cells where its binds to intracellular molecules and gels 
sequentially halved in its intracellular concentration during each mitotic daughter 
cell generation (Lyons, 2000; Lyons eta/., 2001). It has been shown that CFSE 
can be incorporated into different types of lymphoid cells, including T cells 
(Schneider eta/. , 2002; Givan eta/., 2004), B cells (Fulcher eta/. , 1996; 
Cabatingan eta/. , 2002), NK cells (Warren and Kinnear, 1999), dendritic cells 
(Weijer eta/., 2002) and hematopoietic cells (Ristevski et a/., 2003; Servet-
Delprat eta/., 2002). Hence, when using this dye for monitoring lymphocyte 
proliferation, the electronic gating is essential to the separation of the lymphocytic 
population from other constituent cells of PBMC, using their differential FSC and 
SSC properties. Further, while gating PBMC based on their light scatter 
properties, it needs to be considered that resting lymphocytes have lower light 
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scatters than those of proliferating cells. Therefore, the extended gates are 
required to include blastogenic cells, which possess higher FSC VS sse 
properties. As shown in this study, the comparative analysis of flow cytometric 
data demonstrated that woodchuck PBMC share similar, if not identical , light 
scatter and CFSE fluorescence patterns to those of human PBMC. These 
affirmative analogies led to the conclusion that the analytical methods used to 
deconvolute and quantify CFSE fluorescence from experiments with human 
PBMC (e.g. , Angulo and Fulcher, 1998) can also be applied for the assessment 
of cell proliferation rates in CFSE-Iabelled woodchuck PBMC. 
CFSE dye has been used in a wide variety of in vivo and in vitro 
experimental systems for the determination of cell division. However, most of 
these studies report cell division rates in terms of the total number or percentage 
of cells with lowered CFSE fluorescence over that of the non-proliferating parent 
cell generation. In contrast, defining cell proliferation in terms of C.D.I. or P.l. 
allows for the quantification, as well as the gradient comparison of the strength of 
cell division. Nevertheless, magnitudes defined by these units reflect different 
aspects of cell proliferation. Thus, C.D.I. is a semi-quantitative measure of cell 
proliferation and is more useful in quantifying proliferation in response to a weak 
stimulus, because it does not consider different degrees of CFSE fluorescence 
halving in proliferating cells, but instead , all the cells with fluorescence lower than 
that of the parent generation cells are considered as one population . In contrast, 
P.l. evaluation considers the differential CFSE fluroscence halving for grouping 
the dividing cells into different daughter cell generations and then determines the 
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cell population in each generation separately. Therefore, C.D.I. units are more 
useful when determining relatively weak T cell proliferative responses, as seen 
for those against WHc97.,0 peptide (Figure 3.5 and 3.6), while evaluation of P.l. 
has a greater value when grading rather strong proliferative responses, as 
observed in mitogen-triggered division of woodchuck T cells (see Figure 3.4). 
Mitogens are routinely employed in T cell proliferation assays as non-
specific stimulants to measure the generalized competence of the cellular 
immune response and as positive controls in the assay evaluating antigen-
specific responses. However, in most of the studies, only one or two different 
concentrations of any mitogen are tested. During this study, we have observed 
that there was no single concentration of the mitogen examined (i.e., ConA, PHA 
or PWM), which produced uniformly maximum stimulation of PBMC derived from 
different animals. Considering this result, it should be mandatory to assess 
different concentrations of each stimulant to establish the concentration ranges 
producing maximum T cell responses in the majority (or preferentially in all) of 
PBMC samples tested. Subsequently, the pretested range of concentrations 
specific for each mitogen or antigenic stimulant should be routinely applied to 
monitor lymphocyte proliferative responses to determine their true range. 
Previous studies have shown that the magnitudes of antiviral T cell 
proliferation produced by WHV-infected woodchuck PBMC are lower than those 
observed in other viral infections (Menne eta/. 1998). Further, woodchucks 
progressing to or being in chronic phase of WHV hepatitis displayed even lower 
levels of virus-specific T cell response than those detected in animals who 
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resolved the infection (Menne eta/., 2002a). In these studies, either adenine or 
BrdU incorporation assays were implemented. These traditional assays measure 
T cell proliferation at the end of the stimulation period (i.e. , after 4 to 7 days of 
culture) by pulsing cells with nucleotide for 12-18 hours. This approach suffers 
from the short-time cell exposure to a marker nucleotide and from the fact that it 
accounts only for the cells in the S phase of division (Parish and Warren , 2001). 
It was also shown that lymphocyte division in response to the antigenic stimuli is 
followed by a wave of apoptosis (Renno eta/. , 1999; Mannering eta/. , 2002) and 
that this event occurs during the first few days of culture (Usherwood eta/., 
1999). Therefore, cells proliferating during this initial phase are excluded from 
the proliferation analysis in this type of assays. On the other hand, it was shown 
that CFSE remains associated with apoptotic cells, which are readily traced by 
flow cytometry (Oumitriu eta/., 2001). This feature of CFSE makes possible 
monitoring of cell division during a prolonged stimulation period that is normally 
required for testing T cell proliferation in response to antigenic stimuli. 
Furthermore, the CFSE-based assay generates detectable magnitudes of cell 
proliferation even after exposure to a weak antigenic stimulant and , therefore, 
can be used to detect rare antigen-specific T cells and their proliferative 
responses (Mannering eta/. , 2003). This property could be particularly valuable 
when assessing WHV-specific T cell reactivity in chronic WHV hepatitis, as it is 
exemplified by detection of WHc, _,, peptide-specific T cell response in PBMC 
samples from all 6 animals chronically infected with WHV (see Figure 3.68). 
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In summary, the present study shows that the flow cytometry assay 
applying PBMC labelled with CFSE dye offers a new approach to more sensitive 
and informative assessment of WHV-specific and generalized T cell response in 
the woodchuck model of hepatitis B. Implementation of th is assay should 
contribute towards a better understanding of the pathogenesis of liver disease 
and its chronic progression in HBV infection. 
- l 
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CHAPTER 4: CHARACTERIZATION OF BIOACTIVE RECOMBINANT 
WOODCHUCK INTERLEUKIN-2 AMPLIFIED BY RLM-RACE AND PRODUCED 
IN EUKARYOTIC EXPRESSION SYSTEM 
This study has been published in Vet. lmmunol. lmmunopath. 2006; 112(3-4): pp 183-198. 
4.0 SUMMARY 
Woodchucks (Marmota monax) infected with woodchuck hepatitis virus 
(WHV) represent a highly valuable laboratory model of hepatitis B virus (HBV) 
infection, in which molecular, immunological and pathological events occurring in 
infected humans are adequately reflected. To advance studies on T cell immune 
responses and propagation of hepadnavirus in T lymphocytes in this animal 
model, we determined the complete sequence of woodchuck interleukin-2 (wll-2) 
eDNA by utilizing RNA ligase-mediated rapid amplification of eDNA ends (RLM-
RACE) reaction. The wl l -2 sequence revealed a single open reading frame 
encoding for the predicted precursor protein comprised of a signal peptide and a 
134 amino acid-long mature protein. The mature wll -2 protein produced in the 
Escherichia coli expression system, designated as ec-IWIL-2, was found to be 
immunogenic but not biologically active. In contrast, precursor wll -2 protein 
cloned into baculovirus transfer vector and expressed in Sf9 cells, designated as 
bac-rwll-2, demonstrated functional competence. Further, bac-rwll-2 was able 
to stimulate proliferation and to induce multiple daughter cell generations in 
woodchuck T cells, as well as facilitated the survival of standard IL-2-dependenl 
mouse CTLL-2 cells in culture. Western blot analysis of bac-rwll -2 using 
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antibodies generated against ec-rwll-2 revealed a single protein band of 15.5 
kDa. The availability of biologically active recombinant wll -2 should facilitate ex 
vivo studies on functional competence of woodchuck T lymphocytes derived from 
different stages of hepadnaviral hepatitis and assist in recognizing their 
contribution to the pathogenesis of liver injury in the woodchuck model of 
hepatitis B. 
4.1 INTRODUCTION 
lnterleukin-2 (IL-2) was discovered while studying in vitro proliferation of 
human T cells derived from the bone marrow (Morgan eta/., 1976). It had been 
initially named as aT cell growth factor (TCGF). This cytokine is mainly 
produced by activated T lymphocytes (Ho el a/., 1999), while at smaller 
quantities it is also secreted by dendritic cells (Granucci el a/. , 2001), B cells 
(Walker eta/., 1988) and NK cells. IL-2 is required for the antigen-specific 
primary and memory T cell proliferation and during the phenotypic maturation of 
type 1 and type 2 T helper cells (Miyazaki el a/., 1995; Frauwirth and Thompson, 
2004). The cytokine also enhances cytotoxic activity of cos• T and NK cells 
(Carson eta/., 1997), and production of antibodies by B cells (Gaffen eta/., 1996; 
Blackman eta/., 1986). IL-2 binds to the receptor complex, IL-2R, made up of 
three subunits, IL-2Ra (C025 or Tac antigen), which is specific for IL-2, and IL-
2RP (CD122) and IL-2Ry (CD1 32), which belong to the type I cytokine receptor 
superfamily (Waldman, 1993; Gaffen, 2001 ). 
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IL-2 eDNA is composed of the 5'-leader sequence, open reading frame 
(ORF), and the 3'-trailer sequence (see Fig. 4.1). The ORF encodes for a 
precursor protein of 155 to169 amino acids depending on the species origin, 
which contains a 20-23 amino acid-long signal peptide. This signal peptide is 
cleaved off prior to the secretion of the mature, functionally active cytokine from 
cells. In different mammals, the mature IL-2 is glycosylated to varying degrees 
giving molecular masses ranging between 15 to 18 kDa (Robb and Smith, 1981 ; 
Robb eta/., 1981 ; Taniguchi eta/., 1983; Cerretti eta/. , 1986). Two of three 
cysteine residues present in the secreted protein form disulfide bonds and are 
essential for the cytokine's biological activity (Cerretti et at. , 1986). IL-2 belongs 
to the type I cytokines comprised of four a-helical bundles, as it was shown by 
crystal structure analysis of human IL-2 (Bazan, 1992). 
IL-2 sequences from several different species have been determined, 
cloned, and expressed in either prokaryotic or eukaryotic cells to generate a 
functionally active protein. For example, human IL-2 was produced in 
Escherichia coli (E. co/1) (Devos eta/., 1983), COS cells (Cerretti et at., 1986), 
insect cells infected with a recombinant baculovirus vector (Smith eta/., 1983), 
and in tobacco cells (Magnuson eta/., 1998). These studies revealed that the 
biological activity of IL-2 is independent of the glycosylation status and it is 
embraced within the extreme N-terminal 30 amino acid sequence of the mature 
protein, which also contains the binding site for IL-2R (Eckenberg et at., 2000). 
Previous attempts to determine a nucleotide sequence of woodchuck IL-2 
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(wll-2) led to identification of a 3'-terminal portion of the mature protein and the 
3'-trailer sequence (see Figure 4.1) (Nakamura eta/., 1997; Hodgson and 
Michalak, 2001 ). In the present study, we determined the complete sequence of 
wll-2, cloned its full-length eDNA, expressed both mature and precursor wll-2 
proteins and assessed their biological activity, none of which had been known or 
done before. In addition , specific polyclonal antibodies against wll-2 were 
produced . 
Woodchucks (Marmola monax) infected with woodchuck hepatitis virus 
(WHV) represent a highly valuable natural model of human hepatitis B virus 
(HBV) infection and HBV-induced hepatocellular carcinoma (HCC) (Michalak, 
1998; Menne and Tennant, 1999; Michalak, 2000). It is important to indicate that 
HBV is one of the most widely spread human pathogens which chronically infects 
350 to 400 million people worldwide (Lavanchy, 2004). Studies in the 
woodchuck model significantly contributed to recognition of the mechanisms of 
hepadnavirus-induced liver injury (Michalak, 2004). Among others, the strength 
and the broadness of virus-specific T cell responses were found to be crucial in 
determining the outcome of hepadnaviral hepatitis (Ferrari el a/., 1990; Chisari 
and Ferrari , 1995; Menne eta/., 2002). It was also established that both HBV 
and WHV invade and replicate in cells of the immune system (Michalak, 2000; 
Michalak el a/., 2004), although immunological and pathological consequences of 
this infection remain unclear. 
The studies in the woodchuck model of hepatitis Bare hampered by the 
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limited availability of species-specific reagents and assays (Wang and Michalak, 
2005) . The present work was undertaken to generate biologically active 
recombinant wll-2 (rwll-2) to facilitate ex vivo experimentations with woodchuck 
T cells, including those infected in vivo or in vitro with WHV. 
4.2 MATERIALS AND METHODS 
4.2.1. Source of wll-2 RNA 
Healthy woodchucks were maintained in the Woodchuck Research and 
Breeding Faci lity at the Health Sciences Center of Memorial University, St. 
John's, New1oundland, Canada. Blood samples were collected under a general 
inhalant anesthesia and peripheral blood mononuclear cells (PBMC) isolated by 
density gradient centrifugation , as described before (Gujar and Michalak, 2005). 
The cells viabi lity was determined by trypan blue dye exclusion and normally 
exceeded 98%. 
4.2.2 Amplification of wll-2 eDNA fragment 
Total RNA was isolated from woodchuck PBMC in vitro stimulated with 
Concanavalin (ConA). For this purpose, 1 x 10' cells were cultured for 72 h in 10 
ml of complete AIM-V medium (G IBCO-Invitrogen Corp. , Auckland , New 
Zealand) supplemented with 10% fetal calf serum (GIBCO-Invitrogen Corp.) and 
5 ~g/ml of ConA (Pharmacia Fine Chemicals, Uppsala, Sweden). Total RNA was 
extracted using Trizol reagent (Invitrogen, Carlsbad , CA) and 2 ~g of RNA was 
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reversely transcribed to eDNA, as described elsewhere (Hodgson and Michalak, 
2001 ). Expression of wl l -2 in the resulting eDNA preparation was determined 
using primers and PCR conditions reported previously (Hodgson and Michalak, 
2001). For this purpose, sense primer 5'-GGAGGAAGTGCTGAATGTACC, 
homologous to the sequence located in a 3'-portion of the predicted mature wll-
2, and antisense primer 5'-GATGTTATACACGGGAGGCACC, homologous to a 
fragment of the predicted 3'-trailer sequence of wll-2, were used. Based on 
interspecies sequence homology between IL-2 of human, rabbit and mouse, 
several degenerative primers (not shown) were designed in an attempt to amplify 
wll-2 eDNA sequence located upstream from the fragment amplified with the 
primers indicated above using various PCR conditions. However, all these 
attempts were not successful. 
4.2.3. Generation of full-length wll-2 eDNA by RLM-RACE and 
determination of its sequence 
The 5'-end of wll-2 eDNA was amplified using RNA ligase-mediated rapid 
amplification of eDNA ends (RLM-RACE) reaction kit (Ambion Inc. Austin, TX) 
following the manufacturer's instruction. Briefly, 1 0 ~g of total RNA was treated 
with calf intestine alkaline phosphatase to remove the 5'-terminal phosphates 
from the nucleic acid sequences except the capped mRNA. Then, the RNA was 
treated with tobacco acid pyrophosphatase to remove the cap structures, leaving 
monophosphate at the 5'-ends of the full-length mRNAs. The resulting mRNAs 
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were ligated to a 45 base pair (bp)-RNA adapter oligonucleotide using T4 RNA 
ligase. The adapter-ligated RNAs were reversely transcribed to cDNAs using 
random primers. Subsequently, a hot-start PCR was implemented to amplify the 
5'-portion of wl l -2 sequence using as the template eDNA generated above. For 
this purpose , the adapter-specific outer sense primer provided in the kit and wll-
2-specific outer antisense primer 5'-GCTTCGAGATGATGCTTTGGC were used. 
The PCR product was further amplified in a nested reaction with the adapter-
specific inner sense primer from the RLM-RACE kit and wll-2 specific inner 
antisense primer 5'-GTACA TTCAGCACTTCCTCCA. 
To determine a complete sequence ofwll-2, the resulted nested PCR 
product was cloned into TOPO-PCR II vector using a TA cloning kit (Invitrogen) 
and amplified in competent Top 10 cells. Recombinant plasmid was excised and 
the presence of wll-2 insert confirmed after digestion with Hind Ill and Xho I 
restriction enzymes by electrophoresis in agarose gel. The full-length wll-2 
sequence was determined using both the fmol DNA Sequencing System 
(Promega Corp ., Madison, Wi) (Coffin et at. , 2004) and fluorescence-based 
automated sequencing (services provided by the Core Facility of the Department 
of Genetics, the Hospital for Sick Children , Toronto, Canada). 
4.2.4 Expression of rwll-2 in E. coli 
Based on the complete sequence of wll-2 determined as above (also see 
Figure 4.2) , PCR primers spanning the entire predicted sequence of mature wll-
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2 were designed. For this purpose, eDNA derived from ConA-stimulated 
woodchuck PBMC was amplified with the pair of primers constituted by sense 
primer 5'-GCGCATAcatatgGCACCCACCTCCGGC and antisense primer 5'-
GTGctcgagAGTGAGCTICGAGATGATGCTITGGC with introduced Ndel and 
Xhol restriction sites (indicated in lower case letters), respectively . The resulted 
PCR product was cloned into pET -41 b( +) expression vector (Novagen , 
Darmstadt, Germany) and amplified in E. coli Top 10 cells. Kanamycin-resistant 
bacterial colonies were selected , their extracted DNA digested with Nde I and 
Xho I enzymes, and the digests screened for the presence of the rwll-2 insert. 
In the next step, E. coli BL21(DE3) cells were transformed with the recombinant 
plasmid isolated from a single positive colony and cells cultured overnight. 
Subsequently, using the obtained aliquot as the starter inoculum, a new scaled 
up culture was established . When OD600 of the culture reached 2.0, 1 mM 
isopropyi-~-D-thiogalctopyranoside (IPTG) was added and incubation continued 
for 2 h. In parallel , an aliquot of the same cell suspension was incubated in the 
absence of IPTG, as an uninduced cell control. The cells were spun down, 
immediately frozen at -80 ' C for overnight, and then lysed with Bug Buster 
reagent (Novagen) in the presence of 20 Ulml of benzonase (Novagen). The 
resultant inclusion bodies and soluble cytoplasmic fractions were suspended in 8 
M urea and analyzed by SDS-PAGE to assess the presence of E. coli-derived 
rwll-2, designated as ec-rwll-2 , by comparing lysates from IPTG-induced and 
uninduced cells. 
,---------------------- ------ ----1 
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Because ec-rwll-2 was tagged at the C-terminus with a polyhistidine, the 
purification of this recombinant protein was accomplished in the presence of 8 M 
urea using a Ni-NTA agarose immobilized metal affinity chromatography (I MAC) 
column (Qiagen Inc. , Mississauga, Canada), following the procedure proposed 
by the manufacturer. Purified fractions were analyzed by SDS-PAGE and 
Western blotting (see below) using anti-histidine antibodies (Jackson 
lmmunoResearch Lab Inc., West Grove, Pa). The fraclions containing ec-rwll-2 
were pooled and dialyzed against stepwise decreasing concentrations of urea 
from 6 M to 1 M and finally against phosphate-buffered saline, pH 7.4 (PBS) over 
a 7-day period at 4 °C. Using the same approach, unrelated recombinant WHV e 
antigen (ec-rWHe) was expressed and purified, and used as a specificity control 
(Wang and Michalak, 2005). 
4.2.5. Expression of rwiL-2 in insect cells 
The whole precursor sequence of wll-2, encompassing both the mature 
protein and the signal peptide sequences (see Figure 4.1 ), was inserted into the 
baculovirus transfer vector pBiueBac4.5 (Invitrogen). Briefly, the fragment was 
amplified with sense primer 5'-GCCGctcgagCTCTACCGCCATGCACACCC and 
antisense primer 5'-ATGCCCaagcttTCAAGTGAGCTTCGAGATG with introduced 
Xhol and Hindlll restriction sites (indicated in lower case letters), respectively. 
The resulting PCR product was subcloned in pBiueBac4.5 vector and amplified in 
E. coli Top 10 cells. After confirmation of the correctness of the DNA band 
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pattern obtained after digestion with Xhol and Hindlll enzymes by gel 
electrophoresis and the correct orientation of the rwll-2 insert in pBiueBac4.5-
rwiL·2 plasmid by sequence analysis, a Hi-Speed Plasmid Purification Kit 
(Qiagen Inc.) was used to acquire a large quantity of pBiueBac4.5-rwiL-2. This 
purified plasmid was co-transfected along with AcMNPV DNA (Bac-N-Biue DNA; 
Invitrogen) into Spodoptera frugiperda (Sf9) insect cells using a cationic liposome 
reagent, lnsectinPius (Invitrogen). Chromogenic substrate X-gal and plaque 
assay were used to distinguish between recombinant and wild type (WT) viral 
plaques. For the amplification of the recombinant and WT (control) viruses, 
respective plaques were collected and used to infect healthy Sf9 cultures. DNA 
was isolated from supernatants of these cells and screened by PCR using 
primers specific for baculovirus polyhedrin gene (Invitrogen) or wll-2. To 
generate a larger amount of the recombinant virus, the Sf9 cells were infected 
with the confirmed baculovirus-rwll-2 construct and cultured for 8 days. The titer 
of the recombinant virus was determined in the plaque assay with 1 0-fold serial 
dilutions of the final supernatant and was found to be 1.2 x 106 plaque forming 
units/mi. 
For protein production, Sf9 cells were infected with the recombinant 
baculovirus carrying rwll-2 at the multiplicity of infection (MOl) of 5 and cultured 
for 7 days at 27 ' C. The supernatant from this culture containing secreted rwll-
2, designated as bac-rwll-2, was collected and examined by Western blotting 
using guinea pig anti-ec-wll-2 antibodies prepared in the course of this study 
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Figure 4.1 Schematic comparison of IL-2 sequences and their structural 
organizations in different mammalian species. Nucleotide and amino acid 
sequences for human , mouse and rabbit IL-2 were procured from GenBank 
(accession numbers NM000586, NM008366, and AF068057 respectively). The 
lengths of the complete cDNAs and their structural elements are shown as a 
number of nucleotides (nt) and those of the translated proteins as a number of 
amino acids (aa). The lengths of the complete sequence of woodchuck IL-2 
eDNA identified in this study, its predicted constitutive elements, and encoded 
proteins are depicted at the bottom of the figure . The locations of the previously 
identified 237-nt (Hodgson and Michalak, 2001 ) and 497-nt (Nakamura el a/., 
1997) wl l -2 sequence fragments are marked . 
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(See below). 
4.2.6. Assays measuring rwll-2-induced T cell proliferation 
Since proliferating woodchuck PBMC fail to incorporate 3H-thymidine 
(Maschke el a/. , 2001), the ability of ec-rwll-2 and bac-rwll-2 to stimulate 
proliferation of normal woodchuck T cell was examined using 3H-adenine 
incorporation assay and a CFSE (5-and-6-carboxyfluorescein diacetate 
succinimidyl ester)-based flow cytometry lymphocyte proliferation assay, as 
described before (Gujar and Michalak, 2005). Briefly, for ' H-adenine 
incorporation assay, woodchuck PBMC were cultured at 1 x 105 cells/well in 
triplicates in 96-well, flat-bottom tissue culture plates (Becton Dickinson Labware, 
Franklin Lakes, NJ) with 1 0-fold serial dilutions of purified ec-rwll-2 or Sf9 cell 
supernatant containing bac-rwll-2. As controls, !MAC-purified ec-rWHe or 
supernatants from non-infected Sf9 cells and from Sf9 cells infected with WT 
baculovirus were used. After 6 days of culture, cells were pulsed for 12-18 h with 
' H-adenine (0.25 ~Ci/well) (Amersham Pharmacia Biotech AB, Uppsala, 
Sweden) and harvested. Stimulation index (S.I.) was defined by dividing mean 
counls per minute (cpm) obtained after rwll-2 stimulation by mean cpm detected 
in the absence of rwll-2 (Gujar and Michalak, 2005). 
For CFSE assay, woodchuck PBMC were labeled with 1 ~M of CFSE 
(Molecular Probes, Eugene, Or) and then cultured as indicated for the adenine 
incorporation assay. After 7 days of culture, cells were harvested and CFSE 
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fluorescence analyzed using a BD FACSCalibur cytometer (Becton Dickinson, 
Franklin Lakes, NJ), as described previously (Gujar and Michalak, 2005). In this 
assay, supernatants from cultured non-infected Sf9 cells and from Sf9 infected 
with WT baculovirus cells, along with rhll-2 (Roche Applied Sciences, 
Indianapolis, In), served as controls. CFSE fluorescence halving in dividing cells 
was evaluated using Mod Fit LT soflware (Verity Soflware House, Topsham, Me). 
4.2. 7 Assay with CTLL-2 cells 
To further ascertain that the generated ec-rwll-2 and bac-rwll-2 were 
biologically active, murine CTLL-2 cells, a cytotoxic T cell clone which depends 
on IL-2 for survival (Gillis and Smith, 1977), were used to quantify wll-2 activity. 
Briefly, CTLL-2 cells were maintained in complete AIM-V medium in the presence 
of 1:1 0 dilution of supernatant from GenA-stimulated rat splenocytes (Gillis and 
Smith, 1977; Belani and Weiner, 1999). Prior to the assay, the cells were 
washed with PBS containing 1 mM EDTA, counted, and seeded at a density of 5 
x 10'cells/well in a 96-well, flat-bottom tissue culture plate. Ten-fold serial 
dilutions of affinity-purified ec-rwll-2, Sf9 cell supernatant containing bac-rwll-2 
or supernatants from cultures of non-infected Sf9 cells and Sf9 cells infected with 
WT baculovirus or aliquots containing two-fold serial dilutions of recombinant 
human IL-2 (rhll-2) ranging from 40 U/ml to 0.03 U/ml were added to wells in 
triplicates, while AIM-V medium alone was added to control wells. The cells were 
incubated for 24 h at 37 ' C in a tissue culture incubator, then pulsed for 18 h with 
' H-adenine (0.25 ~Ci/well) , and harvested. One IL-2 unit was defined as the 
amount of the cytokine required to induce 50% of maximal 3H-adenine 
incorporation (Stern et at., 1984; Reeves eta/., 1986). 
4.2.8 Production of anti-rwiL-2 antibodies 
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Guinea pigs were immunized intramuscularly with 100 ~g of the I MAC-
purified ec-rwll-2 emulsified in 500 ~I of complete Freund's adjuvant. 
Subsequent booster injections of ec-rwll-2 (50 ~g each) emulsified in incomplete 
Freund's adjuvant were given intramuscularly on days 21 , 28 and 35 following 
the initial injection. One week after the final injection, the animals were 
sacrificed. Serum samples were collected before the first injection (preimmune 
serum) and at autopsy. The presence of anti-wll-2 antibodies and their titer was 
determined by Western blot analysis using ec-rwll-2 and unrelated ec-rWHe 
protein as a specificity control. 
4.2.9 505-PAGE and Western blot analyses 
For SDS-PAGE, preparations of inclusion bodies from the IPTG-induced 
cultures of E. coli expressing ec-IWIL-2 or ec-rWHe and from cultures not 
induced with IPTG were separated along with pre-stained protein molecular 
weight markers (Invitrogen) on 12% or 15% polyacrylamide gels following 
procedures previously described (Michalak and Lin, 1994). Molecular weights of 
the proteins detected after staining with 0.5% Coomassie blue were determined 
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using standard curves derived from the relative electrophoretic mobilities of the 
pre-stained molecular weight markers. 
For Western blot analysis, the recombinant proteins indicated above 
separated by SDS-PAGE were transferred onto a nitrocellulose membrane 
(Amersham Biosciences Ltd., Little Chalfon, UK) using semi-dry protein transfer 
method (Michalak and Lin, 1994). To eliminate possible non-specific binding, the 
membrane was treated with a blocking solution containing 1% normal goat serum 
(Sigma-Aldrich Camp. , St. Louis, Mo) and 0.25% Tween-20 in PBS with 1 mM 
EDTA. The transferred proteins were probed with mouse monoclonal anti-
histidine antibody (Jackson) and then with alkaline phosphatase-labeled goat 
anti-mouse lgG antibodies (Jackson). The reaction was developed with a 
NBT/BCIP substrate solution (Sigma-Aldrich). 
Similarly, the !MAC-purified ec-rwiL-2 and culture supernatants from Sf9 
cells containing bac-rwll-2 or from Sf9 cells infected with WT baculovirus or from 
naive Sf9 cells, along with control unrelated ec-rwWHe, were analyzed by 
immunoblotting. The transferred proteins were probed with guinea pig anti-ec-
rwiL-2 antibodies (1 :100 dilution) and then exposed to alkaline phosphatase-
labeled goat anti-guinea pig lgG (Jackson). Positive reactions were visualized 
with a NBT/BCIP substrate reagent. 
4.3 RESULTS 
4.3.1 Determination of the complete wiL-2 eDNA sequence 
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Prior to this study, only a 497 bp-long fragment of wll-2 encompassing the 
3'-portion of the predicted mature protein and the 3'-trailer sequence had been 
identified (Nakamura et al, 1997; Hodgson and Michalak, 2001 ). The order of 
nucleotides encoding for the 5'-leader sequence, the signal peptide and the 5'-
portion of the mature wll-2 were unknown. After several attempts, in which 
different primer pairs and varied PCR conditions were tested, we were unable to 
generate the 5'-portion of wll-2 eDNA using this approach. However, when the 
5'-terminal sequence of wll-2 eDNA was amplified by RLM-RACE reaction and 
the resulting product cloned, and the cloned fragment expanded, excised and 
sequenced, the desired sequence was obtained (Figure 4.2A). Combining this 
newly determined 290-bp 5'-fragment with the 237-bp sequence previously 
defined in this laboratory (Hodgson and Michalak, 2001 ), and confirmed in the 
course of this study, and with the 3'-terminal 260-bp fragment of the 3'-trailer 
sequence delineated by others (Nakamura et at., 1997), we reconstructed the 
complete sequence of wll-2 eDNA (Figure 4.1). The wll-2 sequence 
determined in this study was submitted to GenBank under accession number 
DQ272238. 
The alignment of the entire wll-2 nucleotide sequence determined in this 
study with those of human, mouse and rabbit revealed an overall homology of 
80%, 71% and 79%, accordingly (Figure 4.2A), while comparison of the predicted 
amino acid sequence showed compatibility of 70%, 55%, and 67%, respectively 
(Figure 4.28). Further analysis, in which the results on an interspecies 
comparison of known IL-2 amino acid sequences were taken under 
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Figure 4.2 Alignments of woodchuck IL-2 nucleotide and amino acid sequences 
with those of human, mouse and rabbit IL-2. (A) Nucleotide sequence 
comparison. The start codon of the predicted precursor protein of wll-2 is 
underlined. (B) Comparison of the amino acid sequences of the precursor IL-2 
proteins. Inverted triangle shows the predicted cleavage site for the mature wll-
2 protein. In consensus sequences (bottom lines), nucleotides or amino acids 
identical in all sequences are marked as asterisks and differences are shown as 
dots. 
145 
Figure 4.2A 
L 
146 
Figure 4.2B 
.... 
Wooclchuck 1 ldHTNPLLSCLALTLALVAHGAPTSGS--------------AEETRQQLEQL L LDLQMLSR 
Rabbit 
1 .YR.Q . . .. I .. I. 
1 .YS.Q.A .. VT. 
. . . S . T-----------KKTKK. QL . .. H . . ILN 
. .. S . TSSSTAE.AQQQQQQQQQQQ. H . . . E. LS 
1 . YKVQ .... I. . , . LTSS .... S . --------------TJC . QE . • 0 . 
1 * · .. ·* ..... . • .• .• ........... . 
Woodchuck 47 GVSNQENSTLTRMLKFK!'YMI?MKASDU.HLQCLEEELKPLQEVLNVPQSKNFHUtDTRNF 
50 . IN . YK.PK ... . . K . . TE . KQ . . . . ... . R-P.DL 
61 RUE.YR.LK.P. . . . L. KQ . TE . KD ... .. D .. G .. RH .. DLT .. . S . Q. E . AE . 
Rabbit 47 .. NOYK .. K . S .. . T ... . .. K . VTE.K .. • . E •• •• LA . G .. S. GGN .• ES 
151 •••••. * . . * .***."***·"'···· · *··*••** ·**.** . . **. ·*·* · 
Woodchuck 107 ISN:rNVTVLKLKGSA'l'T!"rCEYAPETANIVEFLNTWITFCQSIISKLT-
109 .I .. E. . ••• . R .• 
121 . , . . ON .. E .QFDD.S . TV.D .. RR .. A . . .. TSPQ 
Rabbit 107 . .. . . . . ... .. . . E- . . M . . 
121**** ·* ·*······ .. ·· · '"· · ·'"· · · · '" · '"'"· ·'" '" · '"'"'"'" .. '"'" · · 
147 
consideration, predicted the existence of a single ORF in the wll-2 sequence. 
This ORF is comprised of a 465 bp-long sequence encoding for the wll-2 
precursor with the translation initiation codon located at nucleotide 46 and the 
termination codon positioned at residue 508 (see Figure 4.1 and 4.2A). This 
precursor sequence should encode for the 20 amino acid-long signal peptide and 
the 134 amino acid-long mature protein with calculated molecular weights of 1.8 
kDa and 15.5 kDa, respectively. The predicted mature wll·2 protein contains an 
alanine residue at the N-terminus (position 21) and a threonine at the C-terminus 
(position 154). Post factum analysis, in which the entire wll-2 nucleotide 
sequence was compared to the consensus sequence derived from IL-2 of 
human, mouse and rabbit origin, revealed that the 3'-trailer sequence, as 
anticipated, to be most homologous (69%), whereas the region encoding for wll -
2 signal peptide to be most heterogeneous (43%). The sequences encoding for 
wll-2 5'-leader sequence and mature protein showed compatibility with a 
consensus sequence of 63% and 64%, respectively. 
4.3.2 Expression of mature rwiL-2 in E. coli 
A woodchuck eDNA fragment encoding for the predicted mature wll -2 
protein was amplified by PCR, subcloned, and the construct expressed in E. coli. 
By SDS-PAGE analysis (Figure 4.3A), the presence of ec-rwll-2 was evident in 
the inclusion bodies prepared from E. coli cultures induced with IPTG, but not 
from the bacteria cultures not treated with IPTG. These inclusion bodies carried a 
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protein with a molecular size of 16.8 kDa, which was compatible with that 
calculated for the mature wll-2 based on the nucleotide sequence determined in 
this study plus six histidine residues added at the C-terminus along with a 
methionine residue at the N-terminus of the protein. In contrast, soluble cell 
fractions or culture supernatants collected from either IPTG-induced or non-
induced cultures did not show ec-rwll-2 presence (data not shown). An 
irrelevant protein, ec-rWHe with a molecular size of 18 kDa (Figure 4.3A), which 
was cloned and expressed in the same expression system (Wang and Michalak, 
2005), was used as an efficacy control. To facilitate purification by IMAC, both 
ec-rwll-2 and control ec-rWHe were tagged with polyhistidine at their C-termini. 
The affinity-purified ec-rwll-2 and ec-rWHe showed single protein bands of 16.8 
kDa and 18 kDa, respectively, when examined by SDS-PAGE (data not shown). 
These purified proteins were further analyzed by Western blotting using 
monoclonal antibody to polyhistidine as a probe. The immunoblot data 
confirmed the existence of a single protein band of 16.8 kDa for ec-wrll-2, as 
compared with the 18-kDa band given by ec-rWHe (Figure 4.3B). It was 
estimated that the yield of the affinity-purified ec-rwll-2 was 40 ~g per ml of 
culture medium from the IPTG-induced cells. Further investigations revealed that 
although ec-rwll-2 was able to induce specific antibodies in immunized animals 
(see Figure 4.4B), it was functionally inactive when tested in appropriate 
bioassays (see below). 
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Figure 4.3 SDS-PAGE and Western blot analyses of ec-rwll-2 produced in E. 
coli expression system. (A) SDS-PAGE analysis of two randomly selected E. coli 
colonies (indicated as 1 and 2) expressing ec-rwll-2 or control ec-rWHe. Lanes: 
I, inclusion bodies from E. coli celllysates after IPTG induction ; U. uninduced E. 
coli cell lysates; M, pre-stained protein marker ladder. (B) Western blot analysis 
of I MAC-purified ec-rwll-2 and ec-rWHe using anti-histidine monoclonal 
antibodies. Molecular sizes of the identified ec-rwll-2 (16.8 kDa) and ec-rWHe 
(18 kDa) are marked on the right side and the left side of the panel , respectively. 
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4.3.3 Expression of precursor rwll-2 in the baculovirus-insect cell system 
Since generation of biologically active mature wll-2 in the E. coli system 
was not successful, the predicted sequence encoding the entire wll-2 precursor 
protein was amplified by PCR and the purified product subcloned in pBiueBac4.5 
plasmid vector using Xho I and Hind Ill restriction sites. The resulting 
recombinant plasmid, p81ue8ac4.5-wll~2 , along with linearized AcMNPV DNA, 
was co-transfected in Sf9 insect cells. Then, Sf9 cell plaques carrying the 
recombinant baculovirus with wll-2 sequence (bac-rwll-2 virus) were 
differentiated from those carrying WT virus in the plaque assay. The correctness 
of the bac-wll-2 recombinantion was confirmed by PCR using baculovirus 
polyhedrin-specific and wll-2-specific primer pairs. As shown in Figure 4.4A, 
DNA from culture supernatants of two randomly selected Sf9 cell plaques 
expressing bac-wll-2 showed the expected DNA fragments of 900 bp or 465 bp 
after amplification with baculovirus or wll-2 specific primers, respectively. As 
anticipated, a supernatant from uninfected Sf9 cells tested did not show DNA 
amplification signals, whereas a supernatant from Sf9 cells infected with WT 
baculovirus gave a band of 839 bp with polyhedrin-specific primers but not with 
wll -2-specific primers (Figure 4.4A). This PCR analysis ensured that only the 
cell plaques expressing bac-rwll -2 were used for further expansion and studies. 
Further, the selected Sf9 cell plaque carrying bac-rwll-2 virus, as 
confirmed by the PCR analysis, was expanded and its supernatant tested for the 
presence of rwll-2 protein, designated as bac-rwll -2, by SDS-PAGE and 
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Figure 4.4 PCR and Western blot analyses of bac-rwiL-2 DNA or bac-rwiL-2 
protein in culture supernatants from Sf9 insect cells. (A) PCR-based 
identification and purity screening of the recombinant baculovirus DNA in 
supernatants from infected Sf9 cell plaques. DNA isolated from test 
supernatants was amplified with primers specific for either baculovirus polyhedrin 
gene (lanes 1-5) or wiL-2 (lanes 6-10). Lanes: M, molecular marker ladder; 1 
and 6, water instead of DNA as a contamination control; 2 and 7, supernatant 
from uninfected Sf9 cells; 3 and 8, supernatant from Sf9 cells infected with WT 
baculovirus; 4 , 5, 9 and 10, supernatants from two randomly selected Sf9 cell 
plaques transfected with recombinant baculovirus carrying rwiL-2. Molecular 
sizes of PCR amplicons are indicated on sides of the panel. (B) Western blot 
analysis of bac-rwiL-2 protein. Supernatants from Sf9 cell plaques were probed 
with either guinea pig pre-immune serum (top panel) or guinea pig anti-ec-rwiL-2 
antibodies (bottom panel). Lanes: M, pre-stained molecular weight markers; 1, 
I MAC-purified ec-rwiL-2; 2, supernatant from uninfected Sf9 cells; 3, supernatant 
from Sf9 cells infected with WT baculovirus; 4, supernatant from Sf9 cells 
transfected with recombinant baculovirus carrying rwiL-2. Proteins bands of 16.8 
kDa and 15.5 kDa correspond to ec-rwiL-2 and bac-rwiL-2, respectively. 
Figure 4.4 
A 
900 
839 
B 
153 
~ bac ~ ~wiL-2~ 
M 3 4 5 M 10 
465 
Pre-Immune serum 
Antl-ec-rwlL-2 
- 15.5 
154 
immunoblotting using antibodies to ec-rwll-2 produced in the course of this 
study. When analyzed by SDS-PAGE, bac-rwll-2 did not yield a protein band 
(data not shown). However, a clearly visible band of 15.5 kDa was detected 
when bac-rwll-2 was probed with anti-ec-rwll-2 antibodies by Western blotting 
(Figure 4.48), indicating that the cytokine was produced but at the levels not 
detectable by standard SDS-PAGE. The same immunoblot analysis showed that 
anti-ec-rwll -2 antibodies also specifically recognized ec-rwll-2, but they did not 
react with proteins present in supernatants from uninfected Sf9 cells or those 
infected with WT baculovirus (Figure 4.48). Pre-immune serum collected from 
the animal that finally provided anti-ec-rwll-2 antibodies was not reactive with the 
preparations tested (Figure 4.48). 
4.3.4 Induction of woodchuck T cell proliferation by bac-rwll-2 
Recombinant wll-2 proteins, both ec-rwll-2 and bac-rwl l -2, were tested 
for their ability to stimulate proliferation of woodchuck T lymphocytes by using 
P8MC isolated from healthy animals. The proliferation was measured by a 3H-
adenine incorporation assay or a CFSE-based flow cytometric assay, which were 
previously established in this laboratory (Gujar and Michalak, 2005). The results 
showed that the affinity-purified ec-rwll-2 failed to stimulate proliferation of 
woodchuck T lymphocytes under any concentration and assay conditions tested 
(data not shown). In contrast, woodchuck P8MC cultured in the presence of 10-
fold serial dilutions of the supernatant containing bac-rwll-2 demonstrated an 
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extensive, dose-dependent uptake of 3H-adenine, as shown in Figure 4.5A. The 
analysis revealed that bac-rwll-2 was highly potent since measurable 
woodchuck T cell proliferation was found even at the supernatant dilution of 
1:90,000 (Figure 4.5A). Nevertheless, the supernatant at dilutions of 1:1000 or 
1:2000 consistently gave the highest T cell stimulation indices and, hence, bac-
rwll-2 at these dilutions was used in subsequent experiments. Supernatants 
from either uninfected Sf9 cells or those infected with WT baculovirus did not 
induce proliferation of woodchuck PBMC (Figure 4.5A). 
In the subsequent step, division kinetics of woodchuck T lymphocytes 
driven by bac-rwl l -2 was examined using a CFSE flow cytometric assay (Gujar 
and Michalak, 2005). Deconvolution of CFSE fluorescence into daughter cell 
generations showed that the supernatant containing bac-rwll-2 at 1:1000 
produced up to 9 cell divisions of woodchuck lymphocytes, as shown in Figure 
4.58. When dilution 1:100 was tested, up to 7 cell divisions were seen, whereas 
dilutions 1:10 and 1:10,000 generated no more than 5 cell divisions (data not 
shown). In parallel, the effect of a commercially available rhll-2 on proliferation 
of woodchuck T cells was also examined. The results showed that rhll-2 at 5,10 
and 20 U/ml induced no more than 5 to 6 divisions of woodchuck T cells, as 
illustrated for rwll-2 tested at concentration of 5 U/ml in Figure 4.58. It is of note 
that bac-rwll-2 was also able to stimulate proliferation in human T cells, but the 
magnitude of cell division was many fold lower than that induced by rhll-2 (data 
not shown). Culture supernatants from Sf9 cells, either uninfected or infected 
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Figure 4.5 Proliferation and daughter cell generation in woodchuck T 
lymphocytes treated wilh bac-rwll-2. (A) Proliferation of woodchuck T cells in 
response to increasing dilutions of bac-rwll-2 measured by 3H-adenine 
incorporation assay. PBMC isolaled from a healthy woodchuck were incubated 
in triplicates with indicated dilutions of supernatants from Sf9 plaques not 
infected with baculovirus (uninfected), infected with WT baculovirus or infecled 
with the recombinant baculovirus (bac-rwll-2). After 5 days, cells were pulsed 
with 3H-adenine, proliferation ofT cells measured and expressed as stimulation 
index, as outlined in Section 3. (B) Analysis of woodchuck T cell division kinetics 
using a CFSE-based flow cytometric assay. Woodchuck PBMC from a healthy 
woodchuck were labeled with 1 uM of CFSE and incubated with 1:1000 dilulion 
of supernatants from uninfected Sf9 cells, Sf9 cells infected with WT baculovirus, 
Sf9 cells infected with the recombinant baculovirus (bac-rwll2) or with 5 U/ml of 
rhll-2. After 6 days, cells were harvested and analyzed by flow cytometry. 
Using ModFit L T software, CFSE fluorescence halving was deconvoluted into 
daughter cell generations. 
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with WT baculovirus did not induce division of woodchuck T cells (Figure 4.58), 
confirming specificity of the results obtained. 
4.3.5 Survival of IL-2-dependent CTLL-2 cells in the presence of bac-rwll-2 
To further strengthen the conclusion that bac-rwll-2 displays 
characteristics of biologically active IL-2, a classical bioassay with murine IL-2-
dependent CTLL-2 cell line was performed using rhll-2 as a reference. As 
shown in Figure 4.6, serial dilutions of the supernatant containing bac-rwll -2 and 
purified rhll-2 produced comparable kinetics of cell division in CTLL-2 cells when 
measured by 3H-adenine incorporation assay. Taking into consideration the 
bioactivity plot obtained for known concentrations of rhll-2 (Figure 4.6) (Stern el 
at. , 1984), it was estimated that bac-rwll-2 activity was equivalent to 5 x 10' U/ml 
in the culture supernatant produced. 
4.4 DISCUSSION 
In the course of this study, the complete nucleotide sequence of wll -2 
was established. We have successfully resolved the previously unknown 5'-
fragment of wl l -2 eDNA encoding for the cytokine 5'-leader sequence, the 
cytokine signal peptide and the 5'-portion of the mature protein. We also 
confirmed the correctness of the previously identified segments of wll-2 
sequence. Further, the deduced mature protein and the precursor protein of wll-
2 were produced in prokaryotic and eukaryotic expressions systems, 
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Figure 4.6 Quantification of bac-IWIL-2 activity in bioassay with CTLL-2 cells. 
CTLL-2 cells were cultured in triplicates with indicated dilutions of Sf9 cell 
supernatant containing bac~rwll-2 or with indicated amounts of rhll-2 
preparation. After 24-h incubation, cells were pulsed with 3H-adenine, harvested 
and incorporation of adenine determined by measuring cpm. Dotted line 
identifies the amount of bac-rwll-2 needed for producing half maximal 
proliferation in CTLL-2 cells, as extrapolated from a standard curve given by 
serial dilutions of rhll-2. 
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respectively, and their molecular size and biological activity were determined. 
Our initial attempts were directed toward amplification of the 5'-portion of 
wll-2 eDNA by standard PCR using several degenerative primers. The 
sequences of these primers were designed based on the interspecies IL-2 
sequence homology and were located up-stream from the previously identified 
497-bp wll-2 fragment (see Figure 4.1) (Nakamura eta/., 1997; Hodgson and 
Michalak , 2001 ). However, repeated efforts using different primer combinations 
and PCR conditions failed to generate the anticipated sequence. Therefore, the 
RLM-RACE reaction was utilized to retrieve the 5'-portion of wll-2 eDNA. This 
approach was successful allowing for reconstruction of the entire wll-2 
sequence. The alignment of the wll-2 sequence with the IL-2 consensus 
sequence derived from human, mouse and rabbit (Figre 4.2) showed the highest 
degree of heterogeneity (-57%) in the region encoding for the predicted signal 
peptide of the precursor protein . This may explain why efforts to amplify the 5'-
portion of wll-2 eDNA using degenerative PCR primers with sequences 
corresponding to this region were futile. 
Analysis of the wll-2 sequence indicated that the ORF identified should 
encode for the 154 amino acid-long precursor protein comprised of a 20 amino 
acid-long signal peptide and 134 amino acid-long mature protein . The previous 
studies demonstrated that biological activity of recombinant IL-2 derived from 
different species was contained within the mature protein and was independent 
of post-transcriptional modifications (Robb and smith, 1981 ; Robb et a/., 1981). 
These recombinant proteins, which were usually produced in E. coli expression 
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system, displayed signature biological characteristics of IL-2, such as the ability 
to induce division in autologous T lymphocy1es and to support survival of IL-2-
dependent cell lines, such as CTLL-2 or BT2 cells (Miller-Edge and Splitter el a/., 
1984; Cerretti el a/., 1986; Sato el a/. , 1987; Magnuson el a/., 1998; Zhou el a/., 
2005). Considering these facts, the deduced mature protein of wll-2 was 
expressed in E. coli as a polyhistidine-tagged protein, affinity purified from 
bacterial cell lysate on an IMAC column, and reconstituted by gradually removing 
urea from the eluate. Nevertheless, although the obtained protein retained 
antigenic competence of wll-2 and antibodies raised against this protein 
recognized both ec-IWIL-2 and bac-IWIL-2 by immunoblotting, it was not able to 
stimulate proliferation of woodchuck T cells or CTLL-2 cells in culture. This 
suggested that IWIL-2 derived from E. coli was inactive or may have failed tore-
fold properly during purification. 
Recombinant baculovirus vector propagating in insect Sf9 or Sf21 cells is 
an increasingly used system in which expression of a variety of mammalian 
proteins has been achieved (Cochran el a/., 1987; Domingo and Trowbridge, 
1988; Hasemann and Capra, 1990; Luckow, 1993; Barrault et a/., 2005), 
including production of recombinant woodchuck interferon gamma and tumor 
necrosis factor alpha in this laboratory (Wang and Michalak, 2005). This system 
offers an important advantage over the E. coli expression system in which protein 
post-translational modifications, folding and secretion are more compatible with 
those naturally occurring within mammalian cells (Kidd and Emery, 1993; Geisse 
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eta/., 1996). Furthermore, recombinant proteins generated in the baculovirus-
insect cell system are devoid of potentially toxic bacterial contaminations (Stacey 
eta/. . 1993; Wang and Michalak, 2005). In the current study, expression of the 
precursor wll-2 protein in insect cells led to secretion of the biologically active 
cytokine to the culture supernatant, indicating that the cells correctly processed 
this woodchuck protein. Western blot analysis of bac-rwll-2 showed a single 
protein band of 15.5 kDa for which the molecular size was identical to that 
predicted from the nucleotide sequence of the mature wll-2. Of note is that the 
culture supernatant did not reveal a protein with the predicted molecular size of 
17.3 kDa , which might have corresponded to the precursor protein, confirming 
that precursor protein was completely processed to mature protein within the 
infected insect cells prior to secretion . 
The biological activity of IL-2 is traditionally evaluated by measuring its 
potential to induce proliferation of autologous T lymphocytes or other cells of 
which survival or function intimately depend on the cytokine presence. Using 3H-
adenine incorporation and CFSE flow cytometric assays, the specificity and 
magnitude of cell division induced by bac-rwll-2 in samples of normal 
woodchuck PBMC were examined. The data from these evaluations showed 
that the culture supernatants from either uninfected insect cells or those infected 
with WT baculovirus did not stimulate woodchuck T cells , whereas that 
containing bac-rwll-2 induced measurable proliferation of the cells even at very 
high dilutions which corresponded to estimated cytokine concentrations of as low 
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as 0.05 U/ml. Parallel testing of bac-rwll-2 and rhll-2 by CFSE-based flow 
cy1ometry proliferation assay revealed that bac-rwll-2 examined at the 
functionally optimal dilutions was consistently more potent and induced more 
daughter cell generations in woodchuck T lymphocy1es than rhll-2. Moreover, 
deconvolution of CFSE fluorescence showed that there was a smaller 
percentage (<1 %) of undivided parent cells in woodchuck T cells stimulated with 
bac-rwll-2 than in those exposed to rhll-2 (5-10%). Together, these data 
demonstrated that there was a significant degree of cross-reactivity in biological 
activity between human and woodchuck IL-2, as it was also noticed by others 
(Menne eta/., 1998), but bac-rwll-2 was consistently more effective in inducing 
woodchuck T cell proliferation ex vivo than rhll-2. 
To further validate functional capacity of bac-rwll-2 produced in this study 
and, at the same time, to quantify its biological activity, the cytokine was tested in 
parallel with a well characterized preparation of rhll-2 using a standard bioassay 
in which murine IL-2-dependent CTLL-2 cells are used as targets (Stern eta/., 
1984; Sato eta/. , 1987). It was found that bac-rwll-2 supported survival of 
CTLL-2 cells as well as stimulated their proliferation in a dose dependent manner 
giving a profile similar to that induced by rhll-2. Based on the compatibility in the 
proliferation kinetics of CTLL-2 cells in response to serial dilutions of rhll-2 and 
bac-wll-2, the biological activity of bac-rwll-2 in the Sf9 cell culture supernatant 
was estimated. This activity was found to be similar to or greater than that for 
recombinant IL-2 preparations reported in other studies (Taniguchi eta/. , 1983; 
Cerretti el a/., 1986; Reeves el a/., 1986; Sato el a/. , 1987; Magnuson eta/., 
1998;). 
165 
The availability of biologically active wll-2 should facilitate further research 
on hepadnavirus-specific T cell responses in the woodchuck model of hepatitis B 
and aid in the development of WHV-specific T cell clones. It should also 
contribute to the elucidation of a role of hepadnavirus replication in lymphoid cells 
in the natural course of hepatitis and help to establish long-term cultures of 
woodchuck T lymphocytes susceptible to and supporting WHV infection in vitro. 
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CHAPTER 5: ABERRANT LYMPHOCYTE ACTIVATION PRECEDES 
DELAYED VIRUS-SPECIFIC T CELL RESPONSE AFTER BOTH PRIMARY 
INFECTION AND SECONDARY EXPOSURE TO HEPADNAVIRUS IN 
WOODCHUCK MODEL OF HEPATITIS B 
This study has been published in J. Virol. 2008; 82(14): pp 6992-7008 
5.0 SUMMARY 
The contribution of virus-specific T lymphocytes to the outcome of acute 
hepadnaviral hepatitis is well recognized, but a reason behind the consistent 
postponement of this response remains unknown. Also characteristics ofT cell 
reactivity following re-exposure to hepadnavirus are not thoroughly recognized. 
To investigate these issues, healthy woodchucks were infected with liver-
pathogenic doses of woodchuck hepatitis virus (WHV) and investigated 
unchallenged or after challenge with the same virus. As expected, WHV-specific 
T cell response appeared late, 6 to 7 weeks post-infection, remained high during 
acute disease, and then declined but remained detectable long after resolution of 
hepatitis. Interestingly, almost immediately after infection, lymphocytes acquired 
a heightened capacity to proliferate in response to mitogenic (nonspecific) 
stimuli . This reactivity subsided before WHV-specific T cell response appeared 
and its decline coincided with the cells augmented susceptibility to activation-
induced death. Analysis of cytokine expression profiles confirmed early in vivo 
activation of circulating immune cells and revealed impaired transcription of 
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tumor necrosis factor-alpha (TN F-a) and gamma interferon (IFN-y). Strikingly, 
re-exposure of the immune animals to WHV swiftly induced hyper-
responsiveness to nonspecific stimuli followed again by the delayed virus-specific 
response. Our data show that both primary and secondary exposures to 
hepadnavirus induce aberrant activation of lymphocytes preceding virus-specific 
T cell response. They suggest that this deviant activation and augmented death 
of the cells activated , accompanied by a defective expression of cytokines pivotal 
for effective T cell priming, postpone adaptive T cell response. These 
impairments likely hamper initial recognition and clearance of hepadnavirus 
permitting its dissemination in the early phase of infection. 
5.1 INTRODUCTION 
Hepatitis 8 virus (HBV) causes acute liver inflammation which may 
advance to chronic hepatitis, cirrhosis and hepatocellular carcinoma (Chisari, 
2000). In the majority of adults , immune responses induced by HBV are sufficient 
to resolve acute hepatitis (AH), although they commonly fail to eliminate the virus 
entirely leading to an indefinitely long persistence of trace virus replication in the 
liver and cells of the immune system (Rehermann eta/., 1996; Raimondo eta/. , 
2006; Michalak, 2007 ; Michalak el a/., 2007). This residual virus carriage , termed 
as secondary occult HBV infection (SOl) (Michalak el a/., 2004) , is accompanied 
by protracted HBV-specific T cell proliferative and cytotoxic T lymphocyte (CTL) 
responses ( Rehermann eta/., 1996; Thimme eta/., 2003; Guidotti and Chisari, 
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2006) and by persistently elevated intrahepatic transcription of gamma interferon 
(IFN-y) and tumor necrosis factor alpha (TN F-a) , and residual liver inflammation 
in woodchucks convalescent from AH (Michalak et a/., 1990; Hodgson and 
Michalak, 2001). The contribution of the innate and adaptive immunity to the 
control of HBV infection has been overall well delineated (Guidotti and Chisari , 
2001 ). Among others , it was established that the recovery from AH is 
accompanied by a robust polyclonal and multispecific HBV-specific T helper type 
1 (Th1) proliferative and CTL responses (Ferrari eta/., 1990). These virus-
specific reactivities were found to be preceded by upregulated hepatic expression 
of IFN-y and TN F-a , suggesting activation of the local innate immunity (Guidotti et 
a/., 1999; Thimme eta/. , 2003). However, contrary to infections with other 
viruses, HBV is seemingly ignored by the CD4+ and CDS+ T cells for about two 
months after primary infection , even when the infection is finally resolved 
(Bertoletti and Ferrari, 2003). This delay is accompanied by a very low frequency 
of HBV-specific CTL, which usually does not exceed 1% of circulating CDS+ T 
cells during acute phase of self-limiting infection (Maini eta/., 1999). This 
contrasts with infections with other viral pathogens where the primary adaptive T 
cell responses can be detected as early as 5-10 days post-infection and in which 
up to 10% of the peripheral CDS+ T cells might consist of virus-specific CTL 
(Koup eta/., 1994; Rentenaar eta/., 2000). A reason behind this delay in the 
appearance and in the relative weakness of virus-specific T cell response in 
hepadnavirat infection is unknown. Nonetheless, it is likely that this situation may 
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hinder the initial control of viremia and the complete clearance of hepadnavirus, 
as evidenced by the common occurrence of persistent low-level (occult) infection 
continuing after resolution of acute hepatitis (Michalak el a/., 1994; Mulrooney-
Cousins and Michalak, 2007). Furthermore, it is generally accepted that the 
recovery from acute hepatitis 8 is associated with a complete protection from re-
occurrence of HBV infection. However, the nature and characteristics of the 
cellular immune responses following re-exposure to hepadnavirus are not defined 
and a primary protective role for anti-HBV antibodies in this regard is 
acknowledged (Yuki el a/. , 2003; Rehermann and Nascimbeni, 2005; Sjogren, 
2005; Bertoletti and Gehring, 2006). 
Woodchucks (Marmota monax) infected with woodchuck hepatitis virus 
(WHV) represents a highly valuable natural model of HBV infection in which 
sequel! a of virological and molecular events, and the patterns of virus-induced 
liver disease closely resemble those occurring in humans (Michalak, 1998; 
Michalak el a/., 2004; Menne and Cote, 2007). A significant degree of antigenic 
cross-reactivity between HBV and WHV and similarities in the profiles of immune 
responses induced by both infections, make investigations in the woodchuck-
WHV model highly relevant to the recognition of immunological events occurring 
after the primary exposure and subsequent re-exposures to HBV. 
In the present study, we dissected the profiles of hepadnavirus-specific 
and generalized (nonspecific, mitogen-induced) proliferative T cell responses 
during pre-acute and acute phases of WHV infection and after challenge and re-
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challenge with the same virus, along with the expression of cytokines affiliated 
with immune cell activation . We also investigated lymphoid cell susceptibility to 
undergo apoptotic death during progressing acute infection. We have found that 
lymphocytes after primary and secondary exposures to WHV acquire almost 
immediately a strongly augmented capacity to proliferate in response to virus-
nonspecific (mitogenic) stimuli , which each time precedes the delayed 
appearance of virus-specific T cell response. This ex vivo evident hyper-reactivity 
coincides with the augmented expression of cytokines in unmanipulated , 
circulating lymphoid cells indicative of their in vivo activation and with an inhibited 
expression of TN F-a and IFN-y suggesting their impaired function . These 
findings provide new insights into the properties ofT cell reactivity during the early 
stages of hepadnaviral infection and after re-exposure to pathogenic 
hepadnavirus. They raise a possibility that a strong aberrant activation of 
lymphocytes occurring immediately after exposure to hepadnavirus contributes to 
the postponement of virus-specific primary as well as secondary T cell responses . 
These events may hinder recognition and elimination of the virus faci litating its 
dissemination in the prodromal phase of infection. 
5.2 MATERIALS AND METHODS 
5.2.1 Animals and WHV inoculations 
Ten healthy, adult woodchucks housed in the Woodchuck Hepatitis 
Research Facility at Memorial University, St. John's , Canada were infected with 
,----------------------------------------------1 
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large, liver pathogenic doses of WHV. Prior exposure to WHV was excluded 
based on negative serological markers for WHV infection and by the absence of 
WHV DNA in randomly selected serum, peripheral blood mononuclear cell 
(PBMC) and liver biopsy samples assessed by nested polymerase chain reaction-
nucleic acid hybridization (PCR-NAH) assays (sensitivity <1 0 virus genome 
equivalents JvgeJimL) (Michalak eta/., 1999; Coffin eta/., 2004). The animals 
were divided into three groups. Four animals (Group A) were investigated in the 
first phase to determine overall features ofT cell proliferative responses 
accompanying primary infection and subsequent exposures to hepadnavirus. The 
animals were intravenously (i .v.) injected with 1.9 x 10" DNase-protected vge of 
WHV/tm4 inoculum carrying the wild -type WHV, as determined by the whole 
genome sequence analysis (P.M. Mulrooney-Cousins and T.l. Michalak, 
unpublished data). They were followed for 65 weeks post-primary infection 
(w.p.p.i.), then challenged with the same dose of WHV/tm4 andre-challenged 15 
weeks later with either 1.9 x 1 O" vge (1/F and 2/F animals) or 1.9 x 102 vge (3/F 
and 4/M) of the inoculum (see Figure 5.1A) . Four other woodchucks constituted 
study Group B. These animals were injected once with WHV, followed for 16 
w.p.p.i., and investigated to recognize an interdependence between heightened T 
lymphocyte proliferate capacity occurring immediately after WHV exposure 
identified in the first study and the lymphocy1e susceptibility to apoptotic death , 
delayed WHV-specific T cell response, and expression of selected 
proinflammatory and antiviral cy1okines in lymphoid cells. In this group, two 
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animals (5/M and 6/M) were infected with 1.9 x 10" vge of WHV/tm4, while other 
two (7/M and 8/M) with WHV/tm3 inoculum (GenBank accession number 
AY334075) (Michalak et at., 2004) at 1.1 x 10" DNAse-protected vge per dose 
(see Figure 5.1 B). In addition, two woodchucks, each injected with a single dose 
of WHV/tm4 at 1.9 x 10" vge, were examined for 112 w.p.i. as controls. The 
study protocol was approved by the Institutional President's Committee on Animal 
Bioethics and Care. 
5.2.2 Sample collection 
Animals were bled at the time points indicated in Figure 5.1. Sera were 
collected and preserved. PBMC were isolated as described before (Gujar and 
Michalak, 2005). Their viability normally exceeded 98%, as determined by trypan 
blue dye exclusion. Liver biopsies were obtained by surgical laparotomy at time 
points showed in Figure 5.1, and examined for WHV DNA load and histological 
lesions using the scoring criteria reported before (Michalak et at., 1999; Hodgson 
and Michalak, 2001 ; Michalak et at., 2004). 
5.2.3 Serological and WHV DNA detection assays 
Serial serum samples were tested for WHV surface antigen (WHsAg), 
antibodies to WHV core antigen (anti-WHc) and antibodies to WHsAg (anti-WHs) 
by in-house specific enzyme-linked immunoassays reported before (Michalak et 
a/., 1999; Coffin eta/., 2004; Michalak eta!., 2004). WHV DNA in sera and liver 
biopsies was quantified by real-time PCR (Michalak el a/., 2004) and, when 
negative, by PCR-NAH assay, as reported (Michalak el a/., 1999). 
5.2.4 WHV antigens and mitogens forT cell proliferation assays 
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Recombinant WHV core, e and X proteins, designated as rWHc, rWHe 
and rWHx, respectively, and used to measure WHV-specific T cell proliferation in 
vitro, were produced in the pET 41 b( +) Escherichia coli expression system 
(Novagen, Darmstadt, Germany) and affinity purified, as recently reported 
(Wallace eta/. , 1999). They were extensively tested for nonspecific T cell 
proliferation against potential bacterial contaminants and found entirely devoid of 
such activity (Wallace eta/., 1999). In addition, a synthetic WHV peptide, 
containing the immune-dominant epitope corresponding to amino acids 97 to 110 
(WHc97_, , ) of the virus nucleocapsid protein (Menne et a/. , 1997) was 
synthesized. WHV envelope particles carrying WHsAg specificity were purified 
from pooled sera of a chronic WHV carrier, as described (Michalak eta/., 1999; 
Michalak eta/., 2004). As inducers of generalized, nonspecific, polyclonal 
lymphocyte response, concanavalin A (ConA; Pharmacia Fine Chemicals, 
Uppsala, Sweden), pokeweed mitogen (PWM, Phyto/acca americana agglutinin; 
ICN Biochemicals Inc., Aurora, OH) and phytohemagglutinin (PHA; ICN 
Biochemicals) were used (see below). 
5.2.5 Adenine-incorporation T cell proliferation assay 
174 
3H-adenine incorporation T lymphocyte proliferation assay was applied to 
examine WHV-specific and mitogen-induced T cell responsiveness and 
performed as described elsewhere (Kreuzfelder eta/., 1996; Gujar and Michalak, 
2005). Briefly, freshly isolated PBMC were cultured in 96-well flat-bottom plates 
(Becton Dickinson Labware, Franklin Lakes, NJ) at a density of 1 x 105 cells/well 
in complete AIM-V lymphocyte culture medium (Gibco-lnvitrogen Corp., Auckland, 
New Zealand) with 10% fetal calf serum (Gibco-lnvitrogen). Recombinant WHV 
proteins and WHsAg were added in triplicate at 1 ~glml and 2 ~g/ml, whereas 
WHc97_," peptide was used at five two-fold dilutions from 1.25 ~g/ml to 20 ~g/ml. 
Similarly, to assess the generalized lymphocyte response, each PBMC sample 
was exposed in triplicate to five two-fold dilutions of ConA or PHA from 1.25 
~g/ml to 20 ~g/ml and PWM from 0.6 ~g/ml to 10 ~g/ml or to medium alone as 
a control. The cultures were incubated for 96 hours at 37 ' C, pulsed with 0.5 ~Ci 
of 2-' H-adenine (Amersham Pharmacia Biotech, AB, Uppsala, Sweden) per well, 
and incubated for an additional12-18 hours. Then, the cells were harvested and 
their radioactivity counts per minute (cpm) in each well were determined (Gujar 
and Michalak, 2005). The mean cpm values for either stimulated or control cells 
were calculated by averaging the counts in the respective triplicate wells. The 
stimulation index (S.I.) was calculated by dividing mean cpm obtained either after 
WHV antigen or mitogen stimulation by mean cpm detected in control, 
unstimulated wells. S.l. values of ~ 3.1 for rWHc, rWHe and rWHx and ~ 2.1 for 
WHc97_110 and WHsAg were considered as positive based on the cut off values 
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given by three standard deviations (S.D.) above the mean values obtained from 
control wells. Mean mitogenic stimulation index (M.M.S.I.) was determined by 
averaging the S.l. values obtained for all five concentrations of a given mitogen, 
as described (Gujar and Michalak, 2005). 
5.2.6 CFSE-flow cytometry T cell proliferation assay 
Since WHV-specific T cell response examined by the 3H-adenine 
incorporation assay gave readings in samples collected after the third injection 
with WHV, i.e., 80 w.p.p.i., at the detection limit of the assay and to confirm the 
observations made in study Group A in Group B animals, a more sensitive flow 
cytometric assay with 5-and-6-carboxyfluorescein diacetate succinimidyl ester 
(CFSE; Molecular Probes, Eugene, Oregon) was employed, as recently reported 
(Gujar and Michalak, 2005). Briefly, woodchuck PBMC were labeled with 1 ~M of 
CFSE and either stimulated with W HV antigens or WHc97_110 at the same 
concentrations as those in the adenine incorporation assay or left unstimulated as 
controls. The plates were incubated for 5 days. The cells were harvested and 
analyzed in a FACSCalibur flow cytometer (Becton Dickinson, Franklin Lakes, 
NJ). The halved CFSE fluorescence in dividing PBMC was determined by 
applying CeiiQuest Pro software (Becton Dickinson). The cell division index 
(C.D.I.) was defined by dividing the percentage of cells showing halved CFSE-
fluorescence after stimulation with WHV antigens by that of cells with halved 
CFSE-fluorescence cultured in the absence of stimulation, as we described 
before (Gujar and Michalak, 2005). The highest C.D.I. value found at a given 
time point for any concentration of WHV protein/peptide tested was taken as a 
measure of WHV-specific T cell response. The cut off C.D.I. values of ;o: 3.1 
were considered to represent a positive WHV-specific response (Gujar and 
Michalak, 2005). 
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5.2.7 CFSE/annexin-V-PE/7-AAD assay for simultaneous detection ofT cell 
proliferation and apoptosis 
The assay simultaneously measuring lymphocyte proliferation and their 
apoplotic death was adopted using ConA and rWHe as stimulators, and as three-
color CFSE/annexin-V-PE/7-AAD assay. Briefly, freshly isolated PBMC were 
labeled with 1 ~M of CFSE, cultured at a density of 5 x 105 cells per well in 48-well 
tissue culture plate, and stimulated with either ConA (2.5 and 5 ~g/ml) or rWHe (1 
and 2 ~g/ml) as indicated above. The cells were harvested, washed with annexin-
labeling buffer (5 mM NaCI, 5 mM KCI and 2 mM CaCI, in 10 mM HEPES), 
stained for 30 min on ice with 50 ~g/ml of 7-actinomycin-D (7-AAD; Molecular 
Probes) and 50 ~1/ml of R-PE-conjugated recombinant human annexin-V 
(annexin-V-PE; Caltag Laboratories, Burlingame, CA), and analyzed by flow 
cytometry. In addition, to monitor death of lymphoid cells potentially occurring in 
vivo, freshly isolated PBMC were directly labeled with annexin-V/7-AAD, without 
preceding stimulation with ConA or rWHe, and analyzed. The authenticity of 
specific binding of annexin-V and 7-AAD was verified by visualizing intracellular 
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fluorescence distribution (see Figure 5.6A) using an Olympus BX 50WI confocal 
microscopy system (Olympus America Inc., Center Valley, PA). 
The C.D.I. was defined by dividing percentage of CFSE';m cells after stimulation 
with rWHe or ConA by CFSE' ;m cells without any stimulation (medium only), as 
indicated above. The C.D.I. of ~).1 after rWHe or ConA stimulation was 
accepted as a positive T cell response. The cell apoptosis was assessed by 
using CeiiQuestPro software (Becton Dickinson) by separating test cells into four 
quadrants as: live cells, i.e., annexin-Vn-AAD-negative (lower left quadrant), early 
apoptotic, i.e., annexin-V- positive only (lower right quadrant), late apoptotic, i.e., 
annexin-V and 7-AAD-positive (upper right quadrant), and necrotic, i.e. , 7-AAD-
positive only (upper left quadrant), as illustrated in Figure 5.6A. The total 
percentage of apoptotic cells was determined by adding the percentages of early 
apoptotic, late apoptotic and necrotic cells. 
5.2.8 Real-time RT-PCR 
PBMC and liver biopsy samples collected prior to and during WHV 
infection were analyzed for expression of selected cytokines and cell marker 
genes by real time RT-PCR using a LightCycler (Roche Diagnostics, Mannheim, 
Germany). For this purpose, 5 x 105 - 1 x 106 PBMC were resuspended 
immediately after isolation in 1 ml of Trizol reagent (Invitrogen, Auckland, New 
Zealand) and stored at -20' C. After collection of all experimental samples, RNA 
was extracted and 2-~g RNA samples were reversely transcribed to eDNA, as 
- - - - - - - -------- - ------
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reported (Coffin eta/. , 2004). The expression of woodchuck IFN-a , IFN-y,TNF-a , 
IL-2, IL-4, IL-10, IL-12 , CD3, CD4, CD14 and CD56 was quantified using 
equivalent of 50 ng of total RNA and gene-specific primer pairs shown in Table 
5.1 and their transcription normalized against that of woodchuck P-actin . 
To quantify WHV mRNA, eDNA derived from equivalent of 50 ng RNA, along 
with serial 1 0-fold dilutions of complete recombinant WHV DNA (rWHV DNA) as 
standards (Michalak el a/., 1999), was amplified by real-time PCR using WHV 
core gene-specific primers (Table 5.1). When W HV RNA was undetectable, 2 ~g 
of eDNA was analyzed by nested PCR/NAH) using WHV-specific primers and 
conditions described before (Michalak eta/., 2004). 
5.2.9 Statistical analysis 
Two-tailed , unpaired Student t test with 95% confidence interval was 
applied to compare the means of sample groups investigated and P values of < 
0.05 were considered as statistically significant. Differences marked with one 
asterisk were significant at P < 0.05, with two at P < 0.005, and with three at P < 
0.0001 . 
5.3 RESULTS 
5.3.1 Serological and WHV DNA profiles after primary and multiple 
exposures to WHV 
Among animals belonging to study Group A, three woodchucks developed 
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Table 5.1 Sequences of WHV and woodchuck gene-specific PCR primers 
used in this study 
Gere GenBalk nlXTtler Prirrer SEQ.JenCe Anl>icoo sjze (bp) 
Wt./rrRNA AY334075 Fawa"d 5-ATG:::ACXX:ATICTCT<X?AC 221 
Reverse 5'- CT=<XTTGGITACAGT 
IFNa AF425778 Fawa"d 5-CTa;ATGO.G\T~ 204 
Reverse 5'- GGTAGACAGTGA.TCCT 
IFNy AF23W8 Fawa"d 5-Ar:J:31¥XAT~TCA 215 
Reverse 5'-~T03/W3 
TNFa AF333967 Fawa"d 5'· T=crGAAAGTATGA.TCC 283 
Reverse 5'- TOCfACAACAT=rN:JlG 
IL-2 00272238 Fawa"d 5· AAGXTICTGA.CCTGG 185 
Reverse 5-=rN::fCACAA 
IL-4 AF333965 Fawa"d 5· TTIOCfGTCCCCAAGI\AC 200 
Reverse 5'-CCTGGATICACT~ 
IL-10 AF012009 Fawa"d 5-AGGCCGTN:./lGCAAGT<:w¥3 200 
Reverse 5'- ACAACCCT<?AQXI\GO.TITI 
IL-12 X97019 Fawa"d 5· TIGGATIGGCACCCTGACAC 198 
Reverse 5 -IXATCTGGCTCAGA.N::fTCAC 
C03 AF232n7 Fawa"d 5· CTC?CGICTCTOXTCTTATC 536 
Reverse 5'- OCfGGCCTITCCGGAT=rC 
a:l4 EF621765 Fawa"d 5- GGAGA.ATAAGWJAT~ 560 
Reverse 5'· TCAAG\GTCACAGTCAGG 
Ol14 EF621769 Fawa"d 5- N::fGTCTGA.CAATCCT 187 
Reverse 5'· c=TCGA.GTTGTG 
aJ56 EF621771 Fawa"d 5-CATCT~TATCG 187 
Reverse 5'- GGGAocrGA.a;ACATC 
!>-actin AF232730 Fawa"d 5- CAACCGTGA.GWJATGA.CC 338 
Reverse 5'- ATCTCCTOCfCGAAGTCC 
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classical self-limited AH with WHsAg detectable in serum between 3 and 7 
w.p.p.i. (Figure 5.1A). Woodchucks 1/F, 2/F and 3/F seroconverted to anti-WHs 
between 8 and 12 w.p.p.i., while 4/M became transiently anti-WHs reactive one 
week after challenge with WHV, i.e. , at 66 w.p.p.i. (Figure 5.1A). Anti-WHc 
appeared at 6 w.p.p.i. and remained detectable during the entire follow-up period 
in all animals. The level of anti-WHc did not fiuctuate noticeably after challenge 
or re-challenge with WHV. Serum WHV DNA became detectable from one 
w.p.p.i. and persisted until the end of follow-up in all4 woodchucks. After 
clearance of serum WHsAg, the level of circulating WHV DNA declined and 
usually did not exceed 102 vge/ml thereafter, as it has been previously reported 
for animals with SOl continuing after resolution of AH. Serum WHV DNA 
remained at a similar low level after the second and third injections with WHV 
(Figure 5.1A). Hepatic WHV loads were at 2 x 10' - 8 x 102 vge/~g of total liver 
DNA during AH, then subsided to about 3 x 102 vge/~g and persisted at an 
approximately similar level until the end of follow-up (Figure 5.1A), as previously 
observed (Michalak eta/., 1999; Cote eta/., 2000; Michalak eta/., 2004). 
In study Group B, 3 animals infected with WHV/tm3 or WHV/tm4 
developed immunovirological and WHV DNA profiles indicative of a self-limiting 
episode of AH which were closely comparable to those seen in animals in Group 
A (Figure 5.1 B), while 8/M developed histologically evident mild protracted 
hepatitis. In this animal, serum WHsAg appeared 3 weeks post-infection (w.p.i.) 
and persisted until the end of follow-up, i.e. , 16 w.p.i. Anti-WHs became 
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Figure 5.1 General outline of the experimental protocols showing time points of 
injections with WHV, serum, PBMC and liver biopsy collections, serological 
markers of WHV infection and serum WHV DNA detected, hepatic WHV loads, 
and the results on liver histology after primary infection and challenge with WHV. 
(A) Four woodchucks (study Group A) were infected (time 0) with 1.9 x 1 O" 
DNase-protected virions of WHV/tm4 inoculum, challenged with same dose of 
WHV at week 65 and then re-challenged with either 1.9 x 10" (1/F and 2/F 
animals) or 1.9 x 102 virions (3/F and 4/M) at week 80. (B) Four woodchucks 
(study Group B) were infected (time 0) with 1.9 x 1 O" virions of WHV/tm4 (5/M 
and 6/M animals) or with 1.1 x 10" virions ofWHV/tm3 (7/M and 8/M animals) 
and followed for 16 weeks after infection. The appearance and the duration of 
WHsAg, anti-WHs and anti-WHc and serum WHV DNA are shown by horizontal 
bars. The estimated levels of serum WHV DNA are depicted as black bars (>103 
vge/ml), hatched bars (<103 vge/ml) or white bars (not detectable). The PBMC 
collected at the time points marked by the short vertical lines at the bottom of A 
and 8 panels were analyzed for WHV-specific and generalized T cell proliferative 
responses. Samples marked with * were obtained from all woodchucks except 
1/F. WHV DNA load in liver biopsies collected at the time points indicated by 
solid arrow heads is presented as the estimated WHV DNA vge/~g of total liver 
DNA. Liver morphological alterations are presented as the histological degree of 
hepatitis graded on the scale of 0 to 3. 
--- - ----- - ------ ------------------------------------------
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detectable in 6/M and 7/M after clearance of WHsAg from serum around 13 and 
10 w.p.i., respectively. Liver biopsies collected at 7 w.p.i. contained WHV DNA 
loads ranging from 2.4 x 106 to 2.5 x 107 vge/~g of total DNA (mean 1.1 x 107 :+: 
4.9 x 106 vge/~g) and WHV mRNA at 3.1 x 105 to 5.5 x 106 copies/~g of total RNA 
(mean 2.7 x 106 :+: 1.1 x 106 copies/~g). 
5.3.2 Both primary infection and challenge with WHV induce delayed virus-
specific T cell response 
In animals from Group A, the WHV-specific T cell proliferation against 
WHV antigens or WHc97_110 peptide measured by 3H-adenine incorporation assay 
was multispecific and of relatively high magnitude between 10 and 14 w.p.p.i. 
(Figure 5.2). Persistently detectable virus-specific proliferative response to rWHe, 
rWHx and WHc,_,., peptide first appeared around 6-8 w.p.p.i. and preceded that 
against rWHc and WHsAg, which became detectable at 10-14 w.p.p.i. However, 
it is of note that a transient T cell reactivity of very low-magnitude towards rWHe, 
WHc97_110 and WHsAg was also evident at 3 w.p.p.i. The strong WHV-specific 
response was evident for up to 30 w.p.p.i. , then subsided and became 
intermittently detectable by 3H-adenine incorporation assay until challenge at 65 
w.p.p.i. (Figure 5.2). In two control animals, the pattern of WHV-specific 
response during acute phase of infection was similar to that described above and 
the reactivity remained detectable until termination of the experiment at 112 w.p.i. 
(data not shown). Overall, the virus-specific T cell response was strong and 
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mullispecific during the acute phase of primary infection, with the greatest 
magnitudes after ex vivo stimulation with rWHe followed by rWHc or rWHx and 
the lowest after stimulation with WHc97. 110 or WHsAg. 
Challenge of the convalescent woodchucks with the same 1.9 x 1 O" vge 
dose of WHV/tm4 did not induce the expected immediate memory virus~specific T 
cell response (Figure 5.2). However, a strong T cell response to WHV antigens 
was found in all animals between 5 and 10 weeks after challenge, i.e., 70-75 
w.p.p.i. The magnitudes of the secondary response to rWHe (P = 0.01 ), rWHc (P 
= 0.03) and rWHx (P = 0.001) were significantly greater than those during the 
primary infection (Figure 5.2). In contrast, the levels of secondary T cell response 
against WHc97_,0 peptide (P = 0.6) and WHsAg (P = 0.9) were comparable to 
those detected in lhe primary infection. After re-challenge with either high (1/F 
and 2/F) or low (3/F and 4/M) dose of WHV/tm4, all animals demonstrated 
minuscule or undetectable virus-specific T cell reactivity when tested by 3H-
adenine incorporation assay (Figure 5.2). However, a transient increase in the 
magnitude of WHV-specific T cell proliferation was evident when more sensitive 
CFSE-flow cytometric assay was applied (Figure 5.2; insets). 
5.3.3 Lymphocyte generalized proliferative capacity increases immediately 
after primary and subsequent exposures to WHV 
Almost immediately after the primary injection with WHV, i.e., 1-3 w.p.p.i. , 
the lymphocytes acquired from animals in study Group A showed strongly 
~~--- -~- --' 
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Figure 5.2 The kinetics of WHV-specific T cell proliferative responses against 
WHV antigens in woodchucks belonging to study Group A which were infected, 
challenged and re-challenged with WHV. The animals were injected with WHV at 
the time points indicated by solid arrow heads. Freshly isolated PBMC were 
stimulated in vitro with rWHc, rWHe, rWHx, WHc97_110 peptide or WHsAg, and 
their proliferation measured by 3H-adenine incorporation assay. The results are 
presented as stimulation index (S.I.). P values were calculated for peak T cell 
reactivity against each WHV antigen in each animal observed during primary (A) 
and secondary (B) virus exposures in the time periods marked by vertical short 
lines. The insets show T cell proliferative responses against the same WHV 
antigens after re-challenge with WHV as measured by CFSE-flow cytometry 
assay with the results presented as cell division index (C.D.I.). The cut-off values 
for positive responses against rWHc, rWHe and rWHx were ~3.1 and against 
WHc97_110 peptide and WHsAg ,:::2.1 , as indicated by horizontal dotted lines. 
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heightened capacity to proliferate in response to ConA, PWM and PHA (Figure 
5.3). Then, the response subsided between 6 and 30 w.p.p.L, at the time when 
the WHV-specific T cell response appeared and endured at high levels (see 
Figure 5.4). The exception was 4/M with serum WHsAg-negative, but anti-WHc 
and WHV DNA-positive infection in which the nonspecific lymphocyte reactivity 
after the initial lowering increased between 10 and 14 w.p.p.i. During the phase 
of the lowered responsiveness to mitogenic stimuli, temporal increases in this T 
cell response occurred. Interestingly, these periodic increases appeared to be 
synchronized in all animals, as recapitulated in Figure 5.4. It also is of note that 
ConA, PHA and PWM induced similar profiles of the proliferative response 
(Figure 5.3), suggesting that no particular lymphocyte subset was predominantly 
involved in the periodic increases. 
After challenge with WHV at 65 w.p.p.L, this non-specific T cell proliferative 
reactivity was again augmented in all animals with the peak occurring between 
one and 3 weeks following challenge, i.e., 66 and 68 w.p.p.i. (Figures 5.3 and 
5.4 ). However, the magnitudes of the cell proliferation in response to ConA (P = 
0.2), PWM (P = 0.5) and PHA (P = 0.1) were not significantly different from those 
detected after the first injection with WHV (Figure 5.3). This heightened response 
to mitogens subsided between 68 and 75 w.p.p.i., which coincided again with 
arise of the secondary WHV-specific T cell response (Figure 5.3 and 5.4). 
Subsequently, when the virus-specific T cell reactivity progressively decreased, 
the T cell proliferative capacity in response to mitogens rebounded and remained 
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Figure 5.3 The kinetics of mitogen-induced (generalized) T lymphocyte 
proliferation in woodchucks after primary infection, challenge and re-challenge 
with WHV. The same animals shown in Figure 5.2 (study Group A) were injected 
with WHV at the time points indicated by solid arrow heads. The T cell 
proliferation was measured in response to five different concentrations of ConA, 
PWM or PHA by 3H-adenine incorporation assay. The M.M.S.I. values were 
calculated for each mitogen in each animal at indicated time points as explained 
in Materials and Methods. P values were determined as in Figure 5.2. 
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Figure 5.4 Discordance between the kinetics of WHV-specific and generalized T 
cell proliferative responses during primary WHV infection and after challenge and 
re-challenge with WHV. The profiles are compiled from the data generated using 
3H-adenine incorporation assay measuring T cell proliferation in response to 
rWHc, rWHe, rWHx, WHc,.,, peptide and WHsAg (S.I. values) and in response 
to five concentrations of ConA (M .M.S.I. values) . The mean of the highest S.l. 
given by any WHV antigen or that of M.M.S.I. in response to any ConA 
concentration from each of 4 animals constituting study Group A were used to 
construct the profiles of the WHY-specific and generalized T cell responses, 
respectively. Solid and open downward arrows depict peaks of mitogen-induced 
or WHY-specific T cell responsiveness, respectively, after primary infection and 
challenge with WHV. Solid upward arrow heads mark injections with WHV. 
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at a high level unti l 80 w.p.p.i. when the animals were re-challenged with WHV 
(Figure 5.4). The thi rd injection with either a high or low WHV dose induced 
another, although lower in magnitude, immediate increase in the T cell 
generalized proliferative response (Figure 5.3 and 5.4). 
5.3.4 Immediate augmented lymphocyte generalized proliferative and 
delayed virus-specific T cell responses are consistently induced by WHV 
infection 
To confirm findings made in the first study by assessing WHV-specific 
response using CFSE-flow cytometric assay, as well as to test if another WHV 
inoculum will induce the same effects on T cell responses and to systematically 
evaluate lymphoid cell predisposition to apoptotic death after exposure to WHV, 
weekly PBMC samples collected from animals constituting study Group B were 
investigated . Thus , the CFSE-based lymphocyte proliferation assay with rWHe 
confirmed that the primary exposure to WHV induces delayed virus-specific T cell 
response which appeared from 7 w.p.i. and persisted until the end of the 16-week 
follow-up (Figure 5.5A) . Further, the lymphoid cell capacity to proliferate in 
response to stimulation with mitogenic stimulus (ConA) was evident again 
immediately after exposure to WHV, i.e., as early as one w.p.L This response 
rapidly subsided between 4 and 6 w.p.i., then transiently increased between 7-8 
w.p.i., and receded to approximately pre-infection levels thereafter (Figure 5.58). 
All 4 animals belonging to study Group B displayed closely comparable patterns 
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of both WHV-specific and ConA-induced T cell proliferative responses, including 
8/M animal which developed protracted infection suggesting progression to 
chronic hepatitis . 
Considering distinct and , for the most part, opposing kinetics of the 
generalized , mitogen-induced and WHV-specific T cell proliferative responses, 
the progression of acute WHV infection was divided into phases (Figures 5.5A 
and 5.5B) . Thus, phase A corresponded to the time period prior to WHV 
infection; phase 8 or pre-acute phase occurred between one and 3 w.p.i. and was 
characterized by heightened nonspecific and essentially absent WHV-specific T 
cell response; phase C or early-acute phase between 4 and 6 w.p.i. was 
accompanied by subsiding nonspecific and absent virus-specific T cell response, 
and phase D or acute phase (7 w.p.i. onwards) was associated with the initially 
slightly increasing but then normalized mitogen-induced proliferative acapacity 
and with significantly augmented WHV-specific T cell response . As shown in 
Figure 5.5C, the magnitude of WHV-specific T cell reactivity during acute infection 
(phase D) was significantly (P < 0.0001) greater when compared to those 
detected during pre-acute (phase B) and early-acute (phase C) periods of WHV 
infection. In contrast, PBMC displayed significantly (P < 0.0001) increased 
magnitudes of mitogen-induced proliferation immediately after exposure to WHV 
(Figure 5.5D) , i.e., during the pre-acute period (phase B). This reactivity declined 
during the early-acute period (phase C) by displaying a mean response lower (P = 
0.02) than that observed prior to infection (phase A) , and subsequently 
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Figure 5.5 Patterns of WHV-specific and ConA-induced T cell responses in 
Group B woodchucks during self-limited acute WHV infection . (A) WHV-specific 
T cell response was measured by CFSE-based flow cytometric assay against 
rWHe. The data are presented as the mean± SEM of cell division indices (COl) 
obtained from all4 animals measured at 1 and 2 ~g/ml rWHe at each time point 
indicated. (B) ConA-induced T cell proliferative response was measured in the 
same samples by adenine incorporation assay using two-fold dilutions of ConA 
ranging from 1.25 to 20 ~g/ml. The mean mitogenic stimulation index (MMSI) 
was calculated by averaging the Sl from all five ConA concentrations for all4 
animals at each time point showed. The COl or MMSI values detected after 
infection with WHV were compared with those before infection (phase A) from the 
same animal and expressed as fold increase or decrease. Each data point 
represents the mean± SEM of fold increases/decreases from all4 animals. Pre-
infection period (phase A) and stages of WHV infection (phases B to D) are 
marked as defined in Materials and Methods. The cumulative data on (C) WHV-
specific and (D) ConA-induced T cell proliferative responses detected during 
indicated phases of WHV infection are presented as mean ± SEM for fold 
increase or decrease. The data presented as bars B, C and D were compared 
with either those presented by bar A or with each other. Differences marked with 
stars are significant at P values as indicated in Materials and Methods. 
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rebounded in the acute phase (phase D) to a mean level greater (P; 0.03) than 
that prior to infection (phase A), but still significantly (P < 0.005) lower than that 
characterizing phase B. 
5.3.5 Decline in T cell generalized proliferation capacity coincides with 
increased activation-induced cell death 
To recognize a possible reason behind the observed rapid decline in the T 
cell proliferative response to mitogenic stimuli seen during the early-acute period 
(phase C) of WHV infection, the rate of apoptotic death of lymphomononuclear 
cells was evaluated in weekly PBMC samples form Group B animals by the assay 
employing staining with annexin-V-PE, 7-MD and CFSE. In preliminary 
experiments, the authenticity of staining of woodchuck lymphoid cells with 
recombinant human annexin-V-PE and 7-AAD was verified by visualizing 
appropriate subcellular compartments under confocal microscopy. As illustrated 
in Figure 5.6A, annexin-V, 7-MD and CFSE produced cell surface, nuclear and 
cytoplasmic staining, respectively, in woodchuck lymphocytes undergoing 
apoptosis. 
To assess whether naturally circulating lymphocytes from different phases 
of acute WHV infection (Figure 5.5) might be differentially predisposed to 
apoptosis, freshly isolated, unmanipulated, weekly PBMC samples were stained 
with annexin-V and 7-MD. The results showed that the fresh cells from different 
phases did not display any noticeable variations in mean percentage of apoptotic 
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Figure 5.6 Activation-induced apoptosis of lymphoid cells during progression of 
acule WHV infection . (A) A representative flow cytometry dot-plot and a confocal 
microscopy micrograph showing annexin-V-PE and 7-AAD labeling patterns in 
circulating woodchuck lymphoid cells. (B) Freshly isolated or ConA- or rWHe-
stimulated PBMC samples collected prior to inoculation with WHV (phase A) from 
Group B animals or weekly during progression of acute infection were analyzed 
for the rale of apoptosis by flow cytometry with annexin-V and 7-AAD. The 
percentage of apoptotic cells was determined in each weekly sample from 4 
animals, averaged to find the mean percentage of apoptosis for each phase of 
infection (phases B to D), and compared with that calculated for PBMC collected 
prior lo WHV infeclion (phase A) which was Ia ken as 100%. The bars represent 
the mean~ SEM of percent fold increase or decrease in apoptosis for freshly 
isolated PBMC or those stimulated with ConA at 2.5 and 5 ~g/ml or with rWHe at 
1 and 2 IJg/ml. Differences between data bars are marked as outlined in 
Materials and Methods. 
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cells in comparison to the cells collected prior to infection (Figure 5.68). 
However, when the rate of apoptosis was measured in the same cell samples 
after stimulation with ConA or rWHe, significantly greater rates and infection 
phase-dependent changes in apoptotic death were identified (Figure 5.68). 
Overall, the results indicated that lymphocytes derived from the early-acute period 
(phase C) of WHV infection, when nonspecific T ce ll responsiveness profoundly 
declined but WHV-specific response had not yet occurred , were significantly more 
prone to activation-induced death than the cells collected immediately after 
infection (phase B) or during AH (phase 0) . 
5.3 .6 Cytokine and cell marker gene expression profiles in unmanipulated 
circulating lymphoid cells 
Since the expression patterns of anti-viral and pro-inflammatory cytokines 
in peripheral lymphoid cells after primary hepadnaviral infection have been 
described (Guidotti eta/., 1999; Thimme eta/., 2003) , initially (study Group A), we 
examined the kinetics of this expression after re-exposure to WHV. We found 
that following challenge of animals convalescent from AH with WHV, the 
heightened expression of IFN-a became immediately evident in sequential PBMC 
samples collected after challenge , i.e., between 66-69 w.p.p.i. This cytokine 
transcription then subsided and increased again, but to a lower level, around the 
time of re-challenge with the same virus inoculum (Figure 5.7A). This significantly 
increased (P < 0.0001) expression of IFN-a coincided with the phase of 
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augmented T cell proliferative responsiveness to mitogen stimuli (Figure 5.7A and 
Figure 5.3, respectively) . The transcription of TN F-a (P < 0.0001) and , to some 
extent, IFN-y (P; 0.015) was transiently enhanced between 68-69 w.p.p.i .. The 
mRNA levels of IFN-a , IFN-y, TN F-a and , to a lesser degree, CD3 subsided 5 
weeks later, i.e. , around 70 w.p.p.i. In general, the enhanced expression of IFN-
a, IFN-y and TN F-a coincided with highly augmented T cell nonspecific 
proliferative capacity and clearly preceded the re-appearance of W HV-specific T 
cell proliferative response, which occurred between weeks 70 and 75 post 
infection (Figure 5.7A and Figure 5.2 , respectively). The expression profiles of IL-
2 and IL-4 did not correlate with the magnitudes of either specific or nonspecific T 
cell responses, except for 4/M which displayed increased expression of both 
these cytokines at the time of greater expression of IFN-y and TN F-a . CD14 and 
CD56 transcription levels measured in serial PBMC samples showed 
unremarkable profiles (data not shown). Overall , the data revealed a close 
association between the augmented expression of IFN-a, TN F-a and , to a lesser 
extent, IFN-y in circulating unmanipulated lymphoid cells and their heightened 
proliferative capacity in response to mitogenic, but not virus-specifi c, stimuli after 
challenge with WHV. 
To further recognize events accompanying distinctive phases of WHY-
specific and nonspecific T cell proliferative responses accompanying acute WHV 
infection , transcriptional activity of genes encoding selected cytokines and 
immune cell subtype-specific markers was quantified by real-time RT-PCR in 
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Figure 5.7 Expression profiles of genes encoding cytokines and immune cell 
surface markers in serial unmanipulated PBMC samples collected from the 
woodchucks investigated. (A) Expression of IFN-a, IFN-y, TN F-a , IL-4, IL-2 and 
CD3 in lymphomononuclear cell samples collected from Group A animals after 
challenge and re-challenge with WHV. The solid arrow heads mark the time 
points of challenge or re-challenge with WHV/tm4. The peak expression of IFN-a 
(66-69 w.p.p.i.}, and IFN-y and TN F-a (66-69 w.p.p.i.) was compared with that 
during enhanced WHV-specific response (70-74 w.p.p.i.) and P values were 
calculated as indicated in the legend to Figure 5.2 and differences marked as 
outlined in Materials and Methods. (B) Transcription levels of IFN-a, TN F-a , IFN-
y, IL-12, IL-2 , IL-10, IL-4, CD3, CD4 and CD56 in circulating lymphoid cells in 
different phase of acute WHV infection characterized by distinctive rWHe-specific 
and Con-A-induced T cell responses in Group 8 animals. The fold 
increase/decrease for each gene tested in a given phase of infection was 
calculated and statistically compared as outlined in Matrials and Methods. 
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unmanipulated PBMC weekly collected from animals belonging to study Group B. 
As shown in Figure 5.78, the significantly augmented expression of IFN-a (P = 
0.0001), IL-12 (P= 0.005), IL-2 (P= 0.005) and IL-4 (P= 0.01) was evident 
almost immediately after primary exposure to W HV (phase B), as compared to 
the levels detected prior to infection (phase A). This coincided with the elevated 
expression of CD3 (P = 0.04) and CD56 (P = 0.01). This selective upregulation of 
pro-growth lymphoid cell cytokines, along with NK and T cell-specific markers, 
was associated with the significantly heightened lymphocyte proliferative 
responsiveness to stimulation with ConA but not to WHV (see Figues 5.5C and 
5.50). However, these elevated expressions of the cytokines and cell markers 
indicated above became drastically reduced during the early-acute period (phase 
C), which coincided with the augmented susceptibility of lymphoid cells to 
undergo activation-induced apoptosis (Figure 5.6B). It is important to note that 
WHV infection failed to induce the expression of either TN F-a or IFN-y in 
lymphoid cells during both pre-acute (phase B) and early-acute (phase C) periods 
(Figure 5.7B). Finally, during acute WHV infection (phase D), expression of IFN-
a , TN F-a , IFN-y, IL-12, IL-2, IL-10 and IL-4 was synchronously upregulated along 
with significantly greater expression of CD3 (P < 0.0001) and CD4 (P < 0.0001), 
which coincided with the appearance of strong WHV-specific T cell response 
(Figure 5.5A). 
5.3. 7 WHV replication peaks in lymphoid cells after their inc reased 
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Figure 5.8 WHV mRNA loads in serial,unmanipulated lymphoid cell samples 
collected during different phases of acute WHV infection from Group B animals. 
The total RNA isolated from weekly PBMC samples collected before (phase A) 
and after inoculation with WHV was reverse transcribed and virus-specific 
transcripts quantified by real time PCR. The data are represented as means :+: 
SEM for WHV RNA loads detected in all 4 woodchucks at each time point 
indicated. The horizontal line represents the detection limit of real-time RT-PCR 
(-20 copies/0.1 ~g of total RNA). When negative by real-time RT-PCR, samples 
were further analyzed by nested RT-PCR/NAH assay (sensitivity 2.5-5 copies/~g 
of total RNA). 
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susceptibility to activation-induced death subsides 
As shown in Figure 5.8 for animals from study Group B, the WHV mRNA 
was detectable in serial PBMC samples beginning from the first week p.i. at levels 
not exceeding 200 copies/~g of total RNA. From 5 w.p.i. , i.e ., at the time of 
termination of the cells' increased susceptibility to activation-induced apoptosis, 
WHV mRNA levels progressively increased in circulating lymphoid cells , peaked 
around 11 w.p.i., and then subsided until the end of follow-up. Overall , the results 
revealed that WHV replication in peripheral lymphoid cells is established as early 
as one week post exposure to a large, liver pathogenic dose of WHV and persists 
at a low level until the serologically and histologically evident acute infection 
(phase 0). 
5.4 DISCUSSION 
In the present study, the lymphocyte capacity to proliferate in response to 
hepadnaviral antigens and mitogenic stimuli was measured during the pre-acute 
and acute phases of experimental WHV infection , and after challenge and re-
challenge with the same virus. In addition , predisposition of lymphoid cells to 
undergo activation-induced apoptotic death and the expression of the cytokines 
affiliated with activation of immune cells were quantified in serial samples of 
circulating lymphoid cells. The study revealed several previously unidentified 
features ofT cell response accompanying a self-limiting course of hepadnaviral 
AH and re-exposure of the immune host to pathogenic hepadnavirus . Thus , it 
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was found that: (1) A strong lymphocyte activation, evidenced by the heightened 
proliferative responsiveness against nonspecific stimuli, appears soon after both 
primary invasion and challenge and, in both situations, prior to the arise of virus-
specific T cell response; (2) This temporal lymphocyte hyper-responsiveness to 
mitogenic stimuli coexists with the augmented expression of cytokines indicative 
of in vivo activation of immune cells and with the impaired transcription of TN F-a 
and IFN-y; (3) The decline in the lymphocyte nonspecific proliferative 
responsiveness coincides with the cells increased susceptibility to activation-
induced apoptosis; (4) The emergence of virus-specific secondary T cell response 
after re-exposure to virus is delayed similarly as following primary exposure, and 
(5) The virus-specific and nonspecific lymphocyte proliferative responses display 
inverse kinetics during pre-acute and acute phases of infection and after 
challenge with hepadnavirus. 
In regard to characteristics of hepadnavirus-specific T cell response, our 
study confirmed that self-limited AH is associated with a strong T cell proliferation 
reactivity directed towards multiple structural and nonstructural hepadnaviral 
proteins. This finding is consistent with the data from self-limiting AH type B in 
humans and chimpanzees (Ferrari et al. , 1990; Akbar el al., 1993; Bertoletti and 
Ferrari, 2003), and from woodchucks infected with WHV (Menne el al., 1997). 
Another feature compatible with the previous observations was the late 
appearance of WHV-specific T cell response after primary exposure, i.e., from 6 
w.p.p.i. onwards. In this context, virus-specific T lymphocyte proliferative 
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reactivity became detectable from 8 to 12 w.p.i. in HBV-infected humans (4, 63) 
and 6-12 w.p.i. in WHV-infected woodchucks (Menne el a/. , 2002). This 
characteristic of adaptive T cell response differs from that seen in other viral 
infections where such a response appears in the first two weeks after primary 
exposure (Webster el a/., 2000). Further, WHV-specific T cell reactivity remained 
detectable long after resolution of acute infection, albeit at much lower 
magnitudes than during AH (see Figure 5.2). This finding closely resembles the 
detection of HBV-specific proliferative and cytotoxic T cell responses in 
individuals with a history of resolved AH type B (Michalak el a/., 1994; Rehermann 
el a/., 1996), who, as woodchucks (Michalak el a/. , 1999; Cote eta/., 2000; 
Hodgson and Michalak, 2000; Michalak, 2000; Menne eta/., 2007), carry low 
levels of replicating virus for years after apparent complete resolution of AH 
(Michalak el a/., 1994; Rehermann el a/., 1996; Weiland eta/., 2004). In this 
regard, it is expected that the trace hepadnavirus replication provides sustained 
antigenic stimuli maintaining active antiviral immune response keeping the 
persisting virus under relative control (Menne eta!., 2007). However, this control 
may fail leading to clinically evident reactivation of occult infection (Raimondo et 
a/., 2006; Mulrooney-Cousins and Michalak, 2007). 
One of the most intriguing and novel findings in our study was the length of 
the time required for the WHV-specific T cell response to reappear after challenge 
with WHV. It has been well documented that immunocompetent hosts previously 
exposed to a pathogen swiftly mount strong secondary adaptive T cell response 
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appearing within a week following challenge with the same agent. Classical 
examples are infections with influenza A virus (Flynn eta/., 1998; Doherty and 
Christensen, 2000; Swain eta/. , 2006; Rocha and Tanchot, 2006) or lymphocytic 
choriomeningitis virus (LCMV) (Gallimore eta/., 1998; Murali-Krishna eta/. , 1998; 
Rocha and Tanchot, 2006). In our study, instead, the "memory" response in the 
convalescent woodchucks re-exposed to WHV was detected 5 weeks post-
challenge. Further, although the magnitude of this secondary response to the 
majority of WHV antigens was greater than that in the primary infection, there was 
no difference in regard to the order in the relative strength of this response 
towards individual W HV antigens. Overall , the results revealed that both primary 
and secondary exposures to W HV induced delayed virus-specific T cell 
responses with overall similar kinetics. This finding to our knowledge is the first of 
this kind and seems to be a unique feature of hepadnaviral infection. 
Examination of a lymphocyte response to mitogens is frequently used to 
assess the fitness and competence of lymphocytes to perform their 
immunological functions. This type of responsiveness was found to be transiently 
or permanently impaired in many microbial infections and its analysis frequently 
provided valuable insights into the capacity of the immune system to control the 
spread of a pathogen and the progression of infection (Garb eta/. , 1981 ; 
Pedersen eta/., 1990; Wallace eta/., 1999; Niewiesk eta/., 2000). However, this 
response was only sporadically and fragmentally investigated over the course of 
HBV infection. In this regard, it has been noticed that during early phase of 
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serum HBsAg-positive or serum HBsAg-negative HBV infection , lymphocytes 
displayed increased proliferative capacity after stimulation with PHA, as 
compared to that observed during the late phase or in healthy controls 
(Sodomann eta/. , 1979). The reported data also suggested that acute as well as 
chronic hepatitis 8 are associated with diminished lymphocyte proliferative 
responsiveness to stimulation with ConA (Feighery eta/., 1980), PHA (Sodomann 
eta/., 1979) or PWM (De Gast eta/., 1976). Our data showed that the 
proliferative capacity of lymphocytes in response to mitogenic stimuli varied 
depending on the phase of acute infection , providing a possible explanation for 
the previously observed variances. The most interesting finding was that this 
capacity was significantly augmented almost immediately after WHV infection and 
subsided prior to the appearance of adaptive T cell response (see Figure 5.4). 
Surprisingly, a similar sequence of events occurred after challenge of the WHV-
immune animals with the same dose of the same virus which was done more than 
a year following the first inoculation. 
Our finding of the heightened lymphocyte nonspecific proliferation 
preceding virus-specific T cell response is not unique and appears to be 
consistent with findings in some other viral infections. For example , an acute 
infection with simian/human immunodeficiency virus (SH IV) in macaques is 
associated with very early, strong polyclonal activation of lymphocytes followed by 
virus-specific T cell response (Wallace eta/. , 1999). In this model , the delay in 
SHIV-specific T cell reactivity was attributed to inappropriately high generalized 
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activation of lymphocytes leading to the depletion of CD4+ T cells, probably, by 
activation-induced cell death and direct cell killing by the virus, and diminished 
virus-specific T cell immunity which, consequently, allowed the virus to spread in 
the early phase of infection. In this context, it is of note that WHV also is a 
lymphotropic virus which invariably infects the immune system, even when the 
liver is not affected , as observed in woodchucks inoculated with WHV doses 
equal to or below 103 virions or in offspring born to woodchuck dams 
convalescent from AH (Coffin eta/., 2004; Michalak eta/., 2004). Also, WHV 
invasion of the lymphatic system occurs soon after inoculation, as evidenced by 
detection of WHV DNA and its replicative intermediate, covalently closed circular 
DNA, in lymphoid cells as early as 3 days post-inoculation with either liver 
pathogenic or low, liver non-pathogenic dose of WHV (Guy, C.S. and Michalak 
T. l. , unpublished data). 
To gain further insights into the nature of the immune responses 
accompanying the early phase of hepadnaviral infection, the transcription levels 
of the cytokines affiliated with activation of immune cells and those of the markers 
specifying individual immune cell subtypes were quantified in serial samples of 
circulating lymphoid cells. The cytokine expression patterns revealed were 
analyzed in the context of the profiles ofT cell nonspecific and WHV-specific 
responses and to the cells susceptibility to activation-induced apoptotic death. In 
this regard , it is of note that viral infections normally induce immediate type I 
interferon response, i.e., IFN-a and beta interferon (IFN-P), which precedes 
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production of other cytokines , such as TN F-a, IL-1 , IL-12 and IL-2 by antigen 
presenting cells (APC) and natural killer (NK) cells (Kawai and Akira, 2006). 
Together, these cytokines facilitate induction of the effective innate response and 
the prompt development of adaptive immunity. It has also been shown that 
during initial phase of infection activated NK cells can eliminate invading virus 
both by killing infected cells and via a noncytopathic pathway mediated by IFN-y 
(Guidotti and Chisari , 2001 ; Andoniou eta/., 2005; Kawai and Akira , 2006) . At 
the same time, around one w.p.i., activated APC acquire ability to promote the 
virus-specific T cell immune response which inhibits infection onwards (Andoniou 
et al. , 2005). In regard to hepadnaviral infection , investigation of chimpanzees 
infected with a massive dose of HBV (-108 virions) failed to reveal upregulated 
expression of the genes affiliated with activation of innate immune response for 
up to 6-10 w.p.i. when measured by microarray analysis in the liver (Weiland et 
a/. , 2004). Similarly, intrahepatic expression of IFN-y and TN F-a , along with 
CD3-positive lymphomononuclear cell infiltration, was found to be delayed until 
the acute phase ofWHV infection, as determined by gene-specific RT-PCR 
analysis (Hodgson and Michalak, 2001 ; Nakamura eta/., 2001). However, these 
measurements were initiated not earlier than one w.p.i . and were done, in some 
instances, by the methods of relatively low sensitivity, raising a concern that the 
early response or that of a lower magnitude was overlooked. In fact , the recently 
completed analysis of the expression profiles of the genes affiliated with active 
innate immune response in serial liver biopsies collected from one hour post 
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WHV infection and applying highly sensitive real-time RT-PCR assays revealed 
upregulated transcription of IFN-y and IL-12 and activation of APC and NK cells 
as early as 3-6 hours and activation of NK T cells at 48-72 hours post-infection 
with WHV (Guy and Michalak, manuscript in preparation). Therefore, 
hepadnavirus induces intrahepatic innate response but this response arises 
almost immediately after infection, is transient, and is not seceded by the prompt 
appearance of the local adaptive T cell immunity. 
Peripheral lymphoid cells collected weekly from WHV-infected animals in 
our study demonstrated a transient but significantly augmented expression of 
IFN-a, along with IL-12, IL-2 and IL-4 and with CD3 and CD56, between one and 
3 w.p.i. (see Figure 5.68). Unexpectedly, the same cells did not display 
enhanced expression of TN F-a and IFN-y for up to 6 w.p. i., i.e., when AH had 
fully developed. The identified prolonged absence of TN F-a transcription in 
immune cells in the early W HV infection may have important consequences due 
to multiple immunological functions to this cytokine. Among others, TN F-a , 
together with IFN-a , drives the differentiation of dendritic cells (DC) from 
precursors (Sousa eta/. , 1999; Iwamoto eta/., 2007), while DC in the presence of 
IFN-a alone acquire improper mature phenotype characterized by impaired 
antigen-specific and alia-stimulatory capacities (Dauer eta/., 2003; McRae eta/., 
2000). Furthermore, neutralization of TN F-a by specific antibody administred to 
LCMV-infected mice abolished the virus-induced activation of DC (Kadowaki et 
a/., 2000), while DC cultured in the presence of both TN F-a and IFN-a acquired 
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phenotype comparable to that induced in vitro by infection with herpes simplex 
virus (Kadowaki eta/., 2000). Taken together, the prompt expression of TN F-a 
transpires in the appropriate maturation of DC , the effective activation of APC , 
and the expeditious arise of effective adaptive T cell immunity (Sousa et al., 
1999). Nonetheless, along with activation of DC and NK cells, the initiation of 
effective antiviral T cell immunity also requires synchronous expression of other 
cytokines, such as IFN-a , IL-12, IL-2, IL-4 and IL-10 (Orange and Biron , 1996; 
Andoniou eta/., 2005). Thus, the absence ofTNF-a and nonsynchronous 
expression of some other cytokines (e.g. , IL-10; see Figure 5.6B) during the early 
phase of WHV infection could translate into inappropriate differentiation and 
activation of DC , which in turn may fail to promote appropriate presentation of 
WHV antigens and postpone priming of the anti-viral adaptive T cell response. 
On the other hand, early IFN-a response, along with DC-derived cytokines 
induced by viral infection , init iates proliferation and IFN-y production in NK cells 
(Biron and Welsh , 1982; Kobayashi eta/. , 1989). In turn , this cytokine enhances 
NK cell cytotoxic function , as well as shapes the development of antigen-specific 
Th1 immune response (Orange and Biron , 1996; Asselin-Paturel eta/., 2001 ; 
Andoniou eta/. , 2005; Kawai and Akira , 2006; ). Therefore , the absence of IFN-y 
transcription in circulating lymphoid cells for up to 6 w.p.i. after administration of 
WHV further supports the notion of aberrant activation of the innate response in 
the initial phase of hepadnaviral infection . This defect may further hamper early 
elimination of hepadnavirus as wel l as contribute to postponement of virus-
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specific T cell response. 
We found that lymphoid cells displayed significantly higher susceptibility to 
undergo activation-induced apoptosis at the time of decreased proliferative 
responsiveness to mitogenic as well as WHV-specific stimuli. To determine a 
possible reason behind this rapid decline in lymphoid cell proliferative 
responsiveness in the early-acute WHV infection, we measured the rates of 
apoptosis in freshly isolated weekly PBMC samples and in the same samples 
after ex vivo stimulation with ConA or rWHe. The results showed that the rates of 
apoptosis in unmanipulated lymphoid cells were essentially the same during 
different phases of the development of acute WHV infection. A comparable 
observation was reported for unmanipulated, circulating lymphocytes during 
infection with human immunodeficiency virus (HIV) (Gougeon eta/. , 1996). In 
contrast, the same woodchuck cells exposed to Con A or rWHe displayed 
meaningfully different susceptibility to undergo apoptosis depending upon the 
phase of acute WHV infection defined by the kinetics of nonspecific and WHV-
specific T cell responses (see Figures 5.5 and 5.68). Taken together, the 
analysis showed that the decline in the cells proliferative responsiveness to 
mitogenic stimuli in the early WHV infection coincided with the cells significantly 
greater susceptibility to activation-induced apoptotic death. Thus, this co-
occurrence resembled the mechanism proposed for the depletion of 
nonspecifically activated lymphocytes in acute SHIV infection (Wallace el a/., 
1999). 
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The increased susceptibility to activation-induced cell death in our study 
was accompanied by reduced IFN-a, IL-2 and IL-12 transcription, and by 
upregulated expression of IL-10 in circulating lymphoid cells. In this regard, 
seemingly comparable activation-induced death of lymphoid cells was reported 
during experimental infection with SHIV (Wallace el a/., 1999) and in HIV infection 
(Gougeon eta/., 1996), and was attributed to abnormal expression of cytokines or 
to defective antigen presentation by APC (Gougeon el a/. , 1996). It was also 
observed that CD4+ and CDS+ T cells derived from HIV infection and treated ex 
vivo with PWM or anti-CD3 antibodies in the presence of IL-12 demonstrated the 
enhanced survival, while those treated in the same way in the presence of IL-10 
displayed an increased susceptibility to undergo apoptosis (Gougeon eta/. , 
1996). Further, during acute phase of infection with Epstein-Barr virus, an 
increased susceptibility of activated CD45RO+ T cells to undergo apoptosis in 
culture was shown to be reversed by addition of exogenous IL-2 (Akbar eta/. , 
1993). These findings resemble those encountered in the early WHV infection 
(phase C) where decreased expression of cytokines, especially IL-12 and IL-2, 
could initiate defective T cell activation with higher susceptibility of the 
lymphocytes to undergo activation-induced death (see Figures 5.6B and 5.7B). 
This may represent a mechanism by which improperly activated lymphocytes are 
eliminated in vivo. On the other hand, a contribution of WHV to the cell 
enhanced susceptibility to apoptotic death was unlikely, since the peak of virus 
replication occurred in lymphoid cells when acute infection became fully 
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developed (phase D; see Figure 5.8). 
Based on the data acquired in the current study, we postulate that the early 
aberrant lymphocyte activation followed by apoptotic death of the cells activated, 
coinciding with a defective expression of the cytokines critical for the prompt 
initiation of virus-specific T cell response, are responsible for the postponement of 
adoptive T cell responses in hepadnaviral infection. Identification of a mechanism 
by which hepadnavirus induces the immediate, defective lymphocyte activation 
will require further investigation. Similarly, a contribution of the delayed virus-
specific T cell response to the intrinsic ability of hepadnavirus to escape from 
sterilizing elimination by the immune system, leading to establishment of either 
symptomatic or occult persistent infection, needs to be explained. Overall , the 
present study throws a new light on the features of immune cell responsiveness 
accompanying hepadnaviral infection. Because of the high compatibility between 
virological and pathogenic properties of WHV and HBV and strong parallels in the 
induced antiviral responses, the current data should contribute to our better 
understanding of immunological events underlying a prolonged incubation period 
and the delayed initiation of acute hepatitis in HBV infection, and possibly to 
design of methods of halting the development of chronic hepatitis. 
220 
CHAPTER 6: PRIMARY OCCULT HEPADNAVIRUS INFECTION INDUCES 
VIRUS-SPECIFIC T CELL PROLIFERATIVE AND ABERRANT CYTOKINE 
RESPONSES IN THE WOODCHUCK MODEL OF HEPATITIS 8 
This study has been submitted in Journal of Virology 
6.0 SUMMARY 
Although lhe virological features of asymptomatic, serologically silent 
hepadnaviral POl have been relatively well recognized in the woodchuck model 
of hepatitis 8 , characteristics of accompanying immune responses remain 
unknown. In this study, the kinetics of both WHV-specific and nonspecific 
(mitogen-induced) T cell responses and cytokine expression profiles in circulating 
lymphoid cells and the liver, along with WHV-specific antibody responses and 
molecular markers of WHV infection , were investigated during experimentally 
induced POl and subsequent challenge with a liver pathogenic (>103 virions) or 
nonpathogenic (50 virions) dose of the same virus. The data showed that POl , 
which does not prompt WHV surface antigenemia , antibodies against virus or 
hepatitis, was accompanied by a strong WHV-specific T cell response directed 
against multiple virus epitopes that appeared in 8-12 weeks post-infection and 
intermittently persisted to the end of follow-up. Furthermore , immediately after 
exposure to a nonpathogenic virus dose, lymphocytes acquired a heightened 
capacity to proliferate in response to mitogenic stimuli and displayed augmented 
expression of IF N-o , IL-12 and IL-2 , but not tumor necrosis factor alpha. Overall , 
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the kinetics of WHV-specific and mitogen-induced T cell and cytokine responses 
accompanying POl or after challenge of animals with POl were closely 
comparable to those occurring during symptomatic infection caused by a liver 
pathogenic viral dose. The data revealed that serologically silent POl induced by 
liver nonpathogenic quantities of hepadnavirus causes early aberrant cytokine 
expression and delayed virus-specific T cell proliferative response, which closely 
resemble those accompanying serologically evident infection coinciding with self-
limited acute hepatitis . 
6.1 INTRODUCTION 
HBV is a noncytopathic virus causing an infection having several 
distinctive clinical profiles ranging from symptomatic AH or CH to serologically 
undetectable, seemingly asymptomatic infection , designated as occult HBV 
infection (OBI). Following exposure to HBV, more than 90% of adults developing 
AH resolve liver inflammation (Ferrari eta/., 1991; Bertoletti and Gehring , 2006) , 
however they fail to eradicate the virus completely and persistent occult infection 
follows (Michalak el a/. al. , 1994; Mulrooney el a/., 2007; Raimondo eta/., 2006 ; 
Rehermann eta/. , 1996; Yuki eta/., 2003) . The remaining -10% of individuals 
develop CH type 8 , which is diagnosed when detection of HBsAg in serum and 
biochemical and histological indicators of liver inflammation persist for more than 
6 months. This form of hepatitis often advances to life-threatening cirrhosis and 
hepatocellular carcinoma (HCC) (Chisari, 2000 ; Bertoletti and Ferrari , 2003). 
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In the last decade, it became apparent that HBV replication commonly 
persists at low levels after resolution of AH type B in the context of apparent 
absence of clinical symptoms. It is expected that this form of HBV infection could 
also be a consequence of resolution of a clinically asymptomatic, but 
serologically transiently evident (i.e. , serum HBsAg-reactive) exposure to virus. 
The main features of this residual asymptomatic infection, also called secondary 
occult infection or SOl (Michalak el a/., 2004; Mulrooney and Michalak, 2007; 
Michalak, 2000, Michalak el a/., 2007; Raimondo eta/., 2006), are: (1) the lack of 
detectable serum HBsAg, (2) the presence of antibodies to HBV core antigen 
(anti-HBc), (3) detection of HBV DNA in the circulation at levels usually not 
exceeding 200 virus genome equivalents (vge) per ml, and (4) the presence of 
viral genome and its replicative intermediates in the liver and peripheral blood 
mononuclear cells (PBMC) (Michalak el a/., 1994; Murakami el a/. , 2004; 
Rehermann eta/., 1996). This OBI can be a source of infectious virus available 
for transmission to healthy individuals through blood and organ donations, as 
well as a potential cause of diseases of seemingly unknown etiology, including 
HCC (reviewed in Mulrooney and Michalak, 2007; Brechot, 2004; Ikeda eta/., 
2007). 
The infection of eastern North American woodchucks (Marmota monax) 
with woodchuck hepatitis virus (WHV), a member of the hepadnaviridae family 
(Menne eta/., 2007; Michalak, 2007; Michalak, 1998), provides a natural and 
highly valuable laboratory model of HBV infection. The molecular, virological , 
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and pathological events which follow WHV invasion are highly compatible to 
those induced by HBV in humans. Moreover, the understanding of the natural 
course, virological properties, requirements of transmission and potential 
pathological consequences of OBI is owed to a large extent to studies in the 
woodchuck model (reviewed in Michalak eta/., 2007). Among others, it was 
established that replication of hepadnavirus in SOl progresses not only in the 
liver but also in the immune system (Michalak eta/., 1994; Rehermann eta/., 
1 996). In woodchucks, this infection persists for life and virus replicative 
intermediates, including WHV covalently closed circular DNA (cccDNA) and 
mRNA, are detectable by highly sensitive assays employing polymerase chain 
reaction (PCR) and identification of the resulting amplicons by nucleic acid 
hybridization (NAH), i.e., PCR/NAH (Coffin and Michalak, 1999; Michalak eta/. , 
1999). Moreover, the virus assembled during SOl is infectious, liver pathogenic, 
can induce HCC, and is transmissible from SOl mothers to offspring (Michalak et 
a/. , 1999; Coffin and Michalak, 1999; Hodgson and Michalak, 2001; Michalak et 
al. , 2004). Interestingly, SOl can be reactivated following treatment with an 
immunosuppressive agent, cyclosporin A, leading to re-appearance of serum 
WHsAg-positive infection (Menne eta/., 2007) and -20% of woodchucks with 
SOl finally develop HCC (Michalak el a/. , 1999, Korba et 1. , 1989). 
Investigating the woodchuck model of hepatitis B, we have recently 
uncovered yet another form of occult hepadnaviral infection, i.e. primary occult 
infection (POl) (Michalak el a/., 2004; Michalak el a/., 2007; Mulrooney and 
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Michalak, 2007). This form has nol yet been identified in humans, however the 
existence of HBV DNA positive, anti-HBc negative individuals implies its 
existence (Michalak, 2000; Brechot, 2001 ; Torbensen and Thomas, 2002 ; 
Michalak eta/., 2007). Originally, POl was discovered by studying woodchuck 
dams with SOl which were found lo transmit to their offspring a low level WHV 
infection limited lo the lymphatic system that did not engage the liver in the 
majority of the offspring (Coffin and Michalak, 1999). Subsequently, I he same 
form of occult persistence was experimentally induced by inoculation of 
immunocompetent, adult woodchucks with WHV doses lower than 1000 virions 
(Michalak el a/. , 2004). In this experimental situation , PO l again coincided with 
WHV replication restricted to the lymphatic system which with time in some 
animals could spread to the liver. In general , POl is characterized by the 
presence of W HV DNA in serum at levels compatible with those occurring in SOl 
(~ 200 vge/m l ) and in PBMC (~ 103 vge/~g of total DNA) , but not in the liver, the 
absence of serological (immunovirological) markers of infection , including 
antibodies against WHV core antigen (anti-WHc), and by normal liver 
morphology (reviewed in Mulrooney and Michalak, 2007 ; Michalak eta/., 2007) . 
The WHV nucleotide sequence in POl has been found to be wi ld-lype (Michalak 
eta/. , 2004 ; Mulrooney and Michalak, 2008). Further, the virus persisting in POl 
remains biologically competent, since when WHV from serum or lymphoid cells 
of animals with POl was administered to naive woodchucks, symptomatic AH 
was induced (Michalak eta/., 2004 , Coffin and Michalak, 1999). Most 
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interestingly, woodchucks with POl are not protected from re-infection with liver 
pathogenic doses of WHV (i.e. , >1 03 virions) (Michalak eta/., 2004) and develop 
classical AH after the challenge (Coffin and Michalak, 1999; Michalak et a/. , 
1999). Although we have previously documented that POl does not induce 
WHV-specific humoral immune response (reviewed in Michalak eta/., 2007), it is 
not clear whether the virus-specific T cell responses are also lacking in this form 
of WHV infection. 
In regard toT cell responses accompanying symptomatic HBV infection, 
the resolution of AH was found to be associated with strong, polyclonal HBV-
speclfic Th1 proliferative and CTL reactivities, while the reverse was 
demonstrated in chronic hepatitis (Ferrari eta/., 1990; Guidotti and Chisari, 2006; 
Bertoletti and Ferrari, 2003; Chisari, 2000). Hepatic injury in HBV infection is an 
immune mediated process. It was established that the CTL response generated 
against HBV epitopes can inhibit replication of intrahepatic virus, both by directly 
killing infected cells (Maini eta., 1999; Guidotti eta/., 1999; Rehermann eta/., 
1996; Thimme eta/., 2003) and by producing anti-viral cytokines, such as 
gamma interferon (IFN-y) and tumor necrosis factor alpha (TN F-a) (Guidotti and 
Chisari, 2001; Guidotti and Chisari, 2006). In chimpanzees infected with HBV, 
injection of anti-CD8 antibodies during AH resulted in prolonged viremia and 
milder hepatic injury, suggesting the dual role of CDS+ T cells in inhibiting HBV 
replication and mediating liver pathology (Thimme eta/., 2003). Further, Th1 
cytokine profile, coinciding with a greater expression of IFN-y and TNF-a in HBV-
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specific CD4+ and COB+ T cells, was found to be associated with resolution of 
hepatitis (Ferrari el a/., 1990; Guidotti and Chisari , 2001 ; Bertoletti and Gehring, 
2006). On the other hand, the role of the innate immune responses in the 
pathogenesis and determining the outcome of hepadnaviral hepatitis remains 
uncertain. It has been shown that activated natural killer (NK) cells (Kimura et 
a/., 2002), NKT cells (Kakimi el a/., 2000) and antigen presenting cells (APC) 
(Kimura eta/., 2002), as well as cytokines, such as alpha interferon (IFN-a) 
(Weiland eta/., 2000) , interlekin-12 (ll-12) (Cavanaugh eta/. , 1997) and IL-18 
(Kimura el a/., 2002), can independently inhibit virus replication in HBV 
transgenic mice , implying the role of innate immunity in controlling HBV infection 
in this model. Moreover, upregulated hepatic expression of IFN-v and TNF-a 
was found to precede HBV-specific T cell responses and was accompanied by a 
decrease in HBV replication in the liver in chimpanzees, suggesting that 
activation of the local innate immunity is , at least partially, successful in limiting 
virus propagation in acute infection (Thimme et al , 2003 ; Chisari , 2000). Also, in 
our recent study, analyzing the expression profiles of the genes affiliated with 
intrahepatic immune responses in woodchucks immediately after inoculation with 
a liver pathogenic dose of WHV, clear evidence of very early augmented 
transcription of the genes indicative of activation of APC , NK cells and NK T cells 
were found (Guy et al., 2008). However, this early innate response was transient 
and unable to timely prompt a virus-specific T cell response, unlike other 
infections induced by many viral pathogens. In patients who resolved AH, 
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vigorous HBV-specific T cell proliferative and cytotoxic responses were identified 
for many years after recovery, suggesting the pivotal role of the immune system 
in controlling virus replication during OBI (Rehermann et al. , 1996; reviewed in 
Bertoletti and Gehring, 2006). 
In the present study, the kinetics of WHV-specific and mitogen-induced 
(generalized) T cell proliferative responses , humoral responses and the profiles 
of cytokine gene expression in lymphoid cells and in the liver, along with 
immunovirological (serological) and molecular markers of WHV infection, were 
analyzed in the animals with experimentally induced POl and after re-exposure of 
the animals to low (liver nonpathogenic) or high (liver pathogenic) doses of the 
same virus. Our study shows that POl, despite the absence of serological, 
biochemical and histological indicators of infection , is accompanied by strong T 
cell proliferative responses directed towards multiple virus epitopes with kinetics 
compatible with those observed after infection leading to classical AH . The 
appearance of WHV-specific T cell responses was preceded by a heightened 
capacity of lymphocytes to proliferate in response to mitogenic stimuli , as we 
have recently observed in an symptomatic acute infection (Gujar el al., 2008). 
Additionally, there was an aberrant expression of cytokines involved in the 
activation of APC and NK cells. Woodchucks with POl challenged with liver 
either nonpathogenic or pathogenic dose of WHV demonstrated similar profiles 
of virus-specific and mitogen-induced T cell proliferative responses as those 
found after primary infection. However, these strong secondary T cell responses 
were unable to provide sufficient help to prevent hepatitis. 
6.2 MATERIALS AND METHODS 
6.2.1 Animals 
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Twelve healthy. adult woodchucks (Mannola monax) investigated in this 
study were housed in the Woodchuck Hepatitis Research Facility at Memorial 
University, St. John's, Newfoundland, Canada. Their WHV-naive status was 
confirmed by the absence of WHV DNA in randomly selected liver, peripheral 
blood mononuclear cells (PBMC) and serum samples analyzed by specific 
nested PCR-NAH (sensitivity s 10 virus genome equivalents (vge)/mL) and by 
repeated serum negativity for WHsAg and anti-WHc. Experimental protocols 
were approved by the Institutional President's Committee on Animal Bioethics 
and Care. 
6.2.2 Inoculation, challenge and re-challenge with WHV 
Eight woodchucks (Study Group B) were intravenously (i .v.) injected with 
50 DNase-protected vge of WHV/tm3 inoculum (Genbank number AY334075) 
(Michalak eta!. , 2004) (Figure 6.1). It was previously established that WHV 
doses below 1000 virions of WHV/tm3 inoculum, as well as other WHV inocula, 
consistently induce POl in WHV-naive woodchucks (Michalak eta/. , 2004-
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Figure 6. 1 Schematic representation of the experimental protocol used to infect 
and challenge woodchucks with liver pathogenic (Group A) and liver 
nonpathogenic (Group B) doses of WHV. In total , 12 WHV-naive, healthy 
animals were i.v. injected with low (nonpathogenic; 50 vge), medium (liver 
pathogenic; 1.1 x 106 vge) or high (liver pathogenic; 1.1 x 1010 vge) dose of 
WHV/tm3 inoculum to induce POl or symptomatic infection. (A) Animals in study 
Group A (n=4) were injected with either high (1.1 x 1010 vge; n=2) or medium (1 .1 
x 106 vge; n=2) doses of WHV. Animals developed classical, serologically 
detectable WHV infection and were challenged with low (50 vge; n=1) or medium 
(1 .1 x 106 vge; n=1) dose of WHV/tm3 or injected with PBS. (B) Animals in 
experimental Group B (n=8) were initially injected with low (50 vge) dose of 
WHV. All animals developed serum WHsAg and anti-WHc negative but WHV 
DNA reactive POl and were challenged or re-challenged with low (50 vge; n=5) 
or high (1.1 x 1010 vge; n=4) dose of the same inoculum or injected with PBS. 
The animals from Groups A and 8 were divided in to subgroups according to the 
dose of WHV used to challenge or re-challenge or injection with PBS , as 
described in detail in Material and Methods. Letter symbols designation: L, low 
virus dose; M, medium virus dose; H, high virus dose , and N, no virus (injection 
with PBS). 
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WHV/tm3; Mulrooney and Michalak , 2008- WHV/tm3). After 26 weeks post-
primary infection (w.p.p.i.), the animals were challenged with a high dose of 
WHV/tm3 (1 .1 x 1 O" vge; group low-high or LH ; n=3) , low dose (50 vge; group 
low-low or LL; n=3) or injected with 0.5 ml of sterile phosphate-buffered saline, 
pH 7.4 (PBS) as controls (group low-no virus or LN ; n=2) (see Figure 6.1 ). 
Subsequently, the animals from groups LL and LN were re-challenged at 55 
w.p.p.i. with either low WHV dose (50 vge; subgroup low-low-low or LLL; n=2, 
and subgroup low-no virus-low or LNL; n=1) or injected with PBS (subgroup low-
low-no virus or LLN ; n=1 or subgroup low-no virus-no virus or LNN ; n=1). One 
animal (9/M) from subgroup LLL was finally challenged at 77 w.p.p.i. with high 
dose of WHV (1 .1 x 1 O" vge; subgroup LLLH) (Figure 6.1 ). 
As controls (Study Group A) , two healthy woodchucks were infected with 
high dose of WHV/tm3 (1 .1 x 10" vge) and then injected with PBS (subgroup 
high-no virus or HN; n=1) (Figure 6.1) at 30 w.p.p.i . or challenged with low dose 
of WHV/tm3 (50 vge; subgroup high-low or HL; n=1) at 26 w.p.p.i. In addition , 
two other woodchucks were infected with medium dose of WHV/tm3 (1 .1 x 106 
vge) and challenged with medium dose of WHV/tm3 (1 .1 x 106 vge; subgroup 
medium-medium or MM; n=1) at 30 w.p.p.i. or left unchallenged (subgroup 
medium-no virus or MN; n=1). 
6.2.3 Sample collection and PBMC isolation 
Blood samples were collected on sodium-EDT A or without addition of 
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anticoagulant, weekly up to 10 weeks after each injection with virus, then 
biweekly up to 20 weeks, and then approximately monthly until challenge or 
autopsy. Sera were separated from untreated blood and stored at -20 °C. 
PBMC were isolated from EDT A-treated samples on Ficoii-Paque Plus 
(Amersham Pharmacia Biotech , AB , Uppsala , Sweden), as described previously 
(Gujar and Michalak , 2005). The cell viability was measured by the trypan blue 
dye exclusion method and normally exceeded 98% . 
6.2.4 Serological and molecular markers of WHV infection 
Serial serum samples were examined for the presence of WHsAg , anti-
WHc and antibodies against WHsAg (anti-WHs) using specific enzyme-linked 
immunosorbent assays , as reported before (Michalak, eta/., 1999; Michalak el 
a/., 2004; Coffin el a/., 2004). WHV DNA in serum and liver samples was 
detected by nested PCR-NAH assays with WHV core (C) , surface (S) and X 
gene-specific primers (sensitivity <1 0 vge/ml or <1 0 vge/~g of total DNA) 
(Michalak, eta/. , 1999 ; Michalak el a/., 2004; Coffin eta/., 2004). As a 
biochemical measure of liver injury, serum levels of sorbitol dehydrogenase 
(SOH) were evaluated by an appropriate spectrophotometric assay (Asada and 
Galambos, 1963, Weisner el a/., 1965). 
6.2.5 Liver biopsies and histopathology 
Up to seven liver tissue samples were collected from each animal by 
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surgicallaparatomy or at autopsy at time points indicated in Figure 6 .2. The 
samples were routinely processed to paraffin and stained (Michalak eta/. , 2004). 
Hepatic lesions were graded on the numerical scale of 0 to 3 and reported as the 
degree of hepatitis, as described before (Michalak eta/., 1990; Michalak el a/. , 
1999; Hodgson and Michalak, 2001) . 
6.2 .6 WHV antigens and T cell mitogens 
Recombinant WHV core protein (rWHc) , e protein (rWHe) and X protein 
(rWHx) , used to measure WHV-specific T cell proliferative responses, were 
produced in pET41 b(+) Escherichia coli expression system (Novagen , 
Darmstadt, Germany) and purified using histidine-tag affinity chromatography 
(Qiagen, Mississauga, Canada), as described before (Wang and Michalak, 2007; 
Gujar eta/., 2008). These antigens were extensively tested for nonspecific T cell 
proliferation against potential bacterial contaminations by using PBMC from 
WHV-naive animals, including woodchucks prior to injection with WHV 
investigated in this study, and were found entirely free of such impurities (Wang 
and Michalak, el a/., 2007; Gujar el a/. 2008). In addition , WHsAg was purified 
from pooled sera of a woodchuck with chronic WHV infection, as reported 
(Michalak el a/., 2004; Gujar el a/., 2008). Also, a synthetic peptide carrying the 
WHV T cell immune-dominant epitope located between 97-110 amino acids of 
WHc protein (WHc97_, 0) (Menne eta/. , 1997) was synthesized (Synprep 
Corporation ; Dublin , CA). The recombinant WHV antigens and WHsAg were 
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used at 1 and 2 ~g/ml in the T cell proliferative assays, while WHc97_, 0 peptide 
was used at 5 and 1 0 ~g/ml. 
The generalized (nonspecific) proliferative capacity of the woodchuck 
lymphocytes was measured by assessing PBMC proliferation in response to 
stimulation with mitogens, as reported (Gujar el a/. , 2008). For this purpose, 
concanavalin-A (ConA; Pharmacia Fine Chemicals, Uppsala, Sweden), 
pokeweed mitogen (PWM, Phytolacca americana agglutinin; ICN Biochemicals 
Inc., Aurora, Ohio) and phytohemagglutinin (PHA; ICN Biochemicals Inc.) were 
used in T cell proliferation assays at five serial two-fold concentrations ranging 
from 1.2 to 20 ~g/ml for ConA and PHA, and from 0.6 to 10 ~g/ml for PWM. 
6.2.7 CFSE-based f low cytometry T cell proliferation assay 
WHV-specific T cell proliferative response in woodchuck PBMC after 
stimulation with different WHV antigens or WHc97_110 peptide was assessed by 
applying a CFSE-based flow cytometric proliferation assay, as described 
elsewhere (Gujar and Michalak, 2005). Briefly, freshly isolated PBMC were 
labeled with 5-and-6-carboxyfluorescein diacetate succinimidyl ester (CFSE; 
Molecular Probes, Eugene, Oregon) at a final concentration of 1 ~M and cultured 
at a density of 3 x 105 cells/well in 48-well tissue culture plates in triplicate with 
tested concentrations of WHV antigens or WHc97_110, as indicated above, or with 
medium alone as a control. The cells were incubated for 5 days at 37 ' C, 
harvested, and washed in PBS with 1 mM EDTA (PBS-EDT A)_ The data were 
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acquired by using a FACSCalibur flow cytometer (Becton Dickinson, Franklin 
Lakes, NJ). The halving of CFSE fluorescence was deconvoluted using 
CeiiQuest Pro soflware (Becton Dickinson) (Gujar and Michalak, 2005). Cell 
division index (C.D.I.) was defined by dividing the percentage of cells with halved 
CFSE fluorescence after stimulation with a test WHV antigen by percentage of 
cells with halved CFSE-fluorescence cultured in medium only. The C. D. I. values 
of ~ 3.1 for rWHc, rWHe and rWHx and ~ 2.1 for WHsAg and WHc97. , 0 peptide 
were considered as a measure of WHV-specific T cell proliferative response 
(Gujar and Michalak, 2005). However, for clarity of the presentation, only the cut 
off value of :0: 3.1 was marked in the graphs showing WHV-specific T cell 
response. 
6.2.8 Adenine incorporation T lymphocyte proliferation assay 
The generalized proliferative capacity of woodchuck lymphocytes in 
response to virus nonspecific stimulation was evaluated using mitogens and 3(H]-
adenine incorporation assay, as described (Kreuzfelder eta/., 1996; Gujar and 
Michalak, 2005, Gujar eta/., 2008). Briefly, freshly isolated woodchuck PBMC 
were cultured at a density of 1 x 105 cells/well of a 96-well tissue culture plate in 
the presence of different concentrations of mitogens, as indicated above, or 
medium alone in triplicates. After 5 days in culture, cells were pulsed with 0.1 
~Ci of ' [H)-adenine (Amersham Pharmacia Biotech, Uppsala, Sweden) for 12-18 
hours, harvested and counts per minute (cpm) in each test and control wells 
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were measured. The mean cpm values were calculated by averaging the cpm 
values from the respective triplicate wells. The stimulation index (S.I.) was 
calculated by dividing mean cpm obtained after a mitogenic stimulation by mean 
cpm observed without any stimulation (medium only) (Gujar eta/. , 2008). 
6.2.9 Real time RT-PCR analysis of gene expression 
Sequential liver and PBMC samples collected prior to inoculation with 
WHV and after challenge with virus were evaluated for the expression of selected 
cytokine and immune cell marker genes by real time RT-PCR using a LightCycler 
(Roche Diagnostics, Mannheim, Germany) (Gujar eta/., 2008; Guy eta/. , 2008). 
In the case of PBMC, 5 x 105 to 1 x 106 of freshly isolated cells were suspended 
in 1 ml of Trizol reagent (Invitrogen) and stored at -20 ' C. Liver samples 
collected at biopsy or autopsy were stored at -80 °C until RNA isolation with 
Trizol reagent. After collection of all experimental samples , RNA was extracted 
simultaneously and reversely transcribed to eDNA, as reported (Gujar eta/., 
2008 ; Guy eta/. , 2008). The expression of woodchuck IFN-a , IFN-y, TN F-a , IL-
12, IL-2 , IL-4 , and IL-1 0 was quantified using equivalent of 50 ng of total RNA 
and woodchuck gene-specific primer pairs , and was normalized against 
expression of woodchuck 13-actin as reported in recent works from this laboratory 
(Gujar eta/., 2008; Guy eta/., 2008) . The expression levels detected after WHV 
exposure were compared with those determined for the same animal prior to 
infection to define the fold increase or decrease, as previously described (Gujar 
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et al , 2008). 
6.2.10 Statistical analysis 
The two-tailed, unpaired Student t test, with 95% confidence interval, was 
used to compare the means of the groups. P values of s0.05 were considered to 
be statistically significant. The differences marked with one asterisk were 
significant at P < 0.05, with two at P < 0.005, and with three at P < 0.0001. 
6.3 RESULTS 
6.3.1 Infection with low WHV dose induces serologically silent but WHV 
DNA evident primary occult infection 
Serial serum and liver tissue samples collected from woodchucks 
inoculated with low (50 vge), medium (1.1 x 106 vge) or high (1.1 x 10" vge) 
doses of WHV were examined for serum WHsAg, anti-WHc and anti-WHs 
(serological markers) and WHV DNA in serum and hepatic tissue (molecular 
markers). Animals injected with high WHV dose (1/F and 2/M) showed, as 
expected, the appearance ofWHsAg at 3 - 4 w.p.p.i. which persisted until8 - 10 
w.p.p.i. (Figure 6.2). In animals injected with medium dose of WHV (3/F and 
4/M), serum WHsAg became reactive at 10 and 12 w.p.p.i. and the antigen 
cleared from circulation at 16 w.p.p.i. in 4/M, while persisted up to 38 w.p.p.i. in 
3/F. All 4 animals developed anti-WHc beginning from 6-8 w.p.p.i. and remained 
antibody reactive until the end of follow-up (Figure 6.2). Anti-WHs appeared in 
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Figure 6.2 The profiles of serological markers of WHV infection and WHV DNA 
detection in sera and liver tissue samples in animals belonging to Group A and 
Group B. Woodchucks were injected with 5 x 101, 1.1 x 106 or 1.1 x 1010 vge of 
WHV or with PBS at time points indicated by vertical solid lines. For each 
animal, the appearance and duration of positivity of WHsAg, anti-WHc, WHV 
DNA and SDH in sequential serum samples are represented by hatched 
horizontal bars. The liver samples were collected at the time points indicated by 
solid arrow heads and estimated loads of WHV DNA presented in vge/~g of total 
liver DNA and histological degree of hepatitis graded on a scale from 0 to 3 in 
each sample are presented. The liver sample collected at autopsy from 11 /M 
displayed histological features of hepatocellular carcinoma (HCC). 
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1/F and were periodically detectable after 14 w.p.p.i. , while the other 3 
woodchucks remained antibody nonreactive (data not shown). There was no 
difference in the time of the appearance of WHV DNA in serum between 
animals injected with high or medium doses of WHV and the genome became 
detectable starting from one w.p.p. i., and persisted throughout the entire 
observation period in these animals. The levels of WHV DNA in liver biopsies 
obtained at 6 w.p.p.i. were 6 x 106 vge/~g and between 1 x 102 and 3 x 102 
vge/~g in animals injected with high and medium WHV doses, respectively. After 
resolution of acute infection, hepatic load of WHV DNA usually ranged between 1 
x 1 O' to 6 x 103 vge/~g and persisted to the end of follow-up, however, it 
transiently elevated to 1 x 106 vge/~g in the liver sample of 3/F acquired at 55 
w.p.p.i. 
The histological features of AH were found in liver biopsies collected at 6 
w.p.p.i. from woodchuck 1/F and 2/M inoculated with high W HV dose (Figure 
6.2). These alterations coexisted with serum WHsAg positivity in both and 
elevated levels of SOH in 1 F (SOH was measured in 2/M after challenge with 
WHV). In 3/F and 4/M injected with medium WHV dose, liver biopsies obtained 
at 6 w.p.p.i. showed normal liver morphology, at the time when serum WHsAg 
was negative and SOH levels remained normal (Figure 6.2), indicating that these 
samples were acquired prior to acute phase of infection. Following clearance of 
WHsAg, minimal to moderate intermittent liver inflammation remained evident in 
all animals, similarly as it has been observed in previous studies (Michalak el a/., 
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1999; Hodgson and Michalak 2001 ; Michalak 2004) . The challenge of 2/M with 
50 vge and 4/M with 1.1 x 106 vge did not induce the reappearance of WHs 
antigenemia nor increased WHV DNA load in serum or liver (Figure 6.2) . 
In contrast to the woodchucks injected with high or medium doses of 
WHV, inoculation with 50 vge initiated POl in all 8 animals (Group B) , as 
evidenced by the detection of WHV DNA in serum beginning from one to 2 
w.p.p.i. and its long-term persistence at levels ~100 vge/ml in the absence of 
detectable WHsAg and anti-WHc. This serologically mute infection was 
accompanied by WHV DNA absence in the liver and entirely normal liver 
morphology, as was clearly apparent in 5/M followed for up to 96 w.p.p.i. (Figure 
6.2). It is of note that although the liver remained virus genome negative, WHV 
DNA was detected in the bone marrow collected at autopsy of this animal (data 
not shown). The above findings were in full agreement with those reported 
previously for woodchucks with naturally acquired and experimentally induced 
POl (reviewed in Michalak el a/. , 2007 ; Mulrooney and Michalak, 2007; Coffin 
and Michalak, 1999; Michalak el a/., 2004 ; Gujar eta/. , 2008). 
The animals with POl challenged once or twice with a low, liver 
nonpathogenic dose of the virus that induced occult infection in the first instance , 
i.e., 6/M (subgroup LNL), 7/M (subgroup LLL), 8/M (subgroup LLN) and 9/M prior 
to challenge with high WHV dose (subgroup LLLH) , remained WHsAg and anti-
WHc nonreactive, did not show an increase in WHV DNA level in serum and their 
livers remained WHV DNA non-reactive and without histologically evident 
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alterations (Figure 6.2). The exception was 8/M (subgroup LLN) in which WHV 
DNA transiently appeared at approximate levels of 100 vge/~g total DNA in two 
sequential liver biopsies, one collected at 17 w.p.p.i. and the second at 6 week 
after first challenge with WHV (Figure 6.2). This intermittent detection of WHV 
genome was not accompanied by liver injury, as confirmed by histology 
examination and by normal SOH levels. Further, there was an unexplained 
appearance of mild liver inflammation in 6/M at 44 w.p.p.i. that protracted until 
autopsy, but was not accompanied by elevated SDH levels. As mentioned 
above, this inflammation also did not coincide with detection of WHV DNA in the 
liver (Figure 6.2). 
As it has been previously observed in either naturally acquired or 
experimentally induced POl, the challenge with high doses of WHV initiated 
serum WHsAg-positive infection and hepatitis (Coffin and Michalak, 1999; 
Michalak el a/., 2004) . Similarly, all animals with POl which were challenged with 
high dose of WHV in the current study, i.e., 9/M (subgroup LLLH) , 10/F and 12/M 
(subgroup LH) and 11/M (subgroup LHN) (Figure 6.2), developed WHs 
antigenemia and became anti-WHc reactive, as well as demonstrated transiently 
elevated levels of serum SDH. In 9/M, 1 0/F and 12/M, WHsAg eventually 
vanished , while it persisted to the end of the observation period in 11/M, i.e. , up 
to 104 weeks after administration of high virus dose (Figure 6.2) . This animal 
developed chronic hepatitis and finally HCC. After challenge of animals with POl 
with a high dose of WHV, the liver tissue biopsies demonstrated histological 
244 
features of hepatitis, except for the sample from 11/M obtained at 6 weeks post-
challenge with high WHV dose where only minimal inflammatory alterations were 
found (Figure 6.2). The same liver samples also became WHV DNA reactive 
and the livers of these animals remained virus genome positive until the autopsy. 
In summary, woodchucks infected, challenged or rechallenged with 50 vge of 
otherwise pathogenic WHV acquired sustained, serologically, biochemically and 
histologically silent but molecularly evident POl. Furthermore, the animals were 
not protected from infection with high dose of the same virus and acquired acute 
hepatitis, as we have previously reported (Coffin and Michalak, 1999; Michalak et 
al., 2004; Mulrooney et al., 2008). 
6.3.2 POl is accompanied by delayed WHV-specific T cell response 
similarly as in symptomatic WHV infection 
To determine features of WHV-specific T cell proliferative response in the 
course of POl and to compare them with those accompanying serologically 
evident infection associated with hepatitis, sequential PBMC samples were ex 
vivo stimulated with WHV antigens or WHc97_110 peptide and their proliferation 
measured by CFSE-based flow cytometric assay. As illustrated in Figure 6.3A 
for 1/F and 6/M infected with 1.1 x 1 O" vge and 50 vge of WHV, respectively, 
both virus doses induced strong, multispecific T cell proliferative response of 
comparable magnitudes between 8-15 w.p.p.i., which persisted at lower levels to 
the end of follow-up or until challenge with WHV. In animal 6/M, which was 
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Figure 6.3 The kinetics of WHY-specific T cell proliferative responses in 
woodchucks infected with liver pathogenic and nonpathogenic doses of WHV. 
The animals were infected with WHV, serial PBMC samples were isolated , 
stimulated in vitro with four different WHV antigens or WHc97_110 peptide, and 
analyzed for resultant proliferation using CFSE-based proliferation assay to 
define cell division index (C .D.I.) . The dashed vertica l lines and solid arrow 
heads show the time points at which animals were injected or challenged with 
WHV, while the dashed horizontal line represents the cutoff value for virus-
specific positive T cell response . The duration of POl induced in woodchucks 
belonging to study Group B is shown with hatched background. (A) 
Representative profiles of WHY-specific T cell proliferative response in 1 /F 
infected with high, liver pathogenic dose (1 .1 x 1010 vge) and in 6/M inoculated 
with low, liver nonpathogenic dose (5 x 1 O' vge) of WHV after stimulation with 
rWHc, rWHe, rWHx, WHc97.,0 peptide or WHsAg, as determined by CFSE 
assay. The results are represented as C.D.I. The highest C.D.I. va lue given by 
any of the WHV antigens tested or WHc97_1, 0 peptide at a given time point was 
considered as a measure of WHV-specific T cell response and is marked by 
open squares and represented as solid grey shaded area. (B) The profiles of 
WHV-specific T ce ll response identified in individual animals infected with high or 
medium dose of WHV (Group A) or with low WHV dose (Group B) . The PBMC 
collected from these animals were stimulated with rWHc, rWHe, rWHx, WHc97_110 
peptide or WHsAg and the highest C.D.I. value given by any of these antigens for 
each time point is represented as WHV-specific T cell response, as explained 
above. 
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challenged with 50 vge at 55 w.p.p.i. , the augmented T cell proliferation in 
response to WHV antigens reemerged between 59 to 62 w.p.p.i. (Figure 6.3A). 
In animals infected with high or medium WHV dose (Figure 6.3B, Group 
A), a strong WHV-specific T cell response appeared around 8-15 w.p .p.i and 
remained detectable, although at much lower levels up to the end of the 
observation period , as in woodchucks 1/F and 3/F, or until challenge with WHV, 
as in animals 2/M (subgroup HL) and 4/M (subgroup MM). It is of note that the 
challenge of 2/M with 50 vge did not induce any significant increase in the 
magnitude of WHV-specific response , while challenge of 4/M with another 
medium dose (1 .1 x 10' vge) again caused strong, but delayed secondary T cell 
response directed against virus antigens (Figure 6.3B). These findings were 
closely compatible with those recently reported for woodchucks infected and 
challenged with large, liver pathogenic doses of WHV (Gujar et al., 2008). 
The PBMC samples obtained from animals inoculated with 50 vge of WHV 
which established POl displayed overall similar profiles of virus-specific T cell 
response as those encountered in woodchucks injected with high or medium 
doses of the inoculum. Thus, all animals infected with low virus dose (Figure 
6.3B, Group B) responded by generating WHV-specific lymphocyte proliferative 
reactivity of comparable magnitudes as those observed in the animals infected 
with liver pathogenic doses between 8-15 w.p.p.i. Further, the challenge or re-
challenge of the woodchucks with POl with a low dose of WHV, i.e., 6/M 
(subgroups LNL), 7/M (subgroup LLL), 8/M (subgroup LLN ) and 9/M before 
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challenge with high dose (subgroup LLLH), induced similar profiles of WHV-
specific T cell responsiveness as in animals injected and then challenged with 
high or medium doses which peaked between 6-12 weeks after each exposure to 
virus. In the above animals with POl , including 5/M (subgroup LNN), the virus-
specific reactivity was intermittently detectable throughout the entire observation 
period. Furthermore, the profiles of virus-specific T cell response found in 
woodchucks infected in the first instance with low dose and than challenged with 
high dose, i.e., 9/M (subgroup LLLH), 10/F and 12/M (subgroup LH) and 11/M 
(subgroup LHN), were again similar to those observed during primary infection 
induced by high, medium or low dose of WHV and than challenged with virus. 
Taken together, the results clearly showed that both primary and secondary 
virus-specific T cell proliferative responses in POl are strong and multispecific 
despite the lack of serological evidence of infection and biochemical and 
histologcial signs of hepatitis, and that their kinetics closely follow those occurring 
after infection with much greater (-105 or 10 10-fold) doses of the virus. 
6.3.3 Heightened T cell proliferation in response to mitogenic stimuli 
follows inoculation with WHV independently of virus dose administered 
Following our previous findings that WHV invasion is almost immediately 
followed by augmented generalized, nonspecific but not by virus-specific T 
lymphocyte proliferation response (Gujar eta/., 2008), PBMC collected during 
POl and control symptomatic WHV infection were cultured in the presence of 
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two-fold serial dilutions of ConA, PHA or PWM and assessed for their ability to 
proliferate in an adenine incorporation assay. As shown in Figure 6.4A for 
animals 1/F and 6/M, both high and low doses of WHV induced heightened T cell 
proliferation after stimulation with all mitogens tested between 1 and 3 w.p.p.i. 
This increased responsiveness subsided after 4~6 w.p.p.i ., at the time when 
virus-specific T cell response appeared , and then rebounded when virus-specific 
response subsided . A similar pattern of mitogen-induced lymphocyte 
proliferation was also observed after re-exposu re of woodchucks with POl to low 
dose of WHV (see 6/M in Figure 6.4A). Since the kinetics of proliferative 
response following ConA, PHA and PWM stimulation were comparable with each 
other (Figure 6.4A), only ConA-induced profiles are shown for other animals in 
Figure 6.48. 
As shown in Figure 6.48 and previously reported (Gujar el a/., 2008), 
P8MC collected from animals after injection with high (1/F and 2/M) or medium 
(3/F and 4/M) WHV dose displayed heightened capacity to proliferate in 
response to mitogenic stimuli between 1 and 3 w.p.p.i. This proliferative 
reactivity subsided between 4-6 w.p.p.i. when virus-specific T cell response 
appeared and then rose again when the specific response declined. Further, 
challenge of 4/M infected with medium dose with another medium dose of the 
same inoculum induced a similar profile ofT cell proliferative response as that 
observed after primary exposure to WHV (Figure 6.48, Group A). Interestingly, 
infection with a low, liver nonpathogenic dose of WHV also induced immediate 
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Figure 6.4 The comparative kinetics of mitogen-induced (virus nonspecific) and 
WHV-specific T cell proliferative responses in woodchucks infected with high 
(liver pathogenic) and low (liver nonpathogenic) doses of WHV. Freshly isolated 
PBMC were stimulated with two-fold serial dilutions of ConA, PHA and PWM, 
and resultant proliferation was measured by adenine incorporation proliferation 
assay to determine stimulation index (S.I.) for each concentration of mitogens 
tested. The S.l. values obtained for the five serial concentrations of respective 
mitogen were averaged to define mean mitogenic stimulation index (M.M.S.I.) 
which are presented by continued black lines. The dashed vertical lines and 
solid arrow heads show the time points at which animals were injected or 
challenged with WHV, while the dashed horizontal line represents the cutoff 
value for virus-specific positive T cell response. The profile of WHV-specific T 
cell response for each animal is shown with a shaded area under grey line and 
the duration of POl is shown with hatched background. The C.D.I. values for 
WHV-specific T cell response and M.M.S.I. values after mitogenic stimulation are 
shown on left and right axes, respectively. (A) Representative profiles of 
lymphocyte proliferative responses induced by ConA, PHA and PWM and WHV-
specific T cell response in 1/F infected with liver pathogenic (1.1 x 10" vge) dose 
and in 6/M inoculated with liver nonpathogenic (5 x 10' vge) dose ofWHVafter 
stimulation with different mitogens, as explained above. (B) The comparative 
profiles of ConA-induced and WHV-specific lymphocyte proliferative responses in 
individual woodchucks infected with high or medium dose of WHV (Group A) or 
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with low WHV dose (Group B) . 
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augmentation in lymphocyte proliferation in response to nonspecific stimuli which 
declined when virus-specific T cell reactivity appeared, and subsequently 
increased again when specific response declined (Figure 6.4B, Group B). A 
similar transiently augmented mitogen-induced lymphocyte responsiveness was 
detected immediately after each challenge or re-challenge of the animals with 
POl with either low or high dose of WHV. Taken together, the results showed 
that WHV invasion leading to establishment of either POl or serologically evident 
in fection accompanied by hepatitis coincides with the highly compatible profiles 
of generalized as well as virus-specific T cell proliferative responses . 
6.3.4 Induction of POl and subsequent challenge with WHV are 
accompanied by aberrant expression of cytokines in peripheral lymphoid 
cells 
Freshly isolated , unmanipulated PBMC (i.e., not subjected to ex vivo 
stimulation with either mitogens or WHV-specific antigens) collected from 
woodchucks after infection with a low dose of WHV and subsequent challenge 
with either a high or low dose of the same virus were quantified for the 
expression of selected cytokines by real time RT-PCR. Considering the 
opposing profiles of WHV-specific and mitogen-induced lymphocyte responses 
observed in this study and taking under consideration previous findings in 
woodchucks infected and challenged with high (;::1.1 x 10" vge) doses of WHV 
(Gujar eta/. , 2008) , the progression of POl was divided into four phases: (1) the 
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phase before infection (phase A); (2) the phase between 1 and 3 w.p.p.i. 
characterized by the heightened mitogen-inducible T cell proliferative reactivity 
and essentially absent virus-specific T cell response (phase B); (3) the phase 
between 4 and 6 w.p.p.i. accompanied by decreasing nonspecific and 
undetectable virus-specific T cell proliferative responses (phase C), and (4) the 
phase between 7 and 15 w.p.p.i. with essentially absent nonspecific T cell 
proliferative reactivity and arising and then peaking virus-specific T cell response 
(phase D). Similarly, because of the overall opposing kinetics of the specific and 
nonspecific T cell responses identified after challenge of animals with POl with 
WHV, the observation period after the challenge was also divided into phases B 
to D (see Figure 6.5). 
As shown in the top panel of Figure 6.5, the inoculation with a low, liver 
nonpathogenic dose of WHV induced significantly higher expression of IFN-a (P 
= 0.0092), IL-12 (P = 0.0089), IL-2 (P = 0.005) along with elevated transcription 
of IFN-v (P = 0.0196) and IL-4 (P = 0.0358) during phase B, as compared to the 
expression levels before infection (phase A) . Thus, increased mRNA levels of 
these genes were detected in intact PBMC at the time when these cells 
displayed heightened proliferation in response to mitogenic but not to virus-
specific stimuli (see Figure 6.4). Subsequently, during phase C, wherein the 
mitogen-induced T cell proliferative responsiveness subsided, the expression of 
the cytokines mentioned above, except IFN-y and IL-4, significantly decreased. 
Most interestingly, the level of transcription of TN F-a , which remained at 
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Figure 6.5 A quantitative analysis of cytokine gene expression in circulating 
lymphoid cells in animals during different phases of WHV POl and their 
subsequent challenge with either low (liver nonpathogenic) or high (liver 
pathogenic) dose of WHV. The expression of IFN-a , TN F-a , IL-12, IL-2, IFN-y, 
IL-4, and IL-10 was analyzed in freshly isolated PBMC collected from animals 
with POl (n=6) and later after challenge with either low (subgroup LL; n=3) or 
high (subgroup LH ; n=3) dose of the virus. After each primary or subsequent 
exposure to WHV, the time line of infection was divided into four phases 
according to the distinct profiles of WHV-specific and mitogen-induced T cell 
responses, as described in Results. The expression levels of each cytokine were 
normalized against ~-actin and then compared with those observed prior to 
primary infection with WHV (Phase A) to calculate fold increase or decrease. 
The P values above each bar represented by asterisks were obtained by 
comparing the mean expression level of a given gene during phase 8 , C or 0 
with the mean expression determined for this gene in phase A, while the P 
values showed at the top of each panel were obtained by comparing with each 
other the mean expression level of a given gene determined for phases B, C and 
D. Differences marked with one asterisk were significant at a P value of _::0.05 , 
with two at a P value of :o0.005, and with three at a P value of :00.0001. 
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Figure 6.5 
approximately the same level in phases A and B, significantly (P = 0.021) 
declined in phase C (Figure 6.5, top panel). Finally, the expression of IFN-a, 
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TN F-a, IL-12, IL-2 and IFN-y, but not that of IL-4 and IL-10, was synchronously 
upregulated during phase 0 , coinciding with the appearance and peaking of 
WHV-specific T cell response. Following challenge of the animals with POl with 
low dose (i.e., 50 vge) of WHV (Figure 6.5, middle panel), overall similar patterns 
of the cytokines' expression were detected during phases B to 0 as those 
identified after primary injection with the same low dose, although the differences 
in transcription levels between different phases were less pronounced for some 
cytokines after challenge. 
When the woodchucks with POl were challenged with high dose (i.e., 1.1 
x 1 O" vge) of WHV (Figure 6.5, bottom panel), the expression of IF N-o (P = 
0.0167), IL-12 (P = 0.0296) and IL-2 (P = 0.0051) was again elevated during 
phase B, but then subsided in phase C, while transcription of TN F-a remained 
unchanged until phase D. Similarly, during phase D, which corresponded to 
serum WHsAg-positive infection accompanied by histologically evident hepatitis 
(see Figure 6.2, Group B) and the peaking of WHV-specific T cell response, the 
expression of TN F-a (P = 0.001) and IFN-y (P = 0.0063) became significantly 
augmented (Figure 6.5, bottom panel). Overall, the fold increases in the mRNA 
levels of the cytokines were much greater than those detected in phase 0 of POl 
(Figure 6.5, bottom panel) or in animals with POl which were challenged with low 
virus dose (see Figure 6.5, middle panel). After challenge with high dose, the 
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synchronously upregulated expression of IFN-a , TN F-a, IL-12, IL-2, and IFN-y 
was also accompanied by the significantly greater levels of transcription of IL-4 
(P = 0.009) and IL-10 (P = 0.0097) than those accompanying phaseD after 
primary infection or challenge with low dose of virus (see Figure 6 .5 top panel 
and middle panels, respectively). Collectively, the quantitative analysis of the 
cytokine expression in circulating lymphoid cells serially acquired during POl 
revealed that the infection with low, liver nonpathogenic dose of hepadnavirus 
not only almost immediately enhanced T cell responsiveness to mitogenic stimuli 
but also upregulated transcription of a number of functionally important cytokines 
in unmanipulated cells. Although , as in serologically evident infection caused by 
liver pathogenic doses of the virus (Gujar el a/., 2008) , POl did not induce TN F-a 
expression in circulating lymphoid cells that is known to be essential for the 
activation of APC and NK cells. 
6.3.5 Hepatic expression of IFN-a but not tFN-y or TN F-a is upregulated 
during POl 
The liver biopsies obtained at 6 and 18 w.p.p.i. following primary injection 
with low dose and after challenge of the animals with POl with either low or high 
dose of WHV or after control injection with PBS, which were collected at 7 and 
24 weeks post-challenge (w.p.c.), were evaluated for the expression of IFN-a, 
TN F-a, IFN-y, IL-4 and CD3. The results were compared with the transcription 
levels detected for the same genes in the liver samples obtained from the same 
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Figure 6.6 The hepatic expression of selected cytokines and CD3 during POl 
and after challenge with either high or low dose of WHV or injection with PBS. 
The levels of IFN-a , TNF-a , IFN-y, IL-4 and CD3 mRNA were measured by real 
time RT-PCR in liver samples collected during POl (n=B) and after challenge with 
low (subgroup LL; n=3) or high (subgroup LH; n=3) dose of WHV or after control 
injection with PBS (subgroup LN ; n=2). The mean expression level of a 
particular gene during POl or after challenge was normalized against P-actin 
expression and then compared with the mean determined in the liver samples 
collected prior to infection. Differences marked with one asterisk were significant 
at a P value of .:::. 0.05 , with two at a P value of .:::. 0.005 , and with three at a P 
value of s 0.0001 . 
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animals prior to first injection with virus. As shown in Figure 6 .6 , the liver 
samples collected at 7 w.p.p.i. displayed significantly higher mRNA levels of IFN-
a (P = 0.0001), in the absence of significantly elevated TN F-a, IFN-y, IL-4 or CD3 
expression, as compared to the levels detected in the biopsies collected prior to 
infection (Figure 6 .6) . Furthermore, the intrahepatic expression of the genes 
examined , including IFN-a , was not significantly upregulated at 18 w.p.p.i. as well 
as after control injection with PBS , as compared to the levels detected in healthy 
animals prior to injection with WHV. The comparable patterns of cytokine and 
CD3 expression were also observed in the liver biopsies from the animals with 
POl after challenge with low dose of WHV (Figure 6.6). Liver samples collected 
at 24 w.p.c. , but not those obtained at 6 w.p.c. with high dose showed strong 
expression of TN F-a (P = 0.0032) , IFN-y (P = 0.0001) and CD3 (P = 0.0003) , but 
not IFN-a. Collectively, these results showed that POl is associated with 
elevated expression of IFN-a in the absence of TN F-a and IFN-y response and , 
most intriguingly, in the absence of WHV in the liver. 
6.4 DISCUSSION 
In this report , we demonstrated that POl experimentally induced by 
exposure of woodchucks to low, liver nonpathogenic dose of WHV is 
accompanied by: (1) stimulation of anti-viral T cell proliferative response against 
multiple epitopes of structural and non-structural proteins of WHV in the absence 
of virus-specific humoral immunity; (2) induction of a heightened capacity of 
l 
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lymphoid cells to proliferate in response to mitogenic stimuli soon after exposure 
to WHV, similarly as in infection induced by a pathogenic dose of the virus, and 
(3) the aberrant expression in these cells of cytokines mediating early innate 
immune responses. Also , secondary T cell proliferative immune response 
induced in woodchucks with POl by their challenge with either liver 
nonpathogenic or liver pathogenic doses of WHV showed highly comparable 
kinetics to that observed after primary WHV infection. However, this secondary 
response failed to protect animals with POl against development of AH following 
exposure to liver pathogenic dose of the virus. 
Findings from studies on other viral infections, such as with hepatitis C 
virus (HCV) (Quiroga eta/., 2006; Kamal eta/. , 2004 , Koziel eta/. , 1997), human 
immunodeficiency virus (HIV) (Promadej eta/., 2003) and simian 
immunodeficiency virus (SHIV) (Tasca eta/., 2007) , parallel the results from our 
study in regard to the fact that inoculation with a sub-pathogenic quantity of WHV 
induced virus-specific T cell response without stimulating virus-specific antibody 
response. In this context, the sexual partners of patients with acute HCV or HIV 
infections (Langlade-Demoyen eta/., 1994; Kamal eta/., 2004) , individuals 
seronegative for HCV but with a history of a HCV-contaminated needle stick 
injury (Koziel et al , 1997), health care workers with occupational exposure to 
bodily fluids of HIV-infected individuals (Pinto el a/., 1995) or infants born to HIV-
positive mothers (De Maria el a/., 1994), all of whom remain persistently 
seronegative for anti-viral antibodies display multiepitope-specific COB+ CTL and 
268 
CD4+ T cell antiviral proliferative responses. Similarly, in our study, all 8 animals 
exposed to a low virus dose established persistent POl in the face of strong 
WHV-specific T cell proliferative reactivity , without detectable anti-WHc or anti-
WHs antibodies, or liver injury. It has been previously hypothesized that 
following exposure to low doses of hepadnavirus , although T cell response is 
induced , it is sub-optimal and unable to mediate liver injury or protect from 
challenge with a pathogenic dose of the virus (Koziel el af. , 1997, Coffin and 
Michalak, 1999). Further, in woodchucks infected with WHV, a virus-specific T 
cell response during POl was detectable, albeit intermittently and at lower 
magnitudes than that detected after resolution of AH . This suggests protracted 
stimulation of this response, probably by low level WHV replication , as it has 
been observed after recovery from experimental AH in woodchucks (Michalak et 
a/. , 1999) and in patients convalescent from acute HBV infection (Rehermann, et 
a/., 1995). 
The role of virus-specific T cell responses in the pathogenesis and control 
of HBV infection is overall well recognized . It has been shown that strong anti-
viral T cell reactivity directed to multiple epitopes of the virus during the acute 
phase of infection precedes resolution of hepatitis , while a weak and virus 
epitope-restricted response is followed by chronic hepatitis . Nonetheless, 
studies in both humans, ch impanzees and woodchucks have uniformly revealed 
that T cell responsiveness to hepadnavirus is delayed until6-12 w.p.i., as 
compared to the responses observed following invasions with other viral 
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pathogens, such as lymphocytic choriomeningitis virus (LCMV) (Gallimore eta/., 
1998), murine cytomegalovirus (MCMV) (Rentenaar eta/., 2000) or influenza 
virus (Flynn eta/., 1998; reviewed in Rocha and Tranchot, 2006). This delay in 
the appearance of hepadnavirus-specific T cell reactivity was believed to be a 
consequence of the virus' long incubation period or an inappropriate innate 
cytokine microenvironment during the pre-acute phase of infection (Bertoletti and 
Gehring, 2006; Chang and Lewin, 2007). In our most recent study (Gujar el a/. , 
2008), we have shown that this delay in the appearance of virus-specific T cell 
proliferative response in WHV infection is preceded by virus-induced but 
nonspecific, aberrant T cell activation occurring between 1 and 6 w.p.i. , which is 
associated with the impaired expression of cytokines, especially that of TN F-a 
and IFN-y, and followed by apoptotic death of activated cells. In other viral 
infections, the early and synchronous expression of the above cytokines, 
together with IFN-cx, IL-2 and IL-12, initiate the innate responses leading to the 
differentiation and maturation of dendritic cells (DC) to professional APCs, as 
well as to the activation of NK cells to produce IFN-y and acquire cytotoxic 
capacity (Orange and Biron, 1996; Orange and Biron, 1996; Kawai and Akira, 
2006; Kadowaki el a/. , 2000 ). The proper activation of this innate response 
guides the rise of adaptive immunity by stimulating generation of antigen-specific 
T and B lymphocytes (Andoniou el a/. , 2005; Kawai and Akira, 2006; Kadowaki el 
a/. , 2000). On the other hand, APCs and NK cells generated in the absence of 
TNF-cx or IFN-cx have impaired T cell stimulatory capacities and display reduced 
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anti-viral activity (Dauer eta/. , 2003; Iwamoto eta/. , 2007; Mcrae eta/., 2000). 
Thus, similar to our observations made during the period preceding development 
of acute WHV infection (Gujar eta/. , 2008), the data from animals with 
experimentally induced POl suggest that the induction of a strong, nonspecific T 
cell proliferative response and the aberrant expression of innate cytokines soon 
after exposure to a low, nonpathogenic dose of hepadnavirus delays the 
appearance of a virus-specific T cell immune response. It is noteworthy that 
irrespective of the WHV dose, strong T cell proliferation directed against multiple 
antigenic epitopes of the virus occurs only after the synchronous expression of 
IFN-a, TN F-a, IL-12, IFN-y and IL-2 observed from 7 w.p.i. onwards. This 
provides an indirect validation that the initiation of anti-viral T cell response in 
WHV infection has to be accompanied by coordinated expression of appropriate 
cytokines in immune cells. Albeit, the magnitudes of IFN-y and TN F-a 
transcription in the PBMC from animals with POl was significantly lower (P = 
0.024 and P = 0.0075, respectively) than those detected during respective phase 
of acute hepatitis. 
Despite the fact that hepadnavirus core protein is recognized as a strong 
T cell independent antigen (Milich and Mclachlan, 1986), the absence of anti-
WHc antibody responses in the presence of detectable virus-specific T cell 
reactivity after infection with a low dose of WHV, either following primary 
exposure or challenge, is difficult to explain. Nonetheless, similar observations 
have been made in seronegative HCV (Kamal eta/., 2004) and HIV infections 
,-------------------------------------------------------
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(Koziel eta/., 1997). Furthermore , infection with a low dose of LCMV, resulting in 
the inability to detect virus antigens in secondary lymphoid organs, was 
suggested to hamper the development ofT cell-independent antibody response 
(Ochsenbein el a/. , 2000), implying that similarly minute quantities of WHcAg 
might fail to induce specific antibody response in woodchucks with POl. 
Additionally, the initiation ofT cell-dependent B cell activity requires the presence 
of properly activated CD4+ T cells in the context of the appropriate cytokine 
milieu enriched with IL-10 and IL-4 (Hosken eta/., 1995). The analysis of 
expression of cytokines in circulating lymphoid cells obtained during POl in our 
study revealed that after initial exposure to or challenge with low dose of WHV, 
IL-4 and IL-10 expression remain unchanged, even during phase C (see Figure 
6.5), equivalent to acute phase of infection caused by liver pathogenic dose of 
WHV (Gujar el a/., 2008), when expression of IFN-a and TN F-a rebounds. This 
may imply that the absence of anti-WHc response could also stem from the 
inappropriate cytokine milieu. This line of reasoning is indirectly supported by the 
fact that woodchucks with POl challenged with a high dose of WHV, which 
displayed an increased expression of IL-4 and IL-10 in the PBMC during acute 
phase of infection , also showed anti-WHc antibody response. 
The capacity of lymphoid cells to proliferate in response to ex vivo 
stimulation with non-specific mitogens provided valuable insight into the 
generalized immune competency of the cells during infections with a variety of 
microbial pathogens, including HIV (Pedersen el a/., 1990), measles virus 
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(Nieweisk eta/., 2000), MCMV (Allan eta/., 1982), Schistosomajaponica (Garb 
eta/., 1981) and, recently, WHV (Gujar eta/., 2008). Similar evaluations using 
PBMC from patients with CH type B have shown a decreased proliferative 
capacity of lymphocytes after stimulation with mitogens (Sodoman et a/., 1979; 
Feighery el a/., 1980). In our study, irrespective of the quantity of invading virus, 
each primary or secondary exposure to WHV induced immediately a heightened 
capacity of lymphocytes to proliferate in response to mitogen stimulation, which 
eventually declined in magnitude before the virus-specific T cell response 
appeared. This heightened proliferation was also accompanied by the elevated 
transcription of genes encoding IFN-a, IL-1 2 and IL-2 in unmanipulated 
circulating lymphoid cells. The role of IL-2 in T cell and NK cell growth and in 
their survival is well acknowledged and the absence of this cytokine is associated 
with decreased proliferative responsiveness of these cells (Kobayashi et 
a/., 1989; Sciuttoela/., 1995; Murphy eta/., 1992; Seifer eta/., 1993). However, 
5-10% of PBMC is comprised of NK cells, which can undergo blastogenesis and 
incorporate greater amounts of radioactive thymidine in vitro in the presence of 
increased IFN-a expression, as is the case in LCMV and MCMV infections 
(Orange and Biron, 1996; Su el a/., 2001 ; Biron an Welsh, 1982; Biron eta/. , 
1984). Further, NK cells cultured in the presence of both IFN-a and IL-12 
demonstrate greater rates of blastogenesis than those cultured with IFN-a alone, 
and can promote mitogen-induced proliferation of peripheral T cells, probably 
due to their increased ability to produce IL-2 (Orange and Biron, 1996; Su el a/., 
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1994) From this study and from the data on the mitogen-induced lymphocyte 
hyper-responsiveness and concurrent cytokine expression observed immediately 
after exposure to WHV, it could be inferred that the elevated expression of 
cytokines is behind the early, heightened proliferative capacity ofT cells in our 
study. 
Although the appearance and the magnitude ofT cell responses during 
POl are similar to those observed during symptomatic WHV infection , these 
responses do not protect against hepatitis after challenge with large amounts of 
the virus. It has been postulated that the phenotypic heterogeneity of the cells 
mediating cellular and humoral immune responses can be dictated by the dose 
of antigen , with small doses usually favoring the development of cellular immune 
responses (Hosken el a/., 1995; Zannetti eta/., 2006). It also is believed that the 
control of HBV infection is primarily mediated by virus-specific CD8+ T cells 
(Chisari , 2000; Bertoletti and Gehring , 2006), while the contribution of CD4+ T 
cell response in this regard is not as well defined. It is of note that in other 
studies it has been shown that CD4+ T cell responses generated during vesicular 
stomatitis virus infection induced by low doses tend to inhibit the virus-specific 
CDS+ T cell response (Case eta/., 2006). This may suggest that infection with 
low dose of WHV could induce a defective CDS+ T cell response incapable of 
protecting the host against challenge with liver pathogenic doses of WHV. 
Nonetheless, patients who recovered from AH type 8 and those immunized with 
HBsAg vaccine are protected from development of hepatitis after re-exposure to 
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HBV, indicating the important role of anti-HBs. As we have established before 
(Michalak el a/., 2004; Coffin and Michalak, 1999) and confirmed in the course of 
the current study, woodchucks infected with low doses of WHV do not develop 
detectable anti-WHs or anti-WHc. Taken together, this implies that not only 
improper activation ofT cell responses but also the absence of neutralizing 
antibodies could fail to render protective immunity in POL 
The analysis of the cytokine gene expression in liver biopsy samples 
collected during POl and after challenge with a low dose of WHV showed that at 
6-7 w.p.i. the transcription of IFN-a , but not IFN-y or TN F-a, was significantly 
increased. The evidence of IFN-a expression in the liver, along with the absence 
of lymphocytic infiltrations, as evidenced by histological examination at multiple 
time points after primary infection or challenge with low WHV dose, indicates that 
the invasion with such a dose, although unable to prompt immunological 
responses leading to hepatic injury, was not entirely immunologically 
inconsequential (neutral) to the liver. Further, elevated transcription of this 
important cytokine in the context of the absence of detectable WHV replication 
and immune cell infiltrations suggests that the event might be due to activation of 
the cells constitutively residing within the liver or circulating throughout the organ 
after encounter with small quantities of virus. The mechanism of this activation 
and phenotype of the cells involved will require further investigations. The 
absence of intrahepatic expression of IFN-y and TN F-a (see Figure 6.6), as well 
as CD3 (data not shown), at 7 and 18 w.p.i. and following challenge with low 
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dose of WHV is consistent with the protracted absence of hepadnaviral 
replication in the liver during POl , as observed in the current study (see Figure 
6.1) and also reported previously (Coffin and Michalak, 1999; Michalak eta/. , 
2004; reviewed in Michalak eta/., 2007). On the other hand, serologically 
evident infection induced by high, liver pathogenic doses of WHV (Michalak et 
a/., 1999; Michalak et a/. , 2004; Gujar eta/. , 2008; Guy eta/. , 2008) as well as by 
chal lenge of animals with POl with similar high doses (Coffin and Michalak, 1999; 
Michalak eta/., 2004) has been shown to be associated with a significantly 
greater expression of IFN-y, TNF-a and CD3, indicating the successful 
generation and recruitment of virus-specific COB+ CTL and CD4+ Th1 cells to 
the liver. Taken together, the analysis of gene expression in the hepatic tissue 
samples performed in our study implies that a low dose of WHV, although it does 
not initiate infection, induces, by as yet unknown mechanism, a type I interferon 
response in the liver 
Our study demonstrates that a low dose of hepadnavirus, causing an 
asymptomatic infection progressing in the absence of liver infection and virus-
specific humoral immune response, induces multispecific anti-viral T cell 
proliferative responses which kinetics are compatible to those accompanying 
symptomatic infection coinciding with acute hepatitis. Although these virus-
specific T cell responses do not protect against hepatitis after challenge with 
higher doses of the same virus, they represent a reliable immunological correlate 
of the initiation and progression of occult infection. Similar to our observations, a 
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recently published study has demonstrated that patients with HBV OBI 
progressing in the absence of virus-specific antibodies carry circulating HBV-
specific CDS+ T cells, as visualized by staining with class I major 
histocompatibility complex tetramers (Zerbini eta/. , 2008). The assessment of 
this cellular response can aid the diagnosis of low dose HBV infection in high risk 
groups, such as health care workers experiencing contaminated needle stick 
injuries, family members of infected individuals or intravenous drug users, which 
otherwise could be underestimated due to the lack of virus-specific antibody 
responses and the sensitivity of HBV DNA detection assays. Comparative 
analysis of virus-specific and mitogen-induced T cell proliferative capacities along 
with cytokine responses during POl and symptomatic infection caused by liver 
pathogenic doses of hepadnavirus increases our understanding of immunological 
processes underlying the pathogenesis of HBV infection. 
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CHAPTER 7: SUMMARY AND FUTURE DIRECTIONS 
7.1 SUMMARY 
The overall aim of the present study was to investigate the kinetics of 
cellular and cytokine immune responses following experimental hepadnaviral 
infection and after re-exposure to the same virus. Specifically, this study was 
primarily designed : (1) to recognize and understand the reasons behind the 
delayed appearance of virus-specific T cell response normally observed after 
exposure to hepadnavirus, (2) to determine the profiles of virus-specific and non-
specific T cell proliferative as well as cytokine responses occurring after exposure 
and re-exposure to a liver nonpathogenic dose of WHV inducing persistent occult 
infection and , (3) compare those profiles to those induced by a liver pathogenic 
dose causing serologically evident infection and hepatitis. To aid these 
investigations in the woodchuck model, the initial studies were designed to 
develop a CFSE-based flow cytometric T lymphocyte proliferation assay for the 
detection of virus-specific T cell reactivity with a greater sensitivity than that of the 
traditional T cell proliferation assays based on incorporation of nucleotide 
analogues . This CFSE-based T cell proliferation assay was further implemented 
to assess the kinetics of WHV-specific proliferative reactivities in freshly isolated 
PBMC samples serially collected beginning from inoculation with WHV, through 
the pre-acute and acute phases of infection , to seemingly complete recovery. In 
parallel , the lymphocytes ' general capacity to proliferate in response to mitogenic 
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stimulation and the expression of genes encoding for important antiviral and pro-
inflammatory cytokines and immune cell markers were investigated. Further, 
similar investigations were performed in woodchucks inoculated with a liver 
nonpathogenic dose of WHV which developed POl, as well as after challenge of 
these animals with large (liver pathogenic) or low (liver nonpathogenic) doses of 
WHV. Taken together, the data from our studies indicated that the exposure or 
re-exposure to hepadnavirus, independent of its dose, induced delayed 
appearance of virus-specific T cell response, which was preceded by the 
aberrant activation of lymphocytes following invasion by the virus. 
Before the development of the CFSE-based assay during this study, the 
kinetics of WHV-specific T cell responses in woodchucks were evaluated using 
adenine or 5-bromo-2-deoxyuridine (BrDU) incorporation T cell proliferation 
assays. Although, the lower sensitivity of these traditional proliferation assays 
was able to detect strong WHV-specific T cell proliferative responses, the 
detection of low magntitude responses required the development of the more 
sensitive assay. The implementation of a flow cytometric CFSE assay to assess 
the WHV-specific T cell responses enabled more accurate detection of antigen-
specific proliferative reactivities during early pre-acute, AH, resolved and CH 
phases of WHV infection, which otherwise, in some cases, would have been 
deemed as not detectable. The data collected during this study clearly 
demonstrated that the CFSE-based lymphocyte proliferation assay is more 
sensitive than the traditional nucleotide incorporation T cell assays and, thus, 
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more efficient in detecting the virus-specific T cell reactivities, such as those 
observed in woodchucks with CH (see Figure 3.7). Nonetheless, the data 
obtained using the CFSE-based assay also confirmed some of the basic 
observations made before using a traditional T cell proliferation assay, regarding 
the kinetics and strength of virus-specific T cell responses accompanying 
symptomatic hepadnaviral infection. Among others, it concurred with the 
previously acknowledged fact that the magnitude of hepadnavirus-specific T cell 
proliferative response is significantly higher during self-limiting AH that later 
resolves, than those accompanying CH. 
The availability of the more sensitive CFSE-based assay further aided in 
the determination of the precise kinetics of WHV-specific T cell proliferation 
responses during primary as well as secondary exposures to either high, medium 
or low doses of WHV. First, the serial PBMC samples collected from the 
woodchucks infected with a liver-pathogenic dose of WHV showed that the 
appearance of consistently detectable WHV-specific T cell proliferative 
reactivities was delayed until after 7 w.p.i. (see Figures 5.2 and 5.5). The finding 
of the delayed appearance of virus-specific T cell response was consistent with 
that reported by others in the woodchuck model (Menne et a/. , 1997; 1998) and, 
those found in humans during the natural HBV infection of humans (Webster et 
a/., 2000; Bertoletti and Gehring, 2006). Thus, our study supports the notion that 
the late arise of the virus-specific T cell proliferative response is a hallmark of the 
cellular immune response accompanying hepadnaviral infections. 
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Interestingly, the postponement of the WHV-specific T cell proliferative 
reactivities was always preceded by the heightened capability of lymphocytes to 
proliferate after mitogenic stimulation. Similar types of heightened mitogen-
induced proliferative capacities of human PBMC were also seen early after HBV 
infection (Sod oman eta/., 1978). This elevated proliferative capability in 
lymphocytes was equally evident after stimulation with ConA, PHA as well as 
PWM, indicating that this response was not due to activation of a particular 
or sub-type of lymphocytes. These results implied that the exposure to 
hepadnavirus either directly renders the lymphocytes with an ability to undergo 
increased cell division, or indirectly orchestrates the lymphoid environment so as 
to sustain the higher rates of proliferation, after mitogenic stimulations. The 
implication of this heightened capability of lymphocytes to undergo rapid cell 
division is not completely understood yet. It is speculated that such an aberrant 
activation of lymphocytes immediately after exposure to hepadnavirus may 
render them temporarily insensitive to virus-specific activation . In consequence , 
this early plasticity of lymphocytes immediately after exposure to hepadnavirus 
could translate in the failure of prompt development of virus-specific T cell 
response. 
Since, the proliferative capacity of the lymphocytes in response to either 
antigen-specifc or non-specific stimuli is profoundly influenced by the milieu of 
cytokines as well as constituent cells surrounding it, unmanipulated PBMC were 
also analyzed for their inherent expression of selected cytokines along with 
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immune cell markers, to recognize the mechanism underlying the discordant 
profiles of heightened mitogen-induced and delayed virus-specific T cell 
proliferative responses. The quantitative analysis of the cytokine and cell marker 
gene expression suggested that WHV- or non-specific proliferative capacities of 
lymphocytes found during different phases of WHV infection could be associated 
with a distinct expression of cytokines. First of all, our results showed that 
immediately after exposure to WHV, the heightened mitogen-induced 
proliferative capacities in the lymphocytes were accompanied by upregulated 
expression of IFN-a, IL-12 and IL-2 in the absence of increased TNF-a 
expression. IFN-a and IL-12 induce the blastogenesis and increased thymidine 
incorporation in NK cells (Orange eta/., 1996), while IL-2 is a potent T cell growth 
factor that drives and sustains T cell division. Hence, it is postulated that the 
higher expression of these cytokines immediately after exposure to virus may 
endow the higher proliferative capacities to peripheral T and NK cells, which are 
then evidenced in vitro by higher rates of proliferation after mitogenic stimulation. 
This line of reasoning is supported by the fact that the PBMC collected from 
HBV-infected patients show increased NK cell frequency during the pre-acute 
phase of infection (Webster eta/. , 2000). Similarly, mice infected with MCMV 
display increased blastogenesis of NK cells in vivo that can be inhibited by anti-
IFN-a/~ antibodies (Orange el a/. , 1996), suggesting the role of IFN-a in driving 
the expansion of NK cells. Further, NK cells constitute 5-1 0% of PBMC and are 
known to undergo proliferation after mitogenic stimulation and enhance by-
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stander proliferation ofT lymphocytes, most probably through their ability to 
secrete IL-2 (Callewaert eta/., 1978). Our data appears to complement these 
findings by showing higher CD3 and CD56 expression in the PBMC population 
immediately after W HV infection. Taken together, our results suggest that, the 
higher capacity of lymphocytes to undergo proliferation after mitogenic-
stimulation during the pre-acute phase coincides with increased expression of 
pro-growth cytokines, such as IFN-a, IL-12 and IL-2 . 
Interestingly, the non-specific proliferative capability of PBMC eventually 
subsided during the early-acute phase of hepatitis (4-6 w.p.i., see Figure 5.5) and 
was accompanied by the reduced expression of pro-growth cytokines mentioned 
above. The lymphocytes collected during this phase of WHV infection also 
displayed elevated expression of IL-10, shown by others to adversely influence 
mitogen-induced proliferation of lymphocytes from HIV-infected individuals 
(Cierici eta/., 1994). Thus, the absence of IL-2 and IFN-a/IL-12, essential for 
sustaining lymphocyte growth , in the presence of IL-10, could halt the enhanced 
proliferative capacities in these cells, as evidenced by lower adenine 
incorporation and higher rates of apoptosis in woodchuck PBMC during this 
phase of WHV infection (see Figure 5.6). Further, these non-specific proliferative 
capacities of the woodchuck lymphocytes further rebound during acute phase, 
albeit at lower magnitudes than those observed during the pre-acute phase of 
infection. During this phase, the increased expression of IL-2, IL-12 and IFN-a 
reappears along with IFN-y and TN F-a . It is well-known that IFN-y has a 
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potential to impair the proliferation ofT lymphocytes, while TN F-a can decrease 
IF N-o-driven blastogenesis of NK cells (Orange et at. , 1996). This type of 
cytokine milieu during the acute phase of hepadnaviral infection could ensure 
sub-optimal levels of non-specific proliferative capacities in PBMC, despite the 
presence of IL-2, IFN-a and IL-12 and, most probably owing to the strong 
expression of IFN-y and TNF-a (Figure 7.1). 
Considering the lack of information on the early events of innate immunity 
that precede or accompany the initiation of anti-hepadnavirus adaptive immune 
response, we also investigated the connection between the gene expression 
profile of cytokines and cell surface markers in PBMC and its possible 
contribution in shaping the delayed arise of WHV-specific T cell response. This 
gene expression analysis showed that, immediately after exposure to virus 
PBMC had transiently elevated IFN-a in the complete absence of TN F-a 
upregulation up to 6 w.p.i .. The invasion of host with a viral pathogen is known to 
induce strong expression of type I interferons and TNF~a, which activate NK cells 
and APCs that, subsequently, aid in the initiation of virus~specific T cell response. 
Especially, TNF~a expression triggered by virus infection drives the 
differentiation of immature OCs from its precursors (Res sousa eta/. , 1999, 
Iwamoto et al., 2007). On the contrary, the absence of such a TNF~a expression 
induces improper maturation phenotype and functional impairment in APCs as 
characterized by impaired antigen~specific and aile-stimulatory capacities of 
these cells (Dauer et 
284 
Figure 7.1 A proposed model depicting impaired immune responses occurring 
during hepadnavirus infection. Immediately after exposure to hepadnavirus 
(pre-acute phase) the expression of pro-growth cytokines, e.g., IFN-a, IL-12 and 
IL-2, in peripheral lymphoid cells is increased, which can drive and sustain the 
heightened non-specific proliferative capacities of PBMC observed in vitro after 
stimulation with mitogens. Although, this pre-acute infection fails to induce the 
expression of TN F-a and IFN-y in lymphoid cells, which can possibly lead to the 
inappropriate activation of APCs, and transpires in undetectable virus-specific T 
cell reactivity. This elevated expression of pro-growth cytokines is drastically 
reduced in PBMC during the early-acute phase, that may endow lymphocytes 
with impaired capacity to proliferate and an increased susceptibility to undergo 
apoptosis after either virus-specific or mitogenic stimulation. Finally, during the 
acute phase of infection, lymphocytes synchronously display the augmented 
expression of IFN-a , IL-12, TNF-a, IFN-y, IL-2, IL-4 and IL-10, with a potential to 
initiate antigen-specific immune response and sustain higher proliferative 
capacities of lymphocytes. The decreased or absence of the expression of a 
respective cytokine during different phases of hepadnavirus infection is indicated 
by the grey boxes. 
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al. , 2003, McRae el a/., 2007). DCs cultured in the presence of IFN-a and TN F-
a together, show strong expression of CD80, CD83 and CD86 (Chen el a/., 
1998; Kadowaki el a/., 2000) , similar to those generated after in vitro herpes 
simplex virus (HSV) infection , suggesting the synergistic potential of these two 
cytokines in activating APCs . Similar maturation of DCs initiated after LCMV 
infection can be abolished by the administration of anti-TN F-a antibodies in 
infected mice, suggesting the vital role of TN F-a during the differentiation and 
maturation of DCs (Kadowaki el a/. , 2000). Thus , the prompt expression of TN F-
a after infection is accompanied by proper activation of APCs that is 
subsequently associated with presence or absence of antigen-specific adaptive 
immunity. However, along with IFN-a and TN F-a expression , the initiation of 
effective antiviral immunity also requires synchronous expression of other 
cytokines such as IL-12 , IL-2, IL-4 and IL-10 (Andoniou el a/., 2005). Taken 
together, our data in conjunction with others, suggested that the absence of TN F-
a, coupled with non-synchronous expression of other innate cytokines during 
pre-acute and the early-acute phase of WHV infection (i .e ., up to 6 w.p.L, see 
Figure 5.7) could translate in inappropriate differentiation and activation of DCs, 
which then fails to prime anti-viral adaptive immunity as evidenced by delayed 
appearance of WHV-specific T cell reactivity. Interestingly, DCs isolated from 
healthy individuals and exposed to HBV in vitro have impaired functional 
capacities (Beckebaum el a/., 2003), suggesting the inherent potential of 
hepadnavirus to induce the abnormal immune responses mediated by APCs. 
,----- ----------------------------
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Apart from its immunological role, TN F-a released after pathogen invasion 
also triggers platelet activation and local blood vessel clotting , that restricts the 
local dissemination of virus. Thus , the prompt expression of TN F-a is also 
involved in hampering the pathogen spread by maneuvering the 
microvasculature-tissue barrier. It is believed that the absence of such a host 
immune response immediately after exposure to virus represents another 
possible immune evasion mechanism that may aid in establishing a replication 
niche and consequent hepadnaviral persistence. In the clinica l situation, patients 
exposed to HBV show lack of TN F-a-induced symptoms during the pre-acute 
phase of infection , e.g., fever and nausea (Webster eta/. , 2000 ; Bertoletti and 
Gehring , 2006). This observation is consistent with our finding regarding the 
absence of TN F-a expression in WHV-infected woodchucks immediately after 
exposure to the virus . 
The present study also evaluated whether innate and adaptive immune 
responses are initiated by WHV POl in the woodchucks infected with low, liver-
nonpathogenic doses of virus. Intriguingly, infection of woodchucks with 50 
virions triggered a WHV-specific T cell proliferative response, with the kinetics 
comparable to that observed during symptomatic infection induced by a liver-
pathogenic dose of the same virus. The appearance of this virus-specific T ce ll 
response initiated after low dose infection was again delayed up to 6-10 w.p.i. , as 
measured in the CFSE-based assay. This observation was in agreement with 
the previous findings made during asymptomatic HCV (Q uiroga eta/. , 2006 ; 
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Kamal el a/. , 2004, Koziel el a/. , 1997), HIV (Promadej el a/. , 2003) and SIV 
(Tasca el a/. , 2007) infections, wherein detectable T cell proliferative reactivity 
was observed in the individuals or animals exposed to virus in the absence of 
serological or pathological evidence of respective infections. Thus, the results 
implied that exposure to small quantities of hepadnavirus can induce virus-
specific T cell responses with similar profiles of appearance as those observed 
during symptomatic infection. Nonetheless, the WHV-specific T cell proliferative 
reactivities detected during POl were sustained at higher magnitudes for a 
relatively lesser time period than those observed during symptomatic infection. 
is possible that during POl, the small amount of invading virus and resultant low 
level of antigenic stimuli may result in earlier protraction of the stronger WHV-
specific T cell proliferative reactivities. 
The virus-specific T cell responses observed during WHV POl persisted in 
the absence of any detectable anti-viral antibody responses. Thus, even though 
the magnitude of the anti-viral T cell responses was comparable to that during 
symptomatic infection, the qualitative traits of this response during POl and AH 
could be different. This hypothesis was further supported by the fact that the 
virus-specific T cell responses developed during POl failed to protect the animals 
with established POl against AH after challenge with a liver-pathogenic dose of 
the same virus. This observation was in contrast to an otherwise well established 
fact that the virus-specific T cell responses induced after primary exposure to 
hepadnavirus endows the protection against hepatitis that consequents after 
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challenge with the same virus. Thus , our results suggested that virus-specific T 
cell responses accompanying POl may bear differential qualitative features than 
those accompanying serologically evident hepadnaviral infection. 
Additionally, the woodchucks infected with low doses of WHV also 
displayed similarly discordant profiles of virus-specific and mitogen-induced 
lymphocyte proliferative reactivities in serially collected PBMC. The comparative 
analysis of these responses with those observed during symptomatic WHV 
infection indirectly suggested that such inverse profiles of lymphocyte 
proliferative responsiveness is a hallmark of hepadnavirus infection in general, 
and is independent of the dose of invading virus. Also, this type ofT cell 
proliferative responsiveness after mitogenic or virus-specific stimulation is 
independent of the memory immune response status of the animals , as these 
discordant responses were equally detectable after the challenge of woodchucks 
with POl and those recovered from WHV-induced AH. This type of discordant 
relationship between augmented non-specific and delayed antigen-specific 
lymphocyte proliferative reactivities following exposure or re-exposure to the virus 
seems to be a characteristic immunological feature of contact with hepadnavirus, 
irrespective of virus dose . 
Similar to the kinetics of WHV-specific T cell responses , the gene 
expression profiles of selected innate cytokines in the serial , unmanipulated 
PBMC collected during POl were comparable to those identified during 
symptomatic WHV infection. Our data showed that, immediately after exposure 
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of the woodchucks to low WHV dose, PBMC displayed increased transcription of 
IFN-a , IL-12 and IL-2 (i.e. , between 1-3 w.p.i. ), but not that of TNF-a . The 
elevated expression of these above mentioned cytokines decreased between 4-6 
w.p.i., and then increased 7 w.p.i. onwards , accompanied by slightly elevated 
TNF-a expression. As discussed above for symptomatic infection , such an 
aberrant expression of innate cytokines, especially IFN-a and TN F-a , early after 
exposure to hepadnavirus is also believed to result in the postponement of the 
development of virus-specific T cell response during hepadnaviral POl . Again, 
such an impaired expression of cytokines immediately after exposure to 
hepadnavirus seem to be independent of the dose of invading virus. 
Nonetheless , the profile of cytokine gene expression during POl also displayed 
some inherent discrepancies with that observed during infection with high dose . 
Among others, the expression of TN F-a during POl was quantitatively different 
than that observed during symptomatic infection. This expression of TN F-a in 
PBMC collected during POl was only slightly elevated (mean fold increase 2.0 ± 
0.4) as compared to the robust increase (mean fold increase 18.5 ± 4 .3) detected 
during symptomatic infection. It is speculated that this quantitative difference in 
the TN F-a expression could be associated with the differential potential of virus-
specific T cell response developed during POl , since the animals with POl are 
not protected against AH caused by challenge with high dose of the same virus. 
Further, in contrast to symptomatic infection, PBMC collected during POl did not 
show increased expression of IL-4 and IL-10, which may also contribute to the 
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absence of anti-viral antibody responses. 
Another interesting finding made during WHV POl was the induction of the 
significantly stronger upregulation of the intra-hepatic IFN-a expression, in the 
absence of elevated expression of IFN-y, TN F-a, IL-4 or CD3, after exposure to 
low dose as compared to that observed before infection. Such an induction of 
IFN-a expression in the liver was surprising, considering the fact that after 
incoulation with low dose of WHV, virus detection is restricted to the lymphatic 
system, as previously reported (Michalak el a/., 1999; Michalak el a/., 2004; 
Mulrooney el a/., 2008) as well as observed in this study. The induction of a 
strong IFN-a response in the liver during POl indicates that this innate anti-viral 
cytokine response is in fact initiated , and could be sufficient in protecting 
hepatocytes against the minuscule quantities of invading virus. Further, th is 
elevated intra-hepatic expression of IFN-a was not evident after either infection 
of WHV-naive animals or challenge of animals with POl with a liver pathogenic 
dose of the same virus, supporting the previously proposed hypothesis that 
infection with a liver pathogenic dose of hepadnavirus mediates the impaired 
activation of innate response in the livers of infected animals. It is possible that, 
unlike the innate response in the peripheral lymphoid cells, the intrahepatic 
impairment of IFN-a expression requires the presence of higher loads of virus in 
the liver. 
In conclusion, our study has shown that the exposure to hepadnavirus 
induces aberrant profiles of virus-specific and mitogen-induced T cell, as well as 
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innate cytokine responses , irrespective of the dose of invading virus. This type of 
impaired immune responsiveness may facilitate the establishment of 
hepadnavirus replication early after infection and may aid in the subsequent virus 
persistence. In future , it will be imperative to evaluate whether such an 
impairment of immune responses also occurs during the early phase of natural 
HBV infection with either liver nonpathogenic or pathogenic dose of the virus. 
The understanding of the the mechanisms underlying the kinetics of these 
impaired immune responses should establish a basis for design of prophylactic 
and therapeutic interventions to prevent development of long-term pathological 
consequences of HBV infection, including CH, cirrhosis and HCC. 
7.2 FUTURE DIRECTIONS 
The data obtained during this study has unveiled new aspects of immune 
responses occurring after exposure to hepadnavirus. These novel findings, 
along with availability of newly generated assays and reagents, have prompted 
further investigations on other features of WHV infection in the woodchuck model 
of hepatitis B, such as: 
1. Implementation of biologically active wll-2 for the generation of WHV-specific 
T lymphocyte clones. Since it is known that HBV-specific T cell clones produced 
using lymphocytes from HBV-infected patients can provide valuable insight into 
the functional traits of ongoing virus-specific T cell responses , further studies 
could be aimed at generating WHV antigen-specific T cell clones in vitro. This 
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can be achieved by maintaining long term cultures ofT lymphocytes derived from 
WHV-infected woodchucks in the presence of biologically active rwll-2 and the 
respective WHV antigenic peptide. This approach will be more beneficial in 
obtaining woodchuck T cell clones from intrahepatic lymhocytes (IHLs), 
especially considering the fact that these IHLs are scarcely available for the 
analysis due to the constraint on the size of the liver sample that can be 
harvested during biopsy. 
2. Comparative analysis of proliferative and functional capabilities of virus~ 
specific lymphocytes during different phases of hepadnavirus infection. The 
pertinent functional integrity of the antigen-specific T lymphocyte is defined by 
the ability of these lymphocytes to proliferate, as well as produce cytokines, 
especially IFN-y, after stimulation with their cognate antigen in vitro. The inability 
of the lymphocytes to either proliferate or produce IFN-y during these in vitro 
evaluations reflects an anergy or functional impairment. Our study has revealed 
that serial PBMC samples obtained after exposure to different doses of WHV 
display discordance between WHV-specific proliferation and intracellular IFN-y 
gene expression. This observation raises the possibility that these virus-specific 
T cells may have an anergic phenotype, especially during the early phase of 
infection. Further, current evaluations of IFN-y gene expression in PBMC 
samples do not identify the particular subset of lymphocytes in which this 
elevated expression occurs. To address this issue, PBMC samples collected 
during different phases of WHV infection can be labeled with CFSE, stimulated 
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with WHV antigens ex vivo, stained with newly identified anti-IFN-y antibodies 
(Jenkins and Michalak, personal communication) and then analyzed 
simultaneously for proliferation and intracellular expression of IFN-y. Such a 
comprehensive evaluation of virus-specific lymphocyte response during resolving 
AH or progressing CH will provide further insight into the role of these immune 
responses in determining the outcome of hepadnaviral infection. 
3. Investigation of TN F-a expression immediately after hepadnaviral infection . 
The analysis of cytokine gene expression in the serial PBMC samples revealed 
that the expression of TN F-a is not augmented until later during AH . Since, the 
PBMC samples were usually collected on a weekly basis during this study, the 
first sample available for analysis was obtained at 7 days post-exposure. 
However, IFN-a and TN F-a responses can be triggered very promptly after virus 
invasion. Hence , PBMC samples collected within the first few hours after 
exposure to WHV and on a dai ly basis for 7-1 0 days post-infection should be 
analyzed in future, to verify whether the absence of TN F-a expression was an 
immediate consequence of hepadnaviral infection. Alternatively, the expression 
of TN F-a as well as other cytokines can also be studied under in vitro conditions 
by exposing PBMC collected from WHV-naive woodchucks to different doses of 
WHV. 
4. Inhibition of the postponement of WHV-specific T cell response in 
woodchucks using rwTNF-a . Attempts could be made to over-ride the effecls of 
lhe absence of TN F-a by injecting biologically active rwTNF-a , immediately after 
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experimental exposure to WHV. Of course, utmost care should be taken to 
titrate the dose of rwTNF-a to be administered in order to avoid potential 
development of systemic shock. It can be anticipated that the presence of 
artificially provided rwTNF-a , along with inherently expressed IFN-a and IL-12 
induced by WHV infection , could induce proper activation of APCs resulting in 
the prompt arise of virus-specific T cell response and successive resolution of 
infection. Alternatively, freshly isolated PBMC collected immediately after 
infection can be treated ex vivo with rwTNF-a and transferred back into the same 
animal. The success of this approach in promoting early development of virus-
specific T cell response could translate in an efficient clinical treatment regimen 
preventing development of CH and HCC. 
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APPENDIX A: Complete eDNA sequence of woodchuck interleukin-2 (wll-
2) identified during this study 
LOCUS D0272238 527 bp mRNA linear ROD 20-JUL-2006 
DEFINITION Marmota monax interleukin-2 mRNA, complete cds. 
ACCESSION D0272238 
VERSION D0272238.1 Gl82592680 
KEYWORDS 
SOURCE Marmota monax (woodchuck) 
ORGANISM Marmota monax 
Eukaryota; Metazoa; Chordata; Craniata ; Vertebrata ; Euteleostomi ; 
Mammalia; Eutheria ; Euarchontoglires; Glires; Rodentia ; 
Sciurognathi; Sciuridae; Xerinae; Marmotini; Marmota. 
REFERENCE 1 (bases 1 to 527) 
AUTHORS Gujar,S.A. and Michalak,T.I. 
TITLE Characterization of bioactive recombinant woodchuck interleukin-2 
amplified by RLM-RACE and produced in eukaryotic expression 
system 
JOURNAL Vet. lmmunol. lmmunopathol. 112 (3-4) , 183-198 (2006) 
PUBMED 16631932 
REFERENCE 2 (bases 1 to 527) 
AUTHORS Gujar,SA and Michalak,T.I. 
TITLE Direct Submission 
Submitted (31-0CT-2005) Molecular Virology and Hepatology 
Research , Faculty of Medicine, Memorial University, 300 Prince Philip 
Drive, St. John's, NL A 1 B 3V6, Canada 
1 atcacactct ccaatcacta ctccggtaac cttgactcta ccgccatgca caccatgccg 
61 ctgctgtcct gcctcgcact gacactcgca ctggttgcac acggtgcacc cacctccggc 
121 tctgcagagg agacaaggca gcagctggaa caactgctgc tggacttgca gatgctttcg 
181 agaggtgtca gtaatcaaga gaattccaca cttaccagga tgctgaaatt caaattttac 
241 atgcccatga aggcttctga cctggagcat cttcagtgcc tagaggaaga actcaaacct 
301 ctgcaggaag tgctgaatgt acctcaaagc aaaaactttc acttgaaaga taccaggaac 
361 ttcatcagca acatcaacgt gactgttctg aaactaaagg gatccgccac gacgttcact 
421 tgtgagtacg ccccggagac agcgaacatt gtagaatttc tgaacacatg gatcaccttt 
481 tgccaaagca tcatctcgaa gctcacttga gaattaggtg cctcccg 
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APPENDIX B: Frequently used molecular biology buffers and reagents 
ACK buffer: 0.15 M NH,CI, 1 mM KHC03 , pH 7.3, with 0.1 mM EDTA 
Binding buffer A: 50 mM Sodium Phosphate (pH 8.0) , 300 mM NaCI , 8 M Urea 
Denaturing buffer B : 50 mM Sodium Phosphate (pH 7.0) , 300 mM NaCI, 8 M 
Urea 
Washing buffer C: 50 mM Sodium Phosphate (pH 7.0), 300 mM NaCI , 8 M 
Urea , 7.5 mM Imidazole 
Elution buffer E: 45 mM Sodium Phosphate (pH 7.0) , 8 M Urea, 270 mM NaCI , 
150 mM Imidazole. 
GTE (glucose/Tris/EDTA) : 50 mM glucose, 10 mM EDTA in 10 mM Tris-HCI 
buffer, pH 8.0 
P1 solution : 50 mM Tris I (pH 8.0), 10 mM EDTA, 100 lml RNase A 
P2 solution: 200 mM NaOH, 1% SDS (wlv) 
P3 solution : 3.0 M potassium acetate (pH 5.5) 
QBT buffer: 750 mM NaCI, 50 mM MOPS (pH 7.0), 15% isopropanol (v/v), 
0.15% Triton X-100 (v/v) 
QC buffer: 1.0 M NaCI , 50 mM MOPS, pH 7.0;15% isopropanol (v/v) 
QF buffer: 1.25 M NaCI , 50 mM Tris-HCI (pH 8.5) , 15% isopropanol (v/v) 
Superbroth : 12 g Bacto-tryptone, 24 g Bacto-yeast extract, 4.0 ml gylcerol and 
water to a final volume of 900 ml and autoclave. One liter of superbroth is 
prepared by adding 100 ml of a sterile solution of 0.17 M KH2PO, & 0.72 M 
K,HPO,. 
All reagents were obtained from Sigma Chemical Co. unless othenwise noted. 



